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ABSTRACT: Membrane lipids interact with proteins in a variety of ways, ranging from
providing a stable membrane environment for proteins to being embedded in to detailed
roles in complicated and well-regulated protein functions. Experimental and computa-
tional advances are converging in a rapidly expanding research area of lipid−protein
interactions. Experimentally, the database of high-resolution membrane protein
structures is growing, as are capabilities to identify the complex lipid composition of
diﬀerent membranes, to probe the challenging time and length scales of lipid−protein
interactions, and to link lipid−protein interactions to protein function in a variety of
proteins. Computationally, more accurate membrane models and more powerful
computers now enable a detailed look at lipid−protein interactions and increasing
overlap with experimental observations for validation and joint interpretation of
simulation and experiment. Here we review papers that use computational approaches
to study detailed lipid−protein interactions, together with brief experimental and
physiological contexts, aiming at comprehensive coverage of simulation papers in the
last ﬁve years. Overall, a complex picture of lipid−protein interactions emerges, through a range of mechanisms including
modulation of the physical properties of the lipid environment, detailed chemical interactions between lipids and proteins, and
key functional roles of very speciﬁc lipids binding to well-deﬁned binding sites on proteins. Computationally, despite important
limitations, molecular dynamics simulations with current computer power and theoretical models are now in an excellent
position to answer detailed questions about lipid−protein interactions.
CONTENTS
1. Introduction B
1.1. Lipid−Protein Interactions C
1.2. Characterization of Lipid−Protein Interac-
tions C
1.2.1. Experimental Techniques C
1.2.2. Computer Simulations: Atomistic,
Coarse-Grained, and Continuum Mod-
els D
2. G Protein-Coupled Receptors (GPCRs) F
2.1. GPCR−Lipid Interactions F
2.1.1. Rhodopsin F
2.1.2. Adrenergic Receptors G
2.1.3. Adenosine Receptors H
2.1.4. Serotonin Receptors H
2.1.5. Other GPCRs I
2.2. GPCR Scramblase Activity and Lipid Entry
Events I
2.3. GPCR Oligomerization J
3. Ion Channels L
3.1. Channels with General Voltage-Gated Po-
tassium Channel Pore Architecture L
3.1.1. Lipid Interactions with K+-Selective
Channels L
3.1.2. Tentative Lipid Binding Sites in K2P
Channels M
3.1.3. Speciﬁc Binding of PIP2 As a Modulator
for Channel Function M
3.1.4. Cholesterol and PUFAs-Mediated Regu-
lation of K+ Channels N
3.1.5. Lipid Regulation of Nav Channel Func-
tion P
3.2. Lipid Regulation of Ligand-Gated Channels Q
3.2.1. Lipid Modulation of Cys-Loop Recep-
tors Q
3.2.2. Lipid Modulation of ATP-Gated Chan-
nels Q
3.2.3. TRP Channels R
3.3. Bacterial Mechanosensitive Channels R
4. Respiratory Proteins S
4.1. CL Binding Sites T
4.2. CL Mediated Supercomplex Formation U
5. ATP-Binding Cassette Transporters U
6. Outer Membrane Proteins Y
Special Issue: Biomembrane Structure, Dynamics, and Reactions
Received: July 18, 2018
Review
pubs.acs.org/CRCite This: Chem. Rev. XXXX, XXX, XXX−XXX
© XXXX American Chemical Society A DOI: 10.1021/acs.chemrev.8b00451
Chem. Rev. XXXX, XXX, XXX−XXX
This is an open access article published under a Creative Commons Non-Commercial No
Derivative Works (CC-BY-NC-ND) Attribution License, which permits copying and





















































































6.1. OMPs in Simple Mixtures Y
6.2. OMPs in Complex Mixtures Y
6.3. Beta-Barrel Assembly Machinery AA
7. TMEM16 Protein Family and Other Lipid Trans-
port Proteins AC
8. P-Type ATPases AD
9. ATP Synthases AF
10. Aquaporins AF
11. Receptor Tyrosine Kinases and Cytokine Re-
ceptors AH
12. Integrins and L-Selectin AI
13. SLC Transporters AJ
13.1. MFS Fold (SLC2, SLC15−19, and SLC37
Family of Transporters) AJ
13.2. LeuT Fold (SLC5, SLC6, SLC7, and SLC11−
13 Families) AK
13.3. Other Inverted Repeat Folds (SLC9, SLC10,
and SLC4 Families) AM
13.4. Other Folds AN
14. Viral Proteins AO
14.1. Viral Membrane Structural Stability and
Organization AO
14.2. Viral Membrane Fusion, Assembly, and
Budding AQ
15. C99 and γ-Secretase AR
16. Miscellanea AR
16.1. Glycophorin A AR
16.2. Membrane Fluidity Sensors AS
16.3. Lysosome-Associated Proteins AS
16.4. AcrAB-TolC Eﬄux Pump AS
16.5. EmrE AS
16.6. VDAC AS
16.7. Beta-Barrel Toxin Channels AT
16.8. Tetraspanin AT
16.9. Undecaprenyl Pyrophosphate Phospha-
tase AT
16.10. Photosystem II AT
16.11. Sec Translocon AV
17. Discussion AW











Cell membranes, both enveloping internal organelles and the
entire cell, are essential structural elements in all kingdoms of
life. They are composed of a complex mixture of lipids and
proteins with a lateral structure that has yet to be resolved in
detail and depends on the cell type and the location of the
membrane. Cell membranes enable tight regulation of the ﬂow
of energy, information, nutrients, and metabolites. Although
historically these roles were largely attributed to membrane
proteins, it is becoming increasingly clear that lipid−protein
interactions are essential determinants of membrane-bound
processes.1,2 As a direct consequence, membrane proteins are
important drug targets,3 and a growing body of evidence shows
that the lipid component of membranes is an essential player in
understanding the mechanism of action and targeting of many
drugs.4,5
Cell membranes consist of two leaﬂets of lipids, outer and
inner, arranged in a tail-to-tail manner. Lipids are often
grouped into three main classes: glycerophospholipids,
sphingolipids, and sterols. Several modiﬁcations of the polar
head groups and hydrophobic tails exist, thus increasing the
complexity in lipid diversity to more than a thousand types
identiﬁed in living cells.6−8 The lipid repertoire is diﬀerent
across the three domains of life, with many lipid types that are
unique for archaea, bacteria, or eukaryotes. This variety in
principle allows an almost inﬁnite combination of lipid−
protein interactions and roles varying from basic structural
roles to speciﬁcally switching on and oﬀ proteins in response to
highly controlled signaling events involving lipid modiﬁcations.
Although initially the lipid matrix was largely considered as
the solvent media for membrane proteins and a simple barrier
separating two compartments electrically and chemically, for
instance in the ﬂuid mosaic model,9,10 the potential importance
of lipid−protein interactions was recognized several decades
ago.11,12 Some examples are the early studies on the
modulatory eﬀect of cholesterol on rhodopsin,13−16 impacts
of bilayer composition and ﬂuidity on the kinetics of the
gramicidin assembly and ion transport17,18 or the eﬀect of lipid
thickness in regulating the conformational transitions of the
Ca2+-ATPase19 and many others.12
Detailed atomistic computer simulations of membrane
proteins became feasible in the 1990s, although an extensive
body of important computational work using less-detailed
models by, among others, Mouritsen et al. led to the
development of inﬂuential models for lipid−protein inter-
actions, including the mattress model based on hydrophobic
mismatch.20 An early example of atomistic simulations
addressing similar questions used a set of proteins of diﬀerent
size to investigate the range of membrane perturbations due to
the proteins.21 Signiﬁcant emphasis was also placed on the
connections between experimental data and results of atomistic
simulations probing protein impact on the lipid structuring and
dynamics in the ﬁrst and second coordination shell.22 Over the
past 20 years computer power has increased by at least 4
orders of magnitude, and simulation has become a standard
technique to study aspects of membrane protein biophysics.23
In this review, we attempt to provide a comprehensive
overview of molecular dynamics simulation studies aimed
primarily at some aspect of lipid−protein interactions,
published in the past 5 years. We speciﬁcally exclude studies
of membrane proteins that include lipids but do not investigate
lipid−protein interactions, for instance studies of selectivity
mechanisms in ion channels,24 conformational changes upon
ligand-binding of G-protein coupled receptors,25 or studies
dealing with membrane proteins modulated by (membrane
soluble) compounds such as cofactors, drugs, or phytochem-
icals.26 Coarse-grained (much less detailed than atomistic
models or coarse-grained models that retain chemical
speciﬁcity like Martini; see below) and mean-ﬁeld models
have been used to model protein−protein interactions
mediated through the membrane and large-scale phenomena
such as the remodeling of the membrane by caveolins27 or
BAR domains.28 While these are essential and highly
interesting processes, and the insights from more simpliﬁed
models on fundamental principles of protein−protein inter-
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actions and membrane remodeling are fascinating, they are
outside the scope of this review. We also largely exclude studies
of membrane-active peptides,29,30 peripheral membrane
proteins,31 and small model systems like WALP32 and other
synthetic peptides as well as gramicidin A.33 The universe of
single-span membrane proteins is extremely large,34 but only a
fraction has been modeled and experimental structural biology
on these proteins often excludes the transmembrane part. We
have attempted to include most recent simulation studies in
this area based on biological interest, computational approach,
and available structural information. We include a selection of
experimental studies to provide context for the simulation
studies without any attempt to be comprehensive, as well as a
selection of earlier simulation papers (reviewed for instance in
refs 35 and 36) for illustrative purposes.
First, we discuss some general aspects of lipid−protein
interactions, including experimental and computational
approaches to study these interactions. We then proceed
with individual sections on speciﬁc protein families, in part
organized based on the detail of available studies and in part on
biological classiﬁcation. We conclude with a broader outlook.
1.1. Lipid−Protein Interactions
Lipid−protein interactions fall on a continuum ranging from
very speciﬁc interactions between speciﬁc lipids directly
aﬀecting a selective binding site on a protein to much more
generalized interactions involving changes in the physical
properties of the membrane, which may aﬀect membrane
structure on mesoscopic length scales or properties such as
dimerization of two membrane proteins.
At a more detailed level, interactions between lipids and
proteins can, rather artiﬁcially, be classiﬁed based on
speciﬁcity, on functional eﬀects on proteins, or on eﬀects on
local membrane properties. Examples of these cases are given
below in the detailed review of actual cases of lipid−protein
interactions and summarized in the Discussion. These diﬀerent
cases also relate to strengths and weaknesses of computational
methods in ways that should perhaps be more clearly
recognized in the literature. We highlight two issues that are
important to keep in mind in the interpretation of the detailed
papers below.
First, binding sites for lipids present in various membrane
proteins range from explicit, in the sense that they are visible in
crystal structure or mass-spectrometry (with its own issues), to
much less well-deﬁned like the CRAC, CARC, and CCM
motifs that are thought to be involved in cholesterol binding,
despite large numbers of such motifs that do not bind
cholesterol and large numbers of cholesterol that bind but not
to such motifs.37−39 In principle, these binding sites have a
well-deﬁned binding aﬃnity, but this is rarely reported in
experimental studies or calculated. In MD simulations, a
particular binding event is often characterized in terms of
occupancy of a speciﬁc lipid in a speciﬁc protein site observed
in the trajectory. However, given the length of what is
considered “long” simulations in standards of 2018, occupancy
is a poor statistical metric to discuss binding as it does not
allow quantitative assessment of binding aﬃnity due to
exhaustive sampling challenges. More advanced free energy
calculations could be used to test for a speciﬁc site/lipid
combination what the binding free energy is, the kon rate, and
from those the koff rate. This is rarely done as of yet but
eminently possible and as simpler simulations identify more
interesting candidates we expect this to be a growing use of
simulations. This would also allow testing the eﬀect of
mutations in proteins, analogous to what has been common
in the drug binding ﬁeld for a long time.
Second, many experimental studies characterize lipid−
protein interactions in terms of functional relevance of a
particular lipid, following some kind of activity assay or in ion
channels electrophysiological measurements. Although such
associations have drawn considerable attention in the
literature, this type of data does not cleanly translate to
lipid−protein interactions, generally speaking. Below, we
discuss a number of cases, including a lipid-dependent ABC
transporter, cholesterol eﬀects on GPCRs, and binding of PIP
lipids to potassium channels. Although simulations can identify
interactions between these lipids and proteins, they do not
directly access the functional data from the experiments, which
remains an area for improvements both experimentally and
computationally.
1.2. Characterization of Lipid−Protein Interactions
1.2.1. Experimental Techniques. In the last few decades,
several experimental techniques have been used to answer
questions related to the identiﬁcation of lipid binding sites on
the protein surface, the type of lipids found associated with
proteins, and how such lipids inﬂuence protein function.40,41
Structural characterization of lipid binding sites can be
achieved with X-ray crystallography, where high-resolution
structures are obtained by extracting membrane proteins from
lipid bilayers using detergents to allow solubilization.42,43
Because of the use of detergents for protein puriﬁcation and
crystallization, lipids that would be naturally associated with
the protein are often lost, or if they are copuriﬁed and
crystallized, they might not be identiﬁed unequivocally in the
ﬁnal structure. However, despite the many challenges
encountered in working with membrane proteins, tightly
bound lipids that survived the solubilization and puriﬁcation
steps have been identiﬁed via X-ray crystallography for several
proteins.44−48 Structures of membrane proteins in the presence
of lipids have also been solved via electron crystallization.
Here, a puriﬁed membrane protein is reconstituted within a
lipid bilayer to form a periodic array (known as 2D
crystal).49−51 Lipids surround each copy of the membrane
protein, thus mimicking the native lipid environment. This
technique has allowed for the visualization of layers of lipids in
contact with the protein surface (annular lipids) and the study
of how such lipids interact with the protein.52−57
Recent developments in single particle cryo-electron
microscopy (cryo-EM) overcome many of the challenges of
membrane proteins crystallography, by generating high-
resolution 3-dimensional structures from images of proteins
in solution.58 Applications of cryo-EM span from investigating
the structure and function of large complexes to the
elucidation of side chains packing in proteins, with possible
implications for drug discovery.59 The near atomic resolution
that is now achieved with this technique has dramatically
improved the structural landscape of membrane proteins and
can provide molecular details on lipid binding, as seen, for
instance, for the TRPV1 ion channel,60 the TPC1 channel,61 or
the ABC transporter ABCG2.62
Lipid binding to membrane proteins and the local lipid
composition in proximity of the protein can also be studied
using ﬂuorescent methods. Förster resonance energy transfer
(FRET),63 for example, allowed the characterization of a
speciﬁc interaction between a sphingolipid and the COPI
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machinery protein p24,64 while ﬂuorescence cross-correlation
spectroscopy (FCCS) was employed to probe protein
oligomerization as a function of the lipid composition for the
mitochondrial voltage-dependent anion channel (VDAC).65
Additionally, biophysical studies of lipid−protein interac-
tions can be obtained using nanodiscs, discoidal membranes
with a diameter of 8−17 nm and enclosed by helical scaﬀolding
proteins.66,67 Using membrane proteins in nanodiscs protein
function is assessed in controlled lipid environments.68−70
Recently, the application of detergent-free approaches that use
speciﬁc copolymers to extract proteins and native lipids into
nanodiscs has provided a new tool to characterize the lipid
environment of a given membrane protein, as shown for the
potassium channel KcsA.71
Quantitative analyses and identiﬁcation of native lipid
species tightly associated with membrane proteins can be
achieved via mass-spectroscopy (MS) studies, where mem-
brane−protein complexes can be solubilized in nonionic
detergents to provide resistance to the electronspray ionization
step, thus allowing for stable complexes in gas phase.72 This
technique has been applied to several transporters,48,73 and
other membrane proteins,74−76 providing information on lipid
selectivity, stoichiometry of binding and possible roles played
by lipids in protein mechanism. Native MS techniques allow
the thermodynamics of lipid binding to membrane proteins to
be studied, shedding light on the mechanism of molecular
recognition between lipids and proteins. For the E. coli
ammonia channel AmtB, for example, individual lipid binding
events have been characterized in detail, highlighting the
diﬀerent thermodynamics signature of diﬀerent lipid types,
addressing the contribution of the acyl tail length to binding
thermodynamics,77 and providing insights on how lipid
binding can modulate protein−protein interactions.78 Mass-
spectrometry techniques can also be combined with click-
chemistry methods to identify lipid-binding proteins in native
environments. Such methods allow proteins to be cross-linked
with selected phospholipids carrying photoactivable groups,
upon activation via UV light, and the product can be further
characterized by mass-spectometry.79,80
Infrared (IR) spectroscopy has also been applied to the
study of protein or peptide interactions with membranes.81,82
For instance, using attenuated total reﬂection Fourier trans-
form (ATR FT-IR) spectroscopy Güler et al. investigated the
eﬀect of K+ binding on the interactions between anionic lipids
and the Na+-coupled betaine symporter BetP, revealing
weakening of such interactions due to increase K+ concen-
trations following osmotic stress.83 Other spectroscopy
methods that can be applied to the study of both speciﬁc
and nonspeciﬁc lipid−protein interactions include nuclear
magnetic resonance (NMR) methods, such as solid-state
NMR84 and solution NMR, as in the case of outer membrane
proteins of Gram-negative bacteria,85,86 as well as a powerful
technique speciﬁc to lipid−protein interactions using saturat-
ing transfer between protein and lipids.87
1.2.2. Computer Simulations: Atomistic, Coarse-
Grained, and Continuum Models. Computer simulations
of biomolecular systems span a wide range of time and length
scales, with essential approximations at each level. For the
purpose of studying lipid−protein interactions the most useful
levels are atomistic simulations, in which every atom is
described explicitly, and coarse-grained simulations, which
average in some form over multiple atoms. At the more
detailed side of the spectrum simulations incorporating
electronic structure at some level, either through polarizable
force ﬁelds88 or explicit quantum treatment of some or all
degrees of freedom,89 are widely used in biomolecular
simulation but have not yet been used in detailed studies of
lipid−protein interactions, in part because only very basic lipid
parameters are available. At the coarse-grained end of the
spectrum, there is a rich literature on qualitative lipid models
with very simple bead types describing generic head groups
and generic tails, as well as on continuum mechanics models,
usually based on elasticity theory. Continuum approaches can
be used to study generic lipid−protein interactions as well as
the detailed response of a membrane to an atomistic protein
structure.90 We include some studies using the latter approach
in this review but omit the large literature on more generic
models.91
At the atomistic level, simulations numerically solve classical
equations of motion with a time step of 1 or 2 fs, typically over
billions of steps, resulting in a trajectory describing the position
of all atoms as a function of time. The main ingredients of a
successful simulation are an accurate description of the
interactions between the atoms and suﬃcient sampling.
These interactions are described by an interaction function
and a set of parameters called a force ﬁeld. For lipid−protein
simulations, these parameters have to be consistent between
the chemical groups in the lipids and in the proteins, for
instance ideally the same parameters describe the alkane side
chain of a leucine residue and the alkane chain of lipids; well-
tested against experimental data; and cover the universe of
relevant lipids and, typically less limiting, proteins. In practice,
the most commonly used force ﬁelds for lipid−protein
interaction studies are based on the CHARMM92−94 and
AMBER95−99 families of force ﬁelds, as these continue to be
developed for both lipids and proteins. Other force ﬁelds can
be quite appropriate for speciﬁc purposes but tend to have
more limited options in terms of the availability of lipid types
(Slipids,100−103 GROMOS,104−109 and OPLS-AA110). Devel-
oping parameters for new lipid types is not trivial, as even if the
chemical groups are the same or similar to existing lipid models
these parameters might not reliably transfer to new lipid types
and testing against experiments remains essential.
Although a detailed atomistic model matches the chemistry
and physics of interest in lipid−protein interactions, the
maximum time and length scales that can be simulated are
limited with current computer power. In many cases, lipid−
protein interactions are studied in relatively simple models
with a single protein in a lipid environment, increasingly
commonly a lipid mixture. At this level, atomistic simulations
are a reasonable approach, but when protein−protein
interactions or larger systems are of interest less detailed
models are currently essential. An accompanying paper in this
issue reviews progress and issues in simulations of larger
models.111 Many papers in this review use, sometimes
combined with atomistic simulations in a serial multiscale
approach, coarse-grained (CG) models.112 The most widely
used CG model is the Martini model,113−115 in which on
average four non-hydrogen atoms are combined into a single
interaction site. This, clearly, reduces the chemical speciﬁcity
and level of detail, but results in a 2−3 orders of magnitude
speed-up compared to atomistic simulations. Martini has been
parametrized primarily on the accurate solubility of molecular
fragments in diﬀerent environments, combined with extensive
testing and ﬁne-tuning on actual lipids and other biomolecules.
The transferable nature and simpliﬁcation of the molecular
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topologies compared to atomistic simulations makes it
relatively easy to model new lipids, and consistency between
lipids and proteins is nearly guaranteed by the construction of
the interaction parameters of Martini. The coarse-grained
nature also leads to signiﬁcant limitations. Two major
limitations are the lack of accurate internal dynamics of
proteins, which are usually treated with an elastic network to
maintain their secondary and tertiary structure with only
limited ﬂuctuations, and the lack of detailed chemical features,
including hydrogen bonding and water entropy, that play a role
in speciﬁc interactions between lipids and proteins.
There are several other approaches. Marrink et al. review all
currently available coarse-grained force ﬁelds for biomembrane
simulation, but in practice these have not been used to our
knowledge for studying detailed lipid−protein interactions.111
We do review papers116,117 here that use models derived from
the multiscale CG (MS-CG) method.118 This method in
general starts from atomistic reference simulations of the same
or a closely related system and systematically derives
interaction potentials at coarser levels. At a more detailed
level, Feig and co-workers have developed a coarse-grained
model that can be combined with atomistic detail in part of the
system, including recent tests on membrane proteins, using an
implicit membrane environment.119 Such hybrid approaches
may become more widely applicable in the near future.
In addition to the accuracy of the parameters that describe
the interactions between atoms, obtaining enough sampling to
reliably draw conclusions is a major challenge in lipid−protein
simulations. As the complexity of systems increases, the
simulation time required to obtain converged averages also
increases. As an example, in a recent study we estimated that it
takes 30−50 μs to equilibrate a complex lipid mixture120
around a protein and probably more given the nature of the
force ﬁeld used in this study.121 In contrast, interactions
between liquid crystalline POPC and a small membrane
protein probably require simulation lengths of the order of
hundreds of nanoseconds to obtain correct averages for many
properties. In practice, a handful of common molecular
dynamics software packages is used for the vast majority of
published studies due to their ﬂexibility, eﬃciency, and ability
to work on a variety of modern computational architectures.
These include AMBER,122,123 NAMD,124 GROMACS,125,126
as well the special purpose machine with its own software,
ANTON.127 In addition to advanced software, advanced
algorithms can also help in increasing sampling. There is a vast
literature on this topic,128 but applications in lipid−protein
Figure 1. Representative structures of GPCRs. From left to right, the structures of rhodopsin,137 the β2 adrenergic receptor (β2AR),
138 and the
smoothened receptor139 are shown as cartoons, with the 7 transmembrane (TM) helices highlighted in diﬀerent colors. For β2AR, the three
subunits of the G protein (Gα, Gβ, and Gγ) are shown in light gray and blue cartoons. For the smoothened receptor, the extracellular cysteine-rich
domain (CRD) and the long extracellular loop 3 are shown in light blue and gray cartoons, respectively. The top panels show a side view of the
receptors, while the bottom panels provide a view from the extracellular side. Substrates or agonists are labeled and shown in white spheres, and the
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interactions reviewed here have been limited so far. However,
there is major potential in this area. For instance, algorithms
that can swap lipids rather than wait for lipids to switch place
by diﬀusion could speed up sampling mixtures;129 Hamiltonian
replica exchange and similar methods could improve the
sampling of slow interactions at interfaces between lipids and
proteins;130 and path-based free energy methods such as
umbrella sampling can be used to obtain quantitative data on
binding aﬃnities from simulations as well as on the
thermodynamics of lipid mixing.131
While accuracy of the force ﬁeld and degree of sampling are
fundamental issues, simulations of lipid−protein interactions
are suﬃciently complicated that there are practical issues to
consider too. In principle, how a starting model is created in an
MD simulation, whether atomistic or coarse-grained, is
irrelevant and only aﬀects the time it takes to equilibrate the
system, which is not of scientiﬁc interest. However, in practice
these equilibration times can become so long that it is
beneﬁcial to create systems that are as close as possible to the
equilibrium structure (which is generally not known). In the
early days of membrane simulations, ca. 20 years ago, this was
a very active ﬁeld with a large number of technical approaches
to create starting structures. As computers become faster, it
became more feasible to just equilibrate a system, but in lipid
mixtures with equilibration times of microseconds attention to
starting structures is warranted again. In addition, in complex
lipid mixtures with proteins and hundreds of thousands of
atoms a procedure that generates starting structures without
errors that may be very diﬃcult to ﬁnd is very valuable. We do
not attempt to review all possible approaches, but point out
that the two most common methods at the moment are the
online tool CHARMM-GUI,132,133 which can create a variety
of membrane and other systems for diﬀerent MD packages,
and the Martini tool Insane.134 In general, both setup and
equilibration are easier with Martini due to the nature of the
interaction function, and in fact Martini simulations could be
used as an intermediate to generate complex atomistic
simulations.135
2. G PROTEIN-COUPLED RECEPTORS (GPCRS)
G protein−coupled receptors (GPCRs) are the largest
superfamily of membrane proteins and the number one drug
target.136 They are characterized by a highly conserved seven
transmembrane helix (TM) topology with a ligand-binding
extracellular site and G-protein coupling intracellular site
(Figure 1). Ligand binding on the extracellular site triggers a
sequence of conformational changes in the TM domain that
results in the activation of a membrane-anchored G protein.
Due to their localization on the plasma membrane, GPCR
function and activity are exposed to all of the biophysical
processes that characterize cell membranes. In the past few
years, signiﬁcant advances have been made in understanding
this relationship between GPCRs and their lipid environment.
Early evidence for the importance of lipid−protein
interactions in GPCR function and activity dates back to the
early to mid-1990s, when a series of discoveries was made
regarding cholesterol modulation of rhodopsin and oxytocin
function. The equilibrium between meta-rhodopsin I and
meta-rhodopsin II depends on cholesterol concentration13 and
was assumed to be a result of cholesterol’s ability to alter the
physical properties of the bilayer. Albert et al. a few years later,
however, showed that another mechanism is possible, namely a
direct, structurally speciﬁc, interaction between rhodopsin and
cholesterol.14 Gimpl et al. studied this cholesterol-modulatory
eﬀect on the ligand−binding activity of two diﬀerent GPCRs
with peptide−hormone ligands: the oxytocin and the
cholecystokinin receptor.15,16 They found that this eﬀect is
caused by altering the membrane properties in the case of
cholecystokinin, but by a “putatively speciﬁc cholesterol−
receptor interaction” for the oxytocin receptor. More recently,
the cholecystokinin type 1 receptor was shown to be sensitive
to membrane cholesterol levels, as opposed to its type 2
relative cholecystokinin receptor which does not share this
cholesterol sensitivity.140−142
In the last two decades a plethora of experimental and
theoretical techniques have been used to investigate the
existence and signiﬁcance of lipid GPCR interactions. Two
illustrative, although not exclusive, examples of the progress
made are the several solved crystallographic structures of
GPCRs with bound lipids143−152 and a series of papers
published recently clearly and unequivocally demonstrating the
importance of cholesterol in activating the class F GPCR
Smoothened in hedgehog signaling.139,153−156
2.1. GPCR−Lipid Interactions
The most commonly used classiﬁcation of GPCRs uses their
sequence homology to categorize them into classes A−F or,
alternatively, into the GRAFS system (with each letter of the
acronym standing for the most representative member of the
family, e.g., R = rhodopsin).136,157 Class A (or rhodopsin-like)
GPCRs are the largest, most studied, and hence best-
understood GPCR family by practically any metric. MD
literature follows published GPCR structures. Therefore,
GPCR−lipid interactions have mainly been studied in the
context of class A GPCRs. We begin with a discussion of the
prototypical rhodopsin and continue with aminergic receptors,
in no particular order, concluding with a brief section on other
miscellaneous GPCR−lipid interaction papers. Considering
the vast GPCR literature, no single review, no matter how
comprehensive, can do justice at detailing every aspect of their
biology. We limit the discussion to the aspects outlined in the
introduction of this review and refer the reader to several other
excellent reviews.39,158−163 When necessary, the Ballesteros−
Weinstein numbering scheme will be used to identify
residues.164
2.1.1. Rhodopsin. Rhodopsin is found in rod cells
embedded in a membrane that is rich in ω-3 polyunsaturated
lipids and cholesterol (although the content of the latter varies
with cell age). Polyunsaturated lipids, e.g., docosahexaenoic
acid (DHA), have a stabilizing eﬀect on rhodopsin structure
and increase its activity; cholesterol has the opposite eﬀect.
Multiple short-time scale MD simulations of rhodopsin165
embedded in a bilayer with PE and PC lipids with mixed
saturation lipid tails and cholesterol showed that rhodopsin
forms a few, potentially speciﬁc, interactions with DHA, the
unsaturated tail, but no speciﬁc interaction with stearic acid,
the saturated tail, and cholesterol. A later study, employing 1.6
μs simulation of the same system, however, provided more
insight into the cholesterol−rhodopsin interactions.166 Rho-
dopsin contains three structural regions that exhibit increased
aﬃnity for cholesterol molecules: the extracellular sides of the
TM2−TM3 bundle and TM7 helix and the intracellular side of
the TM1−TM2−TM4 helices. Extending these simulations
even further in time scale using the Martini model conﬁrmed
the preferential interaction of cholesterol and DHA with
rhodopsin and suggested a preference of rhodopsin for PE
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headgroup over PC headgroups.167 The eﬀect of polyunsatu-
rated tails and PE headgroups on rhodopsin activity has also
been observed in experiments on reconstituted rhodopsin
receptors in model membranes.168 These experiments show
that PE lipids, by creating a negative curvature, aﬀect the MI/
MII equilibrium of rhodopsin. Increased levels of PE lipids shift
the equilibrium toward the MII state. The implication here is
the possibility of a lipid-regulated inactive−active state
transitioning of the receptor. More recent MD simulation
studies on lipid−rhodopsin interactions, however, highlight a
more dualistic nature of lipid−protein interactions whereby
membrane lipids express their modulatory eﬀects on rhodopsin
by acting, simultaneously, as allosteric modulators and by
altering membrane physical properties (e.g., membrane
ﬂuidity).169
2.1.2. Adrenergic Receptors. Adrenergic receptors are
among the best-studied GPCRs, and their lipid−interaction
proﬁle has consequently been studied and characterized
extensively. In 2008, Hanson et al. solved the structure of
the human β2AR receptor bound to two cholesterol molecules,
strongly indicating structurally speciﬁc cholesterol-binding sites
on the receptor surface.144 Helices I−IV of the β2AR form a
shallow groove that is suﬃcient to accommodate the binding
of two cholesterol molecules, with diﬀerent binding aﬃnities.
These observations enabled the deﬁnition of a cholesterol-
binding motif, which is found in 21% of human class A
GPCRs.144 This domain, coined cholesterol consensus motif
(CCM), is formed by residues in helices II and IV of the
receptor and diﬀers from the CRAC/CARC domains in that it
is formed by a spatial arrangement of residues rather than a
linear one. Cholesterol interactions with adrenergic receptors
have been observed in several other crystal structures.145,147
MD simulations at both the atomic and coarse-grained level of
the receptor embedded in a POPC bilayer in the presence or
absence of cholesterol have shown that β2AR interacts with
cholesterol at several potential interaction sites or hot-spots
(some of which match those observed in several crystal
structures), quantiﬁed by cholesterol occupancy time from the
simulation trajectories.170,171 A possible functional role of these
additional putative interaction sites remains to be established,
but it is reassuring that the simulations agree with each other
and can reproduce with good agreement the cholesterol
interaction sites observed in solved crystal structures.
Interestingly, the interaction of cholesterol with these binding
sites is dynamic and ranges from nanosecond to microsecond
time scales and might serve as a basis for dividing
cholesterol−β2AR binding events into short- and long-lived.
This is an interesting prospect considering recent experimental
evidence supporting it.172 Experiments with unfolding temper-
ature assays and saturation transfer diﬀerence NMR showed
that cholesterol binds to the β2AR with high aﬃnity−slow
exchange rate and low aﬃnity−fast exchange rate, respectively.
Control experiments reveal both these types of binding events
to be speciﬁc to cholesterol.172
When the β2AR and β1AR are each simulated separately in
cholesterol containing POPC bilayers in microsecond-long
atomistic MD simulations, the resulting cholesterol-interaction
proﬁles of the receptors diﬀer signiﬁcantly from each other.173
Most notably, the H1−H8 interface of β2AR seems to interact
preferentially with two cholesterol molecules, while the same
interaction is missing from the β1AR, which can be attributed
to the slightly diﬀerent resides lining the interface. More
generally, this means that lipid interaction data from one
GPCR may not be easily extended to other members of even
the same GPCR family despite sharing a high structural
similarity.
Important advances in the understanding of β2AR−lipid
interactions were made by Kobilka and colleagues who showed
that cholesterol and phospholipids aﬀect the kinetics and
stability of the receptor.174,175 Using force spectroscopy
methods and cholesteryl hemisuccinate as a cholesterol analog
they showed that cholesterol increases the stability of almost all
Figure 2. Eﬀect of cholesterol on β2AR activation. A. Deﬁnition of two distance parameters used to measure the conformational changes as a
function of time.177 The D3.32−S5.46 Cα atom distance (denoted LL) measures ﬂuctuations in the ligand-binding site of the receptor, and the
R3.50−E6.30 Cα atom distance (denoted LG) captures ﬂuctuations in the G protein binding interface. B and C. The conformational space probed
by the simulations in pure DOPC and DOPC−10% Chol concentration bilayer, respectively, plotted as a function of these two distance
parameters.177 Cholesterol signiﬁcantly decreases the conformational space sampled by the receptor. Adapted with permission from ref 177.
Copyright 2016 Manna et al. Licensed under Creative Commons Attribution 4.0.
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structural elements of the β2AR, presumably by making it
diﬃcult for the protein to sample its conformational land-
scape.174 This ﬁnding is also supported by recent exper-
imental176 and computational177 studies. In the latter study,
Manna et al. carried out atomistic MD simulations of the
human β2AR in, among other setups, DOPC bilayers of
varying cholesterol concentration and showed that the
conformational landscape sampled by β2AR is reduced
signiﬁcantly at or above 10 mol % concentrations of cholesterol
(Figure 2).177 Further simulations suggest that this reduced
conformational ﬂexibility of β2AR is a direct result of
cholesterol−receptor interactions not of indirect modulation
through altered bilayer bulk properties. In addition, the
binding of cholesterol agreed well with previous studies,170−172
as several known interaction sites were retrieved. Time-
correlation data also reveal some binding sites to be dependent
on cholesterol concentration and others independent of it,
further supporting the division of cholesterol binding sites
according to their binding aﬃnity or exchange rate.177
While cholesterol is clearly the major lipid type to consider
when looking at lipid−protein interactions in GPCRs,
Dawaliby et al.175 showed recently, experimentally, that
phospholipids also regulate the activity of the β2AR by acting
as allosteric modulators. By testing phospholipids with
diﬀerent headgroup types they found that phospholipids,
depending on the nature of the headgroup, can shift the
equilibrium toward either the active or inactive state of the
receptor, with DOPG, DOPS, and DOPI favoring the former
and DOPE favoring the latter. Remarkably, this eﬀect, in the
case of negatively charged phospholipids is dose-dependent
and present even in the absence of a bilayer, probably by the
headgroup interacting with the cytoplasmic side of the
receptor. These studies show the eﬀect of cholesterol and
phospholipids to be independent of ligand binding. The
importance of phospholipids has been underscored in several
other experimental studies for other GPCRs.178,179
MD simulations have been quite successful in reaﬃrming
and even predicting these phospholipid−β2AR interactions.
Neale et al. showed that POPG stabilizes the active state of the
embedded β2AR through speciﬁc interactions with Arg3.50 on
the intracellular side of the receptor.180 This interaction of
POPG is stronger and more frequent when compared to
equivalent interactions of the zwitterionic POPC. While it is
not possible to attribute this stabilizing activity of POPG solely
on its interaction with Arg3.50, it is clear that it opposes the
closure of H6, a critical step in β2AR activation. More recently,
microsecond-length atomistic simulations of β2AR embedded
in DOPG, DOPE, or DOPC phospholipids reaﬃrm the
diﬀerential eﬀect of negatively charged versus zwitterionic
lipids on the activation of β2AR.
181 DOPC, DOPE, and DOPG
partially inactivate, fully deactivate, and stabilize the active-
state of the β2AR, respectively. While the exact details of these
interactions remain to be deciphered, MD simulations in
combination with many experimental ﬁndings have already
provided a wealth of information with regards to cholesterol−
and phospholipid−β2AR interactions.
MD simulations have also hinted to a possible role of PIP
lipids in mediating lipid−protein interactions by demonstrating
preferential localization of these lipids in microsecond-long
simulations.121,182 Native mass spectrometry studies comple-
mented with CG MD simulations have highlighted the
importance of PIP2 lipids. In particular, experiments by Yen
et al. demonstrate that PIP2 lipids do not only aﬀect the
stability of the active state of these receptors but also exert
inﬂuence on its coupling to G proteins.183 The GPCRs studied
were β1AR, adenosine A2A receptor (A2AR), and neurotensin
receptor 1 (NTSR1), although the CG MD simulations points
to this eﬀect likely being conserved in other class A GPCRs as
well.183
2.1.3. Adenosine Receptors. Evidence for the importance
of cholesterol in the adenosine receptor function and activity
dates to at least 2008.184 The same year a 2.6 Å crystal
structure of the A2A adenosine receptor (A2AAR) was
published185 Lyman et al.186 took this opportunity to
investigate, using MD simulations, the behavior of the receptor
in the presence and absence of cholesterol. In bilayers where
cholesterol is absent, helix II of the A2AAR is remarkably
unstable if the ligand is removed from the simulations.186 If,
however, cholesterol is introduced in these simulations, the
stability of helix II is restored, thanks to cholesterol−protein
interactions. Later MD simulations provided a clearer picture
of the cholesterol−A2AAR interaction proﬁle,187 where three
cholesterol binding sites are identiﬁed. Two of these
cholesterol hotspots are on the extracellular side and one on
the intracellular side of the receptor. One of the cholesterol
interaction sites observed on the extracellular leaﬂet of the
receptor interacting on the interface between helices II and III,
is conﬁrmed by a previously solved X-ray crystallographic
structure of the receptor;148 however, the other cholesterol
hotspots observed lack cross-validation, possibly due to limited
sampling, especially considering more recent results below.
MD simulations of the A2AAR embedded in POPC and POPE
bilayers suggest that the receptor samples a larger part of the
conformational landscape if it is embedded in the former,
although this may be due to generally slower dynamics in the
more ordered POPE bilayer.188 It is tempting to look at similar
ﬁndings obtained for the human β2AR and extend those, but it
remains to be established if such extrapolation of data is
sensible. More recent MD simulations of the A2AAR, by
combining data at both the atomistic and coarse-grained level,
have identiﬁed two new cholesterol−interaction sites.189 One
of these is located on the intracellular side of the interface
formed by helices V and VI (not validated experimentally) and
the other on the extracellular side of helix VI, matching
experimental evidence.148
2.1.4. Serotonin Receptors. Experimental ﬁndings
revealed that cholesterol depletion alters ligand binding and
G-protein coupling to the serotonin 1A receptor.190 Choles-
terol also increases the stability of the human serotonin 1A
receptor191 and in giant unilamellar protein-vesicles has been
observed to increase oligonucleotide exchange.192 Due to the
lack of a crystal structure of serotonin receptors, initial MD
simulations used homology models. One such study, using
Martini coarse−grained MD simulations, showed that in
cholesterol containing POPC bilayers the embedded homology
model of the serotonin 1A receptor displays several preferential
cholesterol interaction sites.193 One of these interactions is
with helix V which represents one (out of three) CRAC motifs
found on the receptor. Atomistic MD simulations of the
activity of serotonin 1A and serotonin 2A receptors as a
function of bilayer cholesterol content, currently portray a
conﬂicting picture as to if cholesterol decreases the conforma-
tional ﬂexibility of the receptor194 or increases it,195
respectively. Ganglioside GM1 and sphingolipids also interact
with the serotonin 1A receptor.196,197 Shan et al. simulated the
conformational changes of the serotonin 2A receptor induced
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by its binding to three diﬀerent ligands (full agonist, partial
agonist, and inverse agonist).198 They found a noticeably
diﬀerent response of the receptor depending on the ligand
bound and that these conformational changes are relayed into
the surrounding membrane environment of the embedded
receptor, conﬁrmed by speciﬁc interactions of the receptor
with cholesterol and distinct membrane perturbations around
the TM core of the receptor.
2.1.5. Other GPCRs. MD simulations either alone or in
tandem with experimental studies have been used to explore
the lipid−binding properties of other GPCRs as well. Marino
et al. carried out extensive Martini coarse−grained MD
simulations of the mu-opioid receptor (μOR) in highly
realistic membrane compositions,182 showing speciﬁc inter-
actions of μOR with cholesterol and with the negatively
charged PIP lipids, which surprisingly, diﬀer to some extent
depending on the conformational state of the receptor. The
implication of these diﬀerences is, however, unclear. Similar
simulations of the delta-opioid receptor (δOR) conﬁrm the
relative enrichment of cholesterol adjacent to the receptor
compared to bulk concentrations.121 This type of simulations
in complex bilayers reveal a unique interaction proﬁle of opioid
receptors with individual membrane lipids (cholesterol, PIP
lipids) and groups of lipids that share a chemical feature
(polyunsaturated, fully saturated, headgroup type, etc.), hinting
toward a functionally relevant involvement in GPCR activity
and oligomerization (see below).121,182
Cholesterol is an essential component in Smoothened
receptor activation.139,153−156 Cholesterol binds to the
cysteine-rich domain (CRD) of Smoothened. MD simulations
showed that cholesterol confers stability to the CRD domain
but did not aﬀect the stability of the TM domain.139 In a series
of experiments, Huang et al.153 and Luchetti et al.154
concurrently showed that cholesterol is the endogenous ligand
that activates Smoothened. Indeed, cholesterol is not only
necessary but also suﬃcient for Smoothened activation.154
Additionally, MD simulations coupled with PMF calculations
point to the existence of an interaction site for cholesterol
formed by TM2 and TM3 helices of Smoothened on the
extracellular site of the receptor.199
Cholesterol also aﬀects the activity and stability of the
neurotensin receptor 1 (NTS1).200 NTS1 also displays a
potential preference for PS lipids201 and its G protein coupling
aﬃnity is signiﬁcantly increased in the presence of PE lipids.202
This dependency of G protein coupling by GPCRs on the lipid
environment is also evident for the cannabinoid type 2
receptor (CB2R), which increases G protein activation in the
presence of anionic lipids.179 Interestingly, CB2R and the
structurally similar CB1R seem to diﬀer in their cholesterol-
interaction proﬁles.203 Sphingosine-1-phosphate receptor 1, in
extensive Martini coarse-grained simulations, consistently
interacts with cholesterol and PIP2 lipids.
204 Membrane
localization of the dopamine D1 receptor is dependent on
membrane cholesterol and sphingolipid levels.205 GPCR−
cholesterol interactions, mainly by way of CRAC motifs, have
also been demonstrated for class A chemokine receptors,206 for
class C metabotropic glutamate receptors,207 and T2R4 bitter
taste receptor208 perhaps highlighting the presence and
importance of this motif across very diﬀerent GPCRs.
2.2. GPCR Scramblase Activity and Lipid Entry Events
An unexpected ﬁnding from MD simulations of GPCRs is the
occasionally observed complete entrance of lipid molecules
from the bilayer into the receptor. Considering the lack of
structural data pointing toward such a possibility, however, not
much attention has been paid to this phenomenon. So far, MD
simulations have demonstrated lipid entry for several GPCRs,




uptake by the opsin receptor is likely achieved via the TMH5/
6 interface as an entrance port and either TMH1/7213 or
TMH5/6209 serving as an all-trans-retinal exit site. In MD
simulations of the cannabinoid type 2 receptor, 2-arachido-
noylglycerol (2-AG) partitions out of the POPC bilayer and
interacts speciﬁcally with the TMH6/7 interface, where it also
enters the receptor.210 In contrast, simulations of the
sphingosine-1-phosphate receptor showed a POPC lipid to
interact speciﬁcally with and enter the receptor through the
TMH1/7 interface.211 The TMH1−TMH7 distance increases
signiﬁcantly during the course of the simulation to
accommodate this lipid entry. Endogenous ligand binding to
GPCRs is expected. More puzzling is the observed complete
entry of bilayer lipids inside receptors that do not have lipids as
natural ligands. In simulations of the β2AR, a POPC lipid
sometimes (estimated at 6% of the time) accesses the inside of
the receptor via the TMH6/7.180 This complete lipid entry is,
however, only observed with one of the two force-ﬁelds the
authors used. More recently, MD simulations revealed that
cholesterol completely enters the A2A adenosine receptor
through TM5/6, in a process that appears to be dependent on
the bulk properties of the surrounding bilayer.212 While in the
interior of the receptor, cholesterol preferentially samples an
area of the receptor that binds the ZM241385 ligand in the A2A
adenosine receptor crystal structure,185 hinting that cholesterol
could aﬀect ligand binding properties. The latter was
conﬁrmed using biotinylation assay experiments.212 It is
unclear what the implications of these ﬁndings are, but they
may add an additional layer of complexity to GCPR−lipid
interactions.
Experiments by Menon et al. showed that opsin acts as a
phospholipid scramblase.214 In a later study, it was discovered
that rhodopsin as well is a phospholipid scramblase with an
activity of >10 000 phospholipids per protein per second.215
The authors demonstrated that this activity of rhodopsin is
independent of the conformational state of the receptor, which
means that phototransduction and scramblase activity are not
coupled to each other. Furthermore, β2AR and A2AAR, as well,
scramble phospholipids, hinting that this activity could be
shared by all class A GPCRs.215 MD simulations and Markov
state model analysis reveal that the mechanism for
phospholipid translocation involves a hydrophilic pathway
that is created between TMH6 and TMH7 of opsin, through
which the phospholipid headgroup crosses from the intra-
cellular to the extracellular leaﬂet, while the lipid tail remains in
the bilayer.216 The simulations also characterize the conforma-
tional changes necessary for this translocation event to occur.
Considering this observed scramblase activity is dependent on
a thin low-cholesterol membrane, it remains to be seen how
this is aﬀected by cholesterol- and sphingolipid-containing
membranes.215 While sampling these events is challenging and
may require specialized methods, MD simulations have already
demonstrated that they can be a useful tool to shed light on
this novel aspect of GPCR activity.
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2.3. GPCR Oligomerization
The physiological role of oligomerization of several GPCRs is a
topic of ongoing discussion (Figure 3). It has been observed
and characterized as functionally important in many experi-
ments,217−220 but at the same time doubts have been raised
about several aspects of its occurrence and importance.221,222
Computer simulations have been used to study membrane-
mediated aspects of oligomerization, which we discuss below.
A more detailed discussion of oligomerization and other
aspects of their relevance and function is available in several
other reviews.219,222−225
Initial MD simulations of GPCR dimerization were focused
on rhodopsin. Periole et al. carried out coarse-grained MD
simulations of several rhodopsin receptors embedded in PC
bilayers of diﬀerent lipid tail lengths and found that the
increase in hydrophobic mismatch with shorter lipid tail length
resulted in local thickening of the bilayer, particularly
noticeable near TM2, TM4, and TM7 helices and thinning
near TM1, TM5, TM6, and TM8.227 These results suggest that
hydrophobic mismatch acts as a driving force for receptor
oligomerization. Additionally, the most prominent interaction
surface involved a symmetric arrangement of TM1, TM2, and
H8, although other dimer interfaces were also observed. Later
studies, however, aﬃrmed that the primary mode of interaction
in rhodopsin dimers involves the TM1/TM2 on the
extracellular side and H8 on the intracellular side.228,229
NMR experiments show that hydrophobic mismatch modu-
lates the MI/MII rhodopsin intermediate equilibrium, with
oligomerization shifting the equilibrium toward MI, and local
thickening of the membrane to compensate for the hydro-
phobic mismatch favors the MII intermediate.230
To characterize the role of hydrophobic mismatch in GPCR
oligomerization, Mondal et al. used Martini coarse-grained
simulations of the prototypical β1AR and β2AR and studied the
energy penalty associated with the residual hydrophobic
mismatch, RHM (the energy penalty resulting from the
inability of the membrane to completely counter hydrophobic
mismatch).231 They found that the highest energy cost of
RHM for the β2AR monomer was at TM1, TM4, and TM5.
Oligomerization of β2AR occurs via the TM1 and TM4/TM5
interface and signiﬁcantly decreases this energy penalty, thus
highlighting hydrophobic mismatch as a possible driving force
behind oligomerization. The highly homologous β1AR in
contrast showed a high RHM only on its TMH1, indicating a
preference of the receptor to form dimers, not oligomers,
through its TMH1/TMH1 interface. In their simulations,
Mondal et al. did not see a signiﬁcant eﬀect of cholesterol on
receptor oligomerization.231 A diﬀerent study, however,
proposes a modulatory role of cholesterol in β2AR dimer
interfaces.171 Without cholesterol present, the preferred β2AR
dimer interface involves TMH4 and TMH5. Increasing
cholesterol concentrations, however, changed the relative
involvement of TM helices at the dimer interface, with 50%
cholesterol favoring a predominantly TMH1 and TMH2
interface. This modulatory role of cholesterol was attributed to
its preferred localization at TMH4.171
Opioid receptors are another GPCR family with extensively
studied oligomerization properties, mainly by the Filizola lab
and collaborators. Umbrella sampling free energy calculations
and metadynamics simulations revealed a short-lived inter-
action of delta-opioid receptors (δOR), mainly through
TMH4, but with a relative involvement of TMH5, as
well.232,233 In a later, more extensive study, Provasi et al.
used the Martini model to simulate the preferred di/
oligomerization pattern of the main opioid receptor (OR)
subtypes: μOR, δOR, and κOR, simulated in their homomeric
and main heteromeric form.234 OR utilize a limited number of
interfaces which are consistent among the subtypes simulated
but diﬀer in their relative fraction of occurrence. Also,
consistent seems to be the shared lack of either TM3 or
TM7 involvement in dimer interfaces. Analysis of diﬀerent
kinetic parameters pointed toward diﬀerent propensities and
association rates of dimers to form, depending on the interface
involved, and an active role of membrane lipids, including
cholesterol, in guiding these associations. Local lipid exchange
and persistence time might aﬀect and serve a modulatory
eﬀect, on the kinetic favorability of diﬀerent interfaces to
form.234 Experimental and computational tools have shown
that μOR homodimerization is facilitated by cholesterol
through a Cys3.55-palmitoyl−cholesterol interaction.235 Sim-
ulations of the active- and inactive-state μOR in more realistic
plasma model provided additional insights into how the
membrane environment guides receptor dimerization.182
Notably, TMH1, TMH5, and TMH6 induced an ordering of
lipids, in contrast to TMH4, which induced a more disordered
region in the membrane. These local membrane adaptations
facilitate receptor dimerization and aﬀect the preferred dimer
interfaces formed. Interestingly, the latter is also dependent on
the conformational state of the receptor.
A recent computational study of A2AAR and dopamine D2
receptor oligomerization suggests that it is highly DHA
concentration dependent.236 DHA displays a preferential
interaction with each receptor and high-levels of it increase
receptor heteromerization. Bioluminescence resonance energy
Figure 3. Experimental structures of GPCR dimers. Side view (upper
panels) and the view from the extracellular side (bottom panels) of
the (left) μ opioid receptor (μOR) dimer149 and (right) the
chemokine receptor type 4 (CXCR4) dimer.226 The 7 transmembrane
(TM) helices of the receptors are highlighted in diﬀerent colors and
shown as cartoons, while one of the monomers is also represented
with a transparent gray surface. Substrates bound to these dimers are
not shown for clarity.
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transfer (BRET) experiments showed the number of oligomers
formed, however, to be independent of DHA levels, under-
scoring a kinetic modulation by DHA. Prasanna et al., using
coarse-grained MD simulations, demonstrated the lipid-
dependent oligomerization of serotonin 1A receptor.237
Speciﬁcally, they observed two main dimer interfaces involving
TMH1/TMH2 and TMH4/TM5/TMH6, and they highlight
the importance of cholesterol in modulating the stability and
ﬂexibility of these dimers. Pluhackova et al. simulated the
chemokine receptor type 4 (CXCR4) in pure phospholipid
bilayers and noticed that the most prominent dimerization
interface involved TM1/TM5−7.238 In bilayers containing
cholesterol, however, this interface was unavailable due to a
cholesterol molecule binding between TM1 and TM7. Instead,
a new symmetric TM3/TM4 interface was observed that
seems to be supported by experiment, highlighting not only its
regulatory role but also the importance of considering its eﬀect
in studies like this. A more recent study further characterized
chemokine receptor homo- and heterodimerization patterns
and their dependence on membrane cholesterol.239 Coarse-
grained MD simulations were also used to study the
oligomerization of S1P1 receptors.
204
A common theme that emerges from both experimental and
theoretical results is the dual modulatory eﬀect of lipids on
GPCRs, by way of either altering membrane bulk properties or
speciﬁc interactions with the receptor. While quantifying this
eﬀect and the contributions from each component is
challenging for GPRCs, current evidence suggests the
modulatory role of membrane lipids on receptor function
and activity is achieved primarily by speciﬁc lipid−protein
interactions. However, to make matters more complicated, that
does not seem to be the case for rhodopsin, where the
modulatory role is currently mainly attributed to local
membrane curvature instead.240
It is challenging to compare the lipid−protein interaction
results across GPCR members given the diﬀerences in
experimental and simulation setups employed. The current
literature suggests that extending results from one GPCR to
others, simply based on structural similarity and sequence
identity might not be enough. MD simulation data show that
Figure 4. Diﬀerent structural topologies of selected ion channels. From left to right the structures of the Shaker Kv1.2,251 the two-pore domains
K2P1,252 the inwardly rectifying Kir2.2253 potassium channels, and the structure of the NavAb sodium channel254 are shown in cartoons. All
structures, with one notable exception of K2P1 channels, are functional tetramers comprised of four identical monomers. Monomers are colored
from yellow to orange to dark brown. The trans-membrane helices forming voltage-sensing domains (VSD) are labeled S1 to S4, while two
transmembrane helices forming the pore domain (PD) in voltage-gated channels are labeled as S5 to S6; Kir2.2 pore is comprised of two
transmembrane helices, outer and inner corresponding to S5 and S6 helices in Kv1.2 or NaVab channels. The location of the pore helix present in
many structures of ion channels is shown on the top-view of Kir 2.2. The functional dimer of the K2P1 channel is comprised of two pore domains
(P1 and P2) with each domain formed by TM helices M1 to M4, where helices M1 and M3 are outer helices of P1 and P2 protomers. For the
K2P1 and the Kir2.2 channels the positions of potassium ions in the ﬁlter region are shown by purple spheres. In, intracellular side; out,
extracellular side. The membrane region is highlighted in gray.
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many GPCRs interact preferentially with cholesterol through
several interaction sites. Some of these are likely of functional
importance, others seem not to be. Recent simulations show
that microseconds are required to obtain statistically signiﬁcant
results on cholesterol−GPCR interactions, a bar that most of
the older papers do not reach.
GPCR oligomerization is a topic of debate and caution is
required when interpreting results from MD simulations.
Regardless of that, however, it seems that insofar as GPCR
association is a true phenomenon, it is regulated and
dependent on speciﬁc membrane lipids (cholesterol, DHA)
and membrane physical properties (hydrophobic mismatch,
lipid order/disorder) that act as molecular driving forces.
3. ION CHANNELS
Ion channels are integral membrane proteins enabling water-
ﬁlled pathways for ion permeation. Ion channels change
conformations from open (or activated) and nonconducting
(inactivated) states in response to a variety of stimuli, ranging
from perturbation of the membrane potential, binding of
modulating ligands, changes in the intracellular pH, and
osmotic stress.241 Substantial evidence shows that membrane
composition plays a role in ion channel structure and function.
As for other membrane proteins, in general, two mechanisms
have been proposed for lipid−protein interactions: either
through speciﬁc interactions between lipids and proteins or
nonspeciﬁc through changes in membrane physicochemical
properties that aﬀect ion channel dynamics. A plethora of
recent studies showed that ion channel gating dynamics or
conductance properties are sensitive to the presence of speciﬁc
lipids such as phosphatidylcholine (PC), phosphatidylethanol-
amine (PE), cholesterol, phosphatidylinositol 4,5 biphosphate
(PIP2), ceramides, or polyunsaturated fatty acids
(PUFA).242−248
Atomistic and coarse grained molecular dynamic (MD)
simulations have been useful tools to understand how lipid−
protein interactions can regulate the function of a variety of ion
channels.36,249,250 In the following sections, we will focus on
the insight given by MD simulations in relation to the role of
lipid−protein interactions in regulating the activity and
function of diﬀerent members of the ion channel superfamily.
Simulations have primarily addressed more speciﬁc inter-
actions between lipids and proteins. Two diﬀerent classes of
bound lipids have been described to explain such interactions:
(i) A ﬁrst layer of lipids surrounding the transmembrane
portion of the membrane protein and (ii) lipids that bind to
certain grooves, especially between protein subunits.
3.1. Channels with General Voltage-Gated Potassium
Channel Pore Architecture
Voltage-gated ion channels (VGICs) are responsible for the
rapid and selective conduction of Na+, K+, Cl−, H+, or Ca2+.
The group includes very diverse structural topologies ranging
from the homotetrameric channels such as the superfamily of
K+-selective channels and Na+-selective bacterial channels
(NaVab, NachBac, etc.) to the membrane-inserted structures
formed by large monomeric α-subunits in eukaryotic Na+ and
Ca2+-selective channels (Figure 4). Regardless of the topology
(e.g., monomer vs homotetramer), two major structural
elements can be easily identiﬁed.241
The alpha-subunit of voltage-gated Na+ and Ca2+-selective
channels contains four repeat domains with structural features
resembling those found in homotetrameric channels. The ﬁrst
highly conserved structural element present in most of the
VGICs is the voltage-sensing domain (VSD) formed by four
trans-membrane helices labeled S1 to S4. The main functional
role for VSDs is to change conformation in response to
changes in the membrane potential, opening or closing the ion
permeation pathway, known as activation/inactivation. The
rapid response to changes in the membrane surface electro-
statics is achieved by the presence of an unusually (for
membrane-inserted proteins) large number of positive charges
(labeled as R1, R2, ..., R7−8) in the trans-membrane S4 helix
(the voltage-sensor). The second essential structural element is
the pore domain (PD) formed by the S5−S6 helices, which
contains the selective permeation pathway. Additional
cytoplasmic N- and C-terminal subunits are common in all
voltage-gated channels and may contain a variety of regulatory
domains.241 The activation process depends on the electro-
mechanical coupling between the VSD and pore domain. The
movement of the VSD in response to the membrane potential
results in opening or closing the intracellular gate in the pore
domain, thus opening or closing ion ﬂow through the pore.
Other closely related families include the family of the bacterial
K+ selective channels46 and eukaryotic inwardly rectifying K+
channels, both containing only 2 transmembrane (TM) helices
per monomer (S5−S6 equivalent) that contribute to the
tetrameric pore domain,255−257 voltage-sensitive phosphatases,
and voltage-gated H+ channels comprised of S1−S4 forming
both VSD and permeation pathway.258,259
While assembly (monomeric vs oligomeric) of functional
units may vary depending on the family, these proteins are
known to be modulated by a variety of membrane lipids. Here
we review primarily the role of lipids in the regulation of
voltage-gated ion channel function.260,261 Speciﬁc lipid binding
in a state-dependent manner to TM domain (TMD) of
voltage-gated ion channels may change the kinetics and/or
energetics of activation and/or impact maximal conductance.
The taxonomy and classiﬁcation of voltage-gated ion channels
is complex.260,261 Below we take a pragmatic approach rather
than a rigorous systematic approach in the organization of the
sections. Transient receptor potential (TRP) channels also
adopt a structural architecture similar to that of voltage-gated
potassium channels, but we discuss them below in section 3.2
together with other ligand-gated channels.
3.1.1. Lipid Interactions with K+-Selective Channels.
The determination of the X-ray crystal structure of bacterial
channel KcsA containing only S5−S6 TM helices in 1998 and
the S1−S5 voltage-gated K+-selective (Kv) mammalian
channels47,262 resulted in a large number of modeling studies
aimed at understanding of gating and permeation mechanisms
present in this superfamily of voltage-gated channels.46,263
Several lipids including cholesterol, ceramides, polyunsaturated
fatty acids (PUFAs) and PIP2 have been suggested to play
modulatory roles in the activation process and permeation
across various K+ selective channels by binding to lipid-speciﬁc
pockets.
One of the ﬁrst simulation studies of K+-channel interactions
with lipids was performed on the bacterial 2TM channel
KcsA.46 KcsA is a homotetrameric channel from the Gram-
positive soil bacterium Streptomyces lividans with 2 TMs per
monomer (S5−S6, sometimes labeled TM1-TM2). It contains
the highly conserved amino-acid sequence in the pore helix
and selectivity ﬁlter characteristic for potassium chan-
nels.47,253,263 The overall pore organization is also well-
conserved in K+-selective channels from higher organisms.264
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00451
Chem. Rev. XXXX, XXX, XXX−XXX
L
Selective ion conductance in KcsA is controlled by the
dynamics of (i) the intracellular or inner gate, which opens at
an acidic pH through a movement of the TM2 helices; and (ii)
the extracellular or outer gate, that has been proposed to
involve dynamics around the selectivity ﬁlter, and generally in a
nonconductive state when the inner gate is open.265−267 KcsA
is arguably the simplest K+ selective channel that contains the
pore domain conserved across the superfamily. Therefore, it
has been used as a template to investigate lipid interactions
with PDs in various families of K+-channels. The crystallo-
graphic structure of the channel suggests the presence of
binding sites for anionic phospholipids at the extracellular side
of the channel. The binding pockets are located in the
intersubunit crevices between S6 (TM2), where binding of
phospholipid head-groups is enabled by interactions with
highly conserved Arg and Thr residues.46,263,268−270 The lipid-
facing surface of the S6 helix (TM2) contains a large number
of hydrophobic and amphipathic residues, further stabilizing
the fatty acid acyl chains of lipids in the proposed binding
site.268,269,271 The lipid binding to the intersubunit pockets was
proposed to be essential for stabilization of the tetrameric
structure and protection from denaturation.271
Atomistic and coarse-grained MD simulations combined
with NMR data showed that KcsA preferentially interacts with
anionic phospholipids.269 MD simulations performed in
DPPC:DPPG bilayers showed marked diﬀerences in the
protein−lipid binding patterns between KcsA and the chimeric
KcsA-Kv1.3 channel. DPPG lipid bound to both channels, but
the occupancy in the binding site was higher in KcsA.
However, neither lipid is biological for KcsA. Using solid state
NMR, electrophysiology, and MD simulations, Van der
Cruijsen et al. reported that lipid composition aﬀects the
open probability of the prokaryotic potassium channel
KcsA.272 Atomistic MD simulations of 25 ns time scale
suggested the possible relevance of protein−lipid interactions
between the negatively charged amino acids and the positively
charged phosphatidylcholine head groups in the pore loop
region of KcsA and in the chimera KcsA-Kv1.3, which is
directly involved in channel activation. Molina et al. combined
mutagenesis, electrophysiology, and MD simulation studies in
PC membranes to characterize the role of phospholipids in
KcsA clustering, which might be involved in the gating
properties of the channel.273 Weingarth et al. proposed an
alternative mechanism to clustering to explain lipid regulation
in the KcsA channel. They pointed out that Arg residues are a
dominant factor in channel-anionic phospholipids interac-
tions.269 In spite of active modeling and experimental work
over last two decades, the details of the role of lipid−protein
i n t e r a c t i o n s i n K c s A f u n c t i o n r em a i n u n -
clear.140,263,269,271,273−275
3.1.2. Tentative Lipid Binding Sites in K2P Channels.
The K2P channels are structural unique potassium channels
containing two pore-domain sequences per subunit (Figure
4).252,276 K2P channels are probably dimers, and the overall
pore architecture resembles the inwardly rectifying bacterial K+
channels (like KirBac1.1), whose three-dimensional structures
have been determined by crystallography.252,276,277 The
structure of K2P1 channel showed tubular regions near
fenestration windows between the intracellular cavity and
lipid bilayer, which were attributed to alkyl chains from
copuriﬁed lipids.278 Miller et al.278 proposed that these lipid
tails could regulate channel function through steric obstruction
of the ion conduction pathway.278 The inﬂuence of lipids on
the fenestrations within the pore of the K2P1 channel has been
investigated with a multiscale approach combining atomistic
and coarse-grained MD simulations.279 For several other
channels including Navs and Kv channels, the presence of a
fenestration between the transmembrane helices forming the
pore structure has been also reported and implicated in various
lipophilic access mechanisms.252,254,276,280 Aryal et al. reported
that in K2P1 the lipid alkyl chains can indeed access the
fenestration zone in the open state, albeit without occluding
the permeation pathway in the central pore.279 It has been also
suggested that the fenestration windows might be contributing
to the overall hydrophobicity of the intracavitary space and
therefore have an indirect impact on the pore dewetting.
3.1.3. Speciﬁc Binding of PIP2 As a Modulator for
Channel Function. One of the most detailed mechanistic
models involving speciﬁc K+ channel-lipid interactions was
developed for the charged PIP2 lipid. Its speciﬁc modulatory
roles have been ﬁrmly established for the inwardly 2TM
rectifying K+ (Kir) channels (Figure 4).281,282 These channels
play an essential role in molecular processes ranging from
control of the resting membrane potential to regulation of
insulin secretion in pancreatic β cells.283 Selective recruitment
of PIP2 lipid is required for the activation process present in
the closely related G protein-gated inwardly rectifying
potassium (GIRK or Kir3).255,256 Atomic resolution structures
are available for Kir and GIRK channels in the presence or
absence of PIP2.256,257
One of the ﬁrst modeling studies combining CG and
atomistic simulations to explore lipid−protein interaction in
the Kir channels was performed by Stansfeld et al.284 In this
study, three Kir channelsthe KirBac1.1 channel, a Kir3.1-
KirBac1.3 chimera channel, and a homology model of the
Kir6.2 channelwere embedded in a POPC bilayer with 4
PIP2 lipid molecules localized in the cytoplasmic leaﬂet.
Analysis of time-averaged density maps revealed PIP2
preferential localization at four sites present in all three Kir
channels structures, located at a conserved binding site.285 At
physiological pH, PIP2 is expected to have a charge of −4, with
one of two phosphates protonated, enabling interactions
between positive charges located in the cytoplasmic N-
terminus and the pore domains, allowing complex control
over the gating process. The authors proposed that relatively
minor diﬀerences in the sequence of cytoplasmic gating may
result in marked diﬀerences between eukaryotic Kir channel
and bacterial Kir channel activation or inhibition by PIP2,
respectively. The modeling study showed that, once recruited,
PIP2 remains bound over 5 μs-long CG simulations. Several of
the residues identiﬁed in this study involved in lipid−protein
interactions were later conﬁrmed by the high-resolution crystal
structure of the Kir2.2 channel in complex with four short
chain (dioctanoyl) PIP2 lipids.286 Moreover, additional
analysis of the interactions between the channel and the
PIP2 lipids found in crystal structures253,286 and a phosphatidic
acid bound state286,287 provided further support for a speciﬁc
role of PIP2 as a gating modiﬁer with conserved binding
sites.286 Recently, Lacin et al. combined atomistic MD
simulations with electrophysiology to investigate the eﬀect of
PIP2 with the GIRK channel which revealed substantial
diﬀerences between GIRKs and channels from Kir family.288
The authors proposed that, in contrast to Kir channels, PIP2
binds and speciﬁcally interacts with the highly conserved
arginine located in the C-linker, which is essential for coupling
between the cytoplasmic and trans-membrane domains.
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The PIP2 lipids play an important role in the gating
dynamics of canonical voltage-gated K+ channels (Kv). The
binding of PIP2 at the interface between VSD and PD allows
the state-dependent lipid-mediated coupling of the VSD
domain and the proximal residues from the C-terminal/
intracellular gate located in the distal S6 helix. The intracellular
surface in many Kv channels contains a large number of basic
residues and therefore the presence of PIP2 plays a signiﬁcant
role in reducing electrostatic repulsion between basic residues
in the VSD and pore domain, stabilizing the open or closed
states of the channel.244 Electrophysiological studies combined
with mutagenesis unambiguously showed that the presence of
PIP2 lipids is an essential element in the gating process of the
Kv7.1 channel.289,290 The decreased aﬃnity of Kv7.1 for PIP2
due to congenital mutations is associated with long QT
syndrome.291 All-atom MD simulations were performed on the
Kv1.2-based homology models for the open and closed states
of Kv7.1.292 This work showed that PIP2 preferentially
interacts with the S4−S5 linker in the open state of the
Kv7.2 channel, whereas it contacts the S2−S3 loop in the
closed state (Figure 5). The modeling was supported by
electrophysiology and mutagenesis studies. The direct
interactions of PIP2 lipids with the S4−S5 linker seems to
lower both the voltage sensitivity and the current amplitude.
The secondary binding site in the S2−S3 loop linker aﬀects the
current amplitude only. The proposed VSD-localized binding
pockets for PIP2 are in agreement with previously reported
sites from electrophysiology experiments and atomistic MD
simulations.293−296
3.1.4. Cholesterol and PUFAs-Mediated Regulation of
K+ Channels. The debate on K+ channel regulation by
cholesterol or dietary PUFAs abundantly present in neuronal
or myocyte membranes revolves around three major
mechanisms. The ﬁrst mechanism postulates that lipid impact
on the channel function is achieved via direct interactions of
fatty acids with amino acids on the lipid facing side of the
channel, reminiscent of interactions around the fenestration
zone. In the second mechanism, the channels’ function is
sensitive to modiﬁcations in chemical composition of the lipid
bilayer where bilayer ﬂuidity may play a role in the activation
process. The third mechanism relies on speciﬁc interactions
between cholesterol or PUFAs disrupting or modifying
interactions within the protein, thereby shifting state
equilibria.297 Experimental data show that K+ channels from
the Kir family are regulated by cholesterol281 in a stereospeciﬁc
orientation, suggesting the existence of speciﬁc cholesterol
binding sites.298 MD simulations combined with molecular
docking approaches were used to identify at least two
cholesterol binding sites in Kir2.1 channels, which were
conﬁrmed by mutagenesis and electrophysiology studies.299,300
MD simulations also enabled a comparison of predicted
cholesterol interactions of bacterial (KirBac) and mammalian
Kir channels.281 MD studies performed independently
suggested a consensus cholesterol binding region in the
cytoplasmic half of the TM domains of Kir channels.281,298,299
Recently, Bukiya et al. used a combination of homology
modeling and molecular docking to identify two putative
cholesterol binding sites in the G protein-gated inwardly
rectifying potassium (GIRK) channel, which are located
primarily at the center of the transmembrane domain and at
its interface with the cytosolic domains of the channel.301 The
results suggest that cholesterol interaction sites in the Kir3.1
channel overlaps with the previously suggested sites for Kir2.1
(Figure 6).299 For a more detailed review of cholesterol
interactions, see the review by Grouleﬀ et al.36
μs-long CG simulations were recently used to characterize
cholesterol interaction sites on the Kir2.2 channel, which share
ca. 70% of sequence identity with Kir2.1.302 The open and
closed states of Kir2.2 were simulated in a POPC membrane
with increasing concentrations of cholesterol (15 and 30 mol
%). The analysis of the simulation data reveals the diversity of
cholesterol interactions with the channel: persistent contacts
are detected for cholesterol molecules bound into deeper
pockets between TM helices, while more frequent and
transient interactions are observed for a number of residues
located at the protein−lipid interface. The simulations allow
Figure 5. State-dependent PIP2 lipid interactions in the Kv7.2
channel. Zhang et al. used atomistic MD simulations to model the
interactions of PIP2 lipids in the open (A) and closed (B) state of the
channel.292 Shown are the trajectories of PIP2 lipid molecules as a
function of time near the channel (viewed from the intracellular side).
PIP2 migrates toward the S4−S5 linker in the open state (A) and
toward the S2−S3 linker in the closed state (B). Adapted with
permission from ref 292. Copyright 2013 Zhang et al.
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the characterization of cholesterol interaction sites that not
only diﬀer between the open (sites I and II) and the closed
(sites III and IV) state but also show a diﬀerent sensitivity to
cholesterol depending on the cholesterol concentration
(Figure 7).
Another group of K+-selective channels sensitive to
cholesterol levels in plasma membranes are the large
conductance voltage- and Ca2+-gated K+ channels, also
known as “big potassium” (BK) channels. BK channels are
found in most human cell membranes and control a variety of
biological processes, such as circadian behavioral rhythms and
neuronal excitability.303 Experimental studies initially related
the reduction of activity in the BK channels with changes in
the physical properties of the bulk lipid bilayer upon
cholesterol insertion in the bilayer.304
Experimental results showed that sterols and PUFAs
embedded in the lipid bilayer also directly modulate gating
of Kv1.5 and Kv2.1 channels.297,305 PUFA binding to Kv1.2 in
both closed and open states was reported recently from μs-long
atomistic MD simulations.306 The authors found a potential
PUFA-Shaker Kv interaction site located on the lipid−facing
side of S3−S4 linker and present only in the open state,
conﬁrmed by electrophysiology. It was also shown that
headgroup charge and PUFA tail structure are both important
determinants of speciﬁc binding to Kv channels.297,307 Thus,
there is mounting evidence for the speciﬁc Kv channel
regulation by cholesterol and PUFAs, a mechanism that can
be potentially explored for therapeutic applications.307 In
addition to PUFAs, polyunsaturated and fully saturated lipids
also adopt a unique distribution around Kv channels, as
recently shown by a CG study where Kv1.2 channels were
simulated for 30 μs in a complex membrane model (Figure
8),121 further highlighting the complexity of the lipid−protein
interplay and the need for a better understanding of lipid-
mediated channel modulation.
The exact mechanisms of Kv function regulation by
membrane lipids are complex and yet to be established.
Recently, Zakany et al. used a combination of two-electrode
voltage-clamp ﬂuorometry with a nonstationary noise analysis
to show that cholesterol impacts predominantly the single-
channel current rather than modifying the gating process in the
Figure 6. Rosenhouse-Dantsker et al. identiﬁed speciﬁc cholesterol-
protein interactions in the Kir2.1 channel by combining molecular
docking, MD simulations, mutagenesis, and electrophysiology experi-
ments.299 A. Cholesterol binding sites identiﬁed via molecular docking
and MD simulations. In blue are residues lining the cholesterol
binding sites, while in red are residues whose mutation alters
cholesterol sensitivity. B. Schematic representation of the identiﬁed
cholesterol interaction sites with respect to the architecture of the
channel. Reproduced with permission from ref 299. Copyright 2013
The American Society for Biochemistry and Molecular Biology, Inc.
Figure 7. Kir2.2 cholesterol binding sites identiﬁed with CG MD
simulations. Simulation snapshots of Kir2.2 with cholesterol
molecules (in yellow) bound to sites I and II in the open state and
to sites III, IV and Ib in the closed state.302 Reproduced with
permission from ref 302. Copyright 2018 Biophysical Society.
Figure 8. Lipid distribution around Kv1.2 described by CG MD
simulations. MD simulations of Kv1.2 in a plasma membrane mixture
revealed an asymmetric distribution of polyunsaturated (PU), fully
saturated (FS) lipids and cholesterol (CHOL) between upper and
lower.121 The simulation system consisted of 4 copies of Kv1.2 and ca.
6000 lipids. Shown are 2D distribution maps for PU, FS lipids,
CHOL, and the class Others (which groups all the remaining lipid
classes of the plasma membrane mixtures), highlighting enrichment
(red) and depletion (blue) with respect to the average value of the
corresponding class in each leaﬂet. Figure generated as described in
Corradi et al. for Aquaporin 1.121
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Kv1.3 and Kv10.1 channels. Sterols may, therefore, have
binding sites in the pore domain of Kv channels.308
3.1.5. Lipid Regulation of Nav Channel Function.
Progress in understanding the roles of lipids in the family of
voltage-gated Na+ channels was facilitated by the X-ray
structure of the bacterial channel NavAb by Payandeh et al.
(Figure 4).254 This structure was followed by several other
bacterial channels.309−312 Unlike their eukaryotic counterparts,
which consist of a single polypeptide chain, the functional unit
of the bacterial Na+ channels is a homotetramer,313,314 but it
has been shown to possess many of the key elements of
mammalian channels.315 The NavAb pore domain features
lateral openings, already mentioned above, directly connecting
the central pore to the surrounding lipid phase. The crystal
structure shows that electron densities assigned to phospho-
lipids protrude through the fenestration zone and may
physically impact ion transport through the pore.254 MD
simulations, focused on the mechanism of Na+ permeation,
have also suggested possible roles of lipids bound to the
fenestrations.316−318 The presence of lipids in these lateral
fenestrations is linked to their size and shape as shown by MD
simulation studies on bacterial Nav channels (NavAb closed,
NavAb inactivated, NavRh and NavMs) embedded in POPC
membranes.319 In this work the authors reported a clear
connection between the presence of lipid in fenestration and
the fenestration size. The fenestration reduced in size when the
lipids retracted from the cavities. The widening of the
fenestrations was inﬂuenced by protein conformational
changes that potentiate the entrance of lipids to these cavities.
Lipid tails also force side-chains toward the sides of the
fenestrations, resulting in a larger pore. Ulmschneider et al.
observed that lipids can access the fenestrations multiple times
over μs-long simulations, showing that channel-lipid inter-
actions are transient.320 Experimental results suggested that
cholesterol regulation of membrane properties indirectly
regulates the function of Nav channels.243 Atomistic MD
simulation of the NavAb channel in POPC:chol membranes
have also shown that cholesterol does not directly interact with
the channel.321 The results suggested that cholesterol may
inﬂuence Nav channel function by aﬀecting the physical
properties of lipid bilayers such as lipid packing, bilayer
thickness, and lipid movement.
Figure 9. Ligand-gated channels. From left to right are the structures of the nicotinic acetylcholine receptor (nAchR),323 the P2X3 channel324 and
the TRPV1 channel.60 For each structure, the individual monomers are colored from light yellow to dark brown. ATP molecules bound to P2X3
and resiniferatoxin (RTX) bound to TRPV1 are shown in white spheres. ECD, extracellular domain; ICD, intracellular domain. The top panels
show a side view of the proteins, with the membrane region highlighted in gray. The lower panels are the view from the extracellular side. The
functional assembly of nAchR includes ﬁve protomers labeled α to γ, with each monomer comprised of trans-membrane sections (helices M1 to
M4) and the extra-cellular domain (ECD). P2X3 channels are assembled as functional trimers with each monomer containing a trans-membrane
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3.2. Lipid Regulation of Ligand-Gated Channels
Ligand-gated channels change state in response to chemical
stimuli. The functions played by members of this family are as
diverse as the family itself (Figure 9). For example, glutamate-
receptor ion channels (iGluRs) mediate the fast component of
excitatory glutamatergic neurotransmission in the central
nervous system. Cys-loop receptors activated by a variety of
neurotransmitters are essential components of the excitatory
and inhibitory transmission in the central and peripheral
nervous systems.322 Excitable membranes show a distinct lipid
composition, which may be related at least in part to lipid−
protein interactions.
3.2.1. Lipid Modulation of Cys-Loop Receptors. The
Cys-loop receptors constitute an important superfamily of
mainly pentameric ligand-gated ion channels (LGICs) named
after a cysteine bridge present in the N-terminal extracellular
domain for all members of the family. Depending on the
preferred charge carrier, this family of the receptors is
subdivided into cation and anion selective cys-loop recep-
tors.322 A unique binding site located in the N-terminal ligand-
recognition domain deﬁnes the type of the receptor, e.g.,
acetylcholine (ACh), serotonin, glycine, glutamate or γ-
aminobuturic acid receptors.322,325−327 The preferred substrate
binding to one or more binding sites triggers pore opening (or
closure) enabling selective permeation, which is controlled by
the selectivity ﬁlter located in the trans-membrane domain of
the receptor. Each subunit is usually formed by three domains:
(i) the large ECD containing the ligand-binding site; (ii) the
transmembrane domains that consist of four transmembrane-
α-helices (M1-M4); and (iii) the intracellular domain (ICD)
that is primarily formed by the large M3-M4 intracellular loop
which permits the access of ions in and out of the pore and is
involved directly in ion permeation (Figure 9). The interface
between the EC and TM domains seems to play a key role in
the gating process and is thought to be additionally regulated
by lipid molecules closely associated with the TMD.322,325,326
One of the best characterized members of the family is the
nicotinic acetylcholine receptor (nAChR), a cation-selective
channel expressed in many kinds of both excitable and
nonexcitable cells (Figure 9). Experimental studies have
demonstrated that the incorporation of cholesterol in lipid
vesicles is essential for nAChr to retain its functional
activity.328 Thus, when the nAChR was reconstituted into
PC membranes without cholesterol, agonists no longer
simulated cation ﬂux. Photolabeling studies have shown that
sterols interact directly with the nAChR’s lipid-exposed TM
helices.329 Brannigan et al. demonstrated the presence of
internal cholesterol binding sites in the cryo-EM structures of
the nAChr channel.330 Also, the authors compared the stability
of these structures with and without cholesterol by atomistic
MD simulations. Overall, the authors suggested that the role of
cholesterol in the membrane is to stabilize the trans-membrane
domain of the channel. Cholesterol and 1-palmitoyl-2-oleyl
phosphatidic acid (POPA) interactions with the channel have
been also proposed to play a more direct role in the gating
process of Torpedo nAChr channels. From 10 ns long MD
simulations performed in POPC:POPA:cholesterol mem-
branes the authors suggested that cholesterol and POPA
bind speciﬁcally to one of the key lysines directly implicated in
activation of nAChR.331 Give the simulation length and the
transient nature of cholesterol-channel interactions discussed
in this review, the exact mechanism of cholesterol-dependent
gating in nAChR requires additional studies.
The lipid-dependent gating was also proposed to exist in the
glycine receptors (GlyRs) and the γ-aminobuturic receptors
(GABAAR). Structural models for GABAAR and GlyR were
built using the eukaryotic chloride channel (GluCl, from
Ceanorhabditis elegans) as a template and then used for MD
simulations.332 This GluCl was cocrystallized with invermectin
(an anthelmintic drug), which behaves as an allosteric agonist
on this receptor and related Cys-loop receptors.327 MD
simulation of GABAAR identiﬁed that the intersubunit
(invermectin) sites in the transmembrane domain are potential
cholesterol-binding sites that were present in other GABAAR
models. In each interface between subunits, residues belonging
to helices M1 and M3 form a belt of nonpolar contacts around
the steroidal nucleus of cholesterol. Also, the conserved Ser
residue from helix M2 was proposed as a key interacting
residue with cholesterol. Combining MD simulations with
homology modeling, Henin et al. proposed that the depletion
and enrichment of cholesterol have a negative impact on the
interaction between the GABAAR and the endogenous ligand
GABA.333 They proposed that the decreased potency at low
cholesterol concentrations may reﬂect the direct interactions
established between GABAAR and this lipid. In contrast, the
decreased potency of the receptor at high cholesterol
concentration may be due to the changes in the physical
properties of the membrane, such as ﬂuidity and thickness.
3.2.2. Lipid Modulation of ATP-Gated Channels.
Ionotropic P2X receptors are canonical ligand (ATP) gated
channels permeable to mono- and divalent cations.334 The P2X
subunit is comprised of two TM domains (TM1 and TM2),
often separated by Cys-rich ectodomains,335 intracellular C-
and N-terminal domains, and a large extracellular ligand-
binding loop with a highly variable sequence in diﬀerent
members of the family.336 The functional assembly of the P2X
is a trimer, where the trans-membrane pore is formed by six α-
helical TMs (TM1 and TM2 from each of the protomers)
(Figure 9).335,337,338 The available high-resolution structure of
the open state of the P2X3 receptor324 displays a continuous
narrow pore with a narrowest constriction radius of only ∼3.2
Å, e.g. consistent with the radius of a dehydrated Na+ ion.
Residues from the TM2 helix line the permeation pathway.
Structural modeling based on the available structure of the
P2X4 receptor from zebraﬁsh also supports an essential role of
TM2 in water and ion permeation.337,338 However, the
functional mechanism of ATP activation of P2X receptors
enabling cation permeation remains highly controversial. For
example, prolonged exposure to ATP was proposed to result in
a “dilated” state of the channel, highly permeable to large
cations such as spermidine or NMDG+ with a cross-sectional
radius considerably greater than that found in the published
crystal structure.339
The functional assembly of the human P2X3 receptor in its
open state shows a separation at the outer ends of the TM
helices with well-deﬁned lipid-exposed surfaces. Rothwell et al.
proposed that membrane lipid must enter in the large cavities
that appear between the outer ends of the TM helices by
comparing the open and closed structure of the receptor.340
The authors combined electrophysiology, homology modeling
and MD simulations to characterize the dynamics of this
region during channel gating.340 They suggested that in the
open state the lipids enter in the interstices between the outer
end of the transmembrane domain, while in the closed state
these residues packed together, diminishing the possibility of
interaction with lipids. Mansoor et al. suggested the
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fenestrations in the open state of the channel as plausible route
for ion transport with polar lipids head groups lining the
fenestration zone.324 In a follow-up study, Scheurer et al.
performed extensive analysis of lipid-ion interactions during
permeation events observed in 0.5 μs of all-atom MD
simulations of P2X3 receptor in POPC membrane.341 The
authors concluded that Na+ interactions with the phospholipid
head-groups may be an essential mechanism of permeant
cation recruitment to the channel’s lumen.
Lipid-speciﬁc eﬀects have also been proposed to play
essential roles in the regulation of P2X function and Na+ or
NMDG+ transport via yet unknown mechanisms. Robinson et
al. showed that the cholesterol content of the plasma
membrane is an essential factor in regulation of P2X7
receptors.342 Cholesterol depletion of cell membranes was
associated with a high rate of agonist-induced pore formation.
Subsequent electrophysiology studies of P2X7 receptor
currents also indicated an enhanced activation and current
facilitation following cholesterol depletion. However, the
sensitivity of the P2X receptors to cholesterol content varies
greatly among various family members.343,344 The experimen-
tal data collected to date suggest that P2X receptor subtypes
may be diﬀerentially targeted to cholesterol-rich regions of the
membrane.
3.2.3. TRP Channels. Transient receptor potential (TRP)
channels form an important family of potassium channels
involved in sensing a variety of stimuli in living organ-
isms.345,346 While TRP channels can be regulated by heat and
membrane voltage, they are most commonly associated with
activation by ligand binding (vanilloid-binding, melastin-
related, etc.). The TRPV1 structures in open and closed
conﬁgurations60,347 show striking organizational similarity to
the Kv channels discussed above. Structurally, TRPV1
channels are homotetramers of subunits organized around a
central aqueous pore (Figure 9), with several additional
domains besides the canonical Kv voltage sensing domain
(S1−S4) and pore domain, including the TRP domain and an
ankyrin repeat domain (ARD) in the intracellular side.
MD simulations combined with molecular docking and
mutagenesis indicated that PIP2 lipids are able to induce
conformational changes in the TRPV1 channel, suggesting this
lipid as agonist.348 The authors identiﬁed a PIP2 lipid binding
site located between the TRP domain and the S4−S5 linker,
where PIP2 interacts with two conserved arginines in the S4−
S5 linker and a lysine in the TPR domain. The binding of PIP2
lipid couples the VSD to the TRP domain and induces
structural changes in the S6 helix. Takahashi et al. showed that
PIP2 binding to the ARD domain of TRPV4 regulates the
activity of the channel.349 This study showed that the ARD
domain interacts with the inositol headgroup of PIP2, which
negatively regulates the channel activity. Additionally, the most
recent cryo-EM study of TRPV1 in a lipid nanodisk showed
that PIP2 lipids are embedded in the vanilloid binding pockets
(VBP) located at the S4−S5 linker of the channel.60 Atomistic
MD simulations of TRPV1 combined with mutagenesis
experiments, showed that at high temperatures the lipids
present in the VBP are displaced and lipid unbinding may act
as a heat sensing mechanism.350 Zimova et al. combined
atomistic MD simulations and homology modeling to identify
residues putatively involved in PIP2 binding in TRPA1 at the
S1−S4 sensor.351 The PIP2 binding sites are very similar to
previously reported in the TRPV1 and TRPV2 struc-
tures.60,352,353 These results reaﬃrm the role of PIP2 as
coupling elements regulating the voltage sensing properties of
the TRP channels by occupying channel hydrophobic pockets
with PIP2’s aliphatic chain. TRP channels have been also
reported to be regulated by cholesterol. Experimental evidence
suggests that cholesterol may inﬂuence TRP channel proper-
ties such as threshold activation temperatures and channel
currents.344,354 Saha et al. predicted possible interactions of
cholesterol with CRAC-like domains present in the hTRPV1
channel sequence.355 Docking studies suggested high aﬃnity
cholesterol binding to the conserved CRAC-motif in TRP
channel. However, future atomistic simulations may be needed
to provide detailed information on apparent aﬃnities and
residence times, as well as speciﬁc mechanism of TRPs
function regulation by cholesterol.
3.3. Bacterial Mechanosensitive Channels
Bacterial mechanosensitive channels (MS) regulate and
maintain osmotic homeostasis. During hypo-osmotic shock,
MS channels transition from a closed to an open conforma-
tional state, allowing for cytoplasmic osmolytes to escape and
prevent cell lysis.356 MS channels, rather than directly sensing
the increase in cell volume, are activated by membrane tension
which is a result of increased internal cell pressure.357 In
prokaryotic cells, MS are classiﬁed into large (MscL), medium
(MscM), and small (MscS) conductance, an example of which
is shown in Figure 10. The classiﬁcation is mainly functional,
Figure 10. Open and closed structures of the MscS channel. Side view
(upper panels) and view from the periplasmic side (bottom panels) of
an open and closed MscS channel.359,360 Each monomer is shown in
cartoons and colored on a scale from light yellow to dark brown. Per,
periplasm; In, intracellular side. The hydrophobic region of the
membrane is highlighted in gray.
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but they also diﬀer in their primary sequence, spatial topology,
and, in what is becoming increasingly more evident, the driving
forces governing their opening mechanism.356,358
MscS induces a local bilayer curvature361 that could, at least
in part, account for its sensitivity to lateral membrane
tension,362,363 whereas global curvature was found to have a
negligible eﬀect.363 The discovery of lipid acyl chains ﬁlling
crevices on the TM domain of MscS suggested the
involvement of lipid−protein interactions in its gating
mechanism.359 Biophysical experiments and MD simulations
showed that this acyl chain binding is in a dynamic equilibrium
with lipids in the membrane and more prevalent in the closed
state of the channel. Membrane tension shifts this equilibrium
toward the bilayer, inducing the transitioning of the receptor to
the open state.359 MscL activation, in comparison, involves an
increase in channel cross-section area leading to hydrophobic
mismatch.357 Essentially, an increase in lateral membrane
tension produces the acute tilting of MscL TM helices,
necessary to trigger channel opening.358 This tilting-mediated
channel opening was also seen in previous CG MD
simulations.364365 Bavi et al., using an array of experimental
techniques combined with MD simulations, found the N-
terminus of MscL is located at the lipid−solvent interface and
responsible for translating the membrane tension-generated
torque into a conformational change mechanical force.366
Interestingly, lipid tail binding and expulsion from MscL
pockets resembles that of MscS; however, their continued
interaction with the N-terminus points suggests removal of
lipid tails does not trigger MscL activation but, rather, is a
result of it.,366367 MS channel sensing of membrane tension is
not contingent on the availability of other proteins or
cofactors, but can be modulated by the presence of membrane
additives such as alcohols or short chain lipids as demonstrated
in combined experimental and simulation studies.368,369
Current evidence supports a complex mechanism of MscL
and MscS channel gating involving membrane curvature and
hydrophobic mismatch, respectively, and an intimate relation-
ship with individual lipid chains.357,367,370
4. RESPIRATORY PROTEINS
Mitochondria are essential intracellular compartments found in
most eukaryotic cells. These membrane-bound organelles
synthesize most of the energy used by our cells. A complex
mechanism involving a series of oxidoreduction reactions
Figure 11. CLs stabilize supercomplexes in large scale CG MD simulations. Top: Snapshot of ﬁnal conﬁguration of the system containing CIII and
CIV, indicating the presence of many supercomplexes. Bottom: Close-up view on a particular supercomplex with CLs present at the protein−
protein interface. Figure courtesy of Clement Arnarez.
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carried out by several enzymes embedded in the inner
membrane of mitochondria, known as the respiratory chain,
is responsible for this synthesis. The enzymes forming the
respiratory chain are complex I (NADH dehydrogenase),
complex III (cytochrome bc1), and complex IV (cytochrome c
oxidase); these proteins act in unison to create the proton
gradient required by the ATP synthase, often called the
complex V of the respiratory chain, to convert ADP into ATP.
Complex II, succinate dehydrogenase, is not directly involved
in the building of the proton gradient. Another important
player is the ADP/ATP carrier (AAC), also known as adenine
nucleotide translocase, which exchanges ADP and ATP across
the inner mitochondrial membrane. Figure 11 illustrates key
aspects of complexes III and IV.
The proton gradient used by the ATP synthase to construct
ATP is the result of a series of electron transfers. Most of these
transfers are carried out between speciﬁc redox centers
included in, or diﬀusing between, the three respiratory chain
protein complexes I (CI), III (CIII), and IV (CIV). One cycle
of the respiratory chain involves at least three protein
complexes (CI, CIII, and CIV) and two electron carriers
(QH2/Q and the cytochrome c). The buildup of the proton
gradient, and, by extension, the rate of ATP synthesis are thus
limited by the encounter rate of these molecules and depends
critically on the large scale organization of the respiratory chain
complexes. Over the last decades, the existence of a higher-
order organization of the respiratory chain has been
demonstrated through various techniques, notably blue-native
gel electrophoresis (BN-PAGE) and electron microscopy. The
three protein complexes seem to assemble into larger
structures named supercomplexes (together deﬁning the
respirasome),371−373 which potentially would facilitate the
electron transport between them.
The composition of the inner mitochondrial membrane
plays a critical role in the respiratory chain process. The lipid
environment includes a speciﬁc variety of head groups, with
three major components being phosphatidylcholine (PC),
phosphatidylethanolamine (PE), and cardiolipins (CL). In
particular CL has been shown to have an eﬀect on both
stability and functionality of the whole respiratory chain, with
CL alterations causing malfunction and disease.374,375 In Barth
syndrome (caused by a mutation leading to cardiomyopathy,
skeletal myopathy, and growth retardation), for instance, the
mitochondrial inner membrane shows a lower content of CL
and/or a spread in the composition of their alkyl tails.376 BN-
PAGE analyses performed on such cells report a decrease in
supercomplex formation and an increase in monomeric free
complexes. CL seems to be involved at every level of the
respiratory chain process: maintaining the functionality of
independent complexes, allowing the formation of super-
complexes and stabilizing them, and preserving the function-
ality of these assemblies.377−379 Zhang et al. labeled CL as the
“glue holding supercomplexes together”.380 CLs are present in
the crystal structures of the respiratory chain complexes,381
however, deeply embedded inside the core of the proteins. It is
therefore not clear how these CLs could regulate supercomplex
formation.
In addition, CL has been implicated as an important
signaling lipid,382 involved in shaping or stabilizing cristae,383
and as proton carrier. To shed light on this multifaceted role of
CL, simulation studies have recently entered this ﬁeld.
4.1. CL Binding Sites
To explain the putative role of CLs in gluing respiratory chains
together, Arnarez et al. hypothesized that CL binding sites exist
at the membrane-exposed surface of the proteins that
constitute the respiratory chain.384 The use of protocols to
purify proteins in which detergents often wash away lipids that
are exposed to the bulk membrane can easily rationalize the
absence of such bound CLs in the crystal structures. To test
the hypothesis, Arnarez et al. performed extensive (100 μs)
CG MD simulations of the cytochrome bc1 (CIII) dimer from
bovine heart, embedded in a model mitochondrial membrane
composed of POPC lipids together with CL at a 20:1 molar
ratio.384 The length of the simulation allowed observation of
reversible binding and unbinding events of CLs around the
protein. Subsequent analysis of the average CL density
revealed the existence of six binding sites, all on the matrix
side of the protein and including sites known from earlier
structural studies and buried into protein cavities. The sites
proved stable upon backmapping the conﬁguration to all-atom
resolution and performing an additional 100 ns atomistic
simulation. Interestingly, identical CL binding sites were found
in simulations of the same complex extracted from yeast. Using
a similar protocol, the same authors analyzed the CL density
around bovine heart CIV.385 Here, seven binding sites were
found on either leaﬂet of the membrane. In a related study,
also based on the Martini CG force ﬁeld, Duncan et al.
revealed transient CL binding sites on the rotor part of ATP
synthase (CV), discussed in more detail below.386
Poyry et al. also studied the role of CL, through atomistic
MD of the CIII dimer of the purple photosynthetic bacterium
Rhodobacter capsulatus, embedded in mixed PC/PE/CL
membranes.387 Although the time scales explored in this
study (200 ns) are much smaller than accessible with a CG
model, evidence for CL binding sites was obtained. In
particular, the authors observe CLs to spontaneously diﬀuse
to the dimer interface, in the immediate vicinity of the
complex’s catalytic quinone reduction sites and in agreement
with crystallographic studies of the complex. Sharma et al.
performed atomistic simulations of CIV, embedded in mixed
PC/PE/CL membranes, focusing on the stability of lipids near
one of the proton uptake pathways.388 The results show that
diﬀerent lipid types can be bound, in line with crystallographic
data from diﬀerent organisms. The authors further predict that
CL also forms stable interactions.
CL binding sites were also observed in simulations of the
ATP/ADP carrier (AAC) protein. Using simulations at both
coarse-grained and atomistic resolutions, Hedger et al.
identiﬁed three CL binding sites on this translocase, in
agreement with those seen in crystal structures and inferred
from nuclear magnetic resonance measurements.389 An
overlapping study of Duncan et al. conﬁrmed these ﬁndings.390
The studies described above conﬁrm previously found CL
binding sites and reveal hitherto unknown sites on the
membrane−exposed surfaces of the respiratory chain com-
plexes. These surface bound CLs could play an important role
in, e.g., proton uptake,385−388 or by providing structural
integrity of the complexes and supercomplexes.384 Analysis of
the distribution of residues in contact with the CLs show that,
in general, the binding sites observed in MD simulations are
enriched in positively charged residues. This behavior is
consistent with the negative charge of cardiolipins and in
agreement with a generic analysis on CL binding motifs across
the protein databank.381 Nevertheless, the bulky tails of CL are
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also important. In the study of Arnarez et al. on CIV, the
potential of mean forces (PMFs) of CL binding between
diﬀerent CL variants were compared, revealing an almost
equally strong contribution of the tails and the charged
headgroup to the overall binding strength.385 PMFs computed
in the study of Hedger et al. furthermore show that other
anionic lipids, such as PS, have an aﬃnity intermediate
between CL and PC.389
4.2. CL Mediated Supercomplex Formation
Respiratory chain complexes self-organize into supramolecular
structures called respiratory supercomplexes or respira-
somes.371−373 Numerous experimental studies have shown
the existence of supercomplexes consisting of CI, CIII, and
CIV. The formation and stability of these supercomplexes
strongly depends on the presence of CLs in the membrane
environment.377−380 Arnarez et al. hypothesized that the
bound CLs identiﬁed on the membrane-exposed surface of
the complexes actually play a key role in gluing the respiratory
chain together.384 The presence of CLs at speciﬁc locations of
the protein surface might either prevent the binding of
potential partners at that same location (“protective mode”) or
the CL binding sites might deﬁne the actual location at which
the proteins interact and CLs glue the proteins together
(“bridging mode”).
Initial small scale self-assembly CG MD simulations of
respiratory chain complexes CIII and CIV indeed show
formation of a CIII−CIV supercomplex, with CL present at
the interface between the complexes.384 In a follow up study,
the formation of supercomplexes was simulated at a much
larger scale.391 Here, the system included 9 CIII dimers, 27
CIV monomers, 18 679 POPC lipids, and 1165 CLs, being one
of the ﬁrst example simulations of a realistically complex and
crowded membrane system. This system was simulated for 20
μs, starting from an initial randomized distribution of the
protein complexes. Although this time scale is too short to
obtain an equilibrium lateral distribution of the proteins in the
membrane (lateral diﬀusion and binding/unbinding of
membrane proteins are notoriously slow processes), the
formation of supercomplexes was clearly observed as shown
in Figure 11 (top). Analysis of the protein−protein interfaces
of the supercomplexes shows that CLs are becoming enriched
during the simulation. At the end of the simulations, the ratio
of PC/CL lipids is increased from 1:15 in the bulk to 1:5 in the
annular shell of the isolated proteins and 1:2−3 considering
the protein−protein interfaces. A typical example of a CIII−
CIV supercomplex is shown in Figure 11, with the CLs present
at the interface highlighted. Further analysis reveals that the
CL binding sites are conserved on each of the complexes and
are shared in the supercomplex formed, suggesting that they
operate according to a bridging mode. CG MD simulation of
large patches of a model mitochondrial membrane containing
multiple copies of the ATP/ADP carrier also show that CL
interactions persist in the presence of protein−protein
interactions and suggests CL may mediate interactions
between translocases.389 CG simulations in combinations
with experimental biophysical methods also propose that
CLs mediate the interactions between components of the
translocase of the inner mitochondrial membrane 23 (TIM23)
complex.392
Taken together, MD data support a role for CL in steering
the formation of supercomplexes in mitochondrial membranes
and reveal a mechanism that implies supercomplex organ-
ization is regulated by CL binding sites.
5. ATP-BINDING CASSETTE TRANSPORTERS
ATP-binding cassette (ABC) transporters constitute a large
superfamily of membrane proteins and include both exporters
(in prokaryotes and eukaryotes) and importers (in prokar-
yotes).393 Their substrates cover a broad range of chemical
diversity, ranging from ions to sugars, amino acids, peptides,
proteins, toxins, metabolites, drugs, sterols, and lipids. With the
exception of a few subfamilies, all ABC transporters feature two
cytosolic nucleotide-binding domains (NBDs), and two
transmembrane domains (TMDs), whose structural architec-
ture and hallmarks diﬀer between importers and exporters, as
well as across subfamilies.394 This structural diversity is
reﬂected in diﬀerent mechanistic details of the transport
cycle, although general features exist.394 Transport is powered
by ATP binding and hydrolysis at the NBDs, triggering their
dimerization and dissociation, respectively. These motions are
in turn coupled with changes in the TMDs, which provide a
translocation pathway ﬁrst accessible from one side of the
membrane for substrate uptake and then open to the opposite
side for substrate release (Figure 12).
Figure 12. Structural features of an ABC exporter. The two halves of
P-glycoprotein are shown in orange and light yellow cartoons for the
(left) inward-facing395 and (right) outward-facing396 state. ATP
molecules bound to the nucleotide binding domains (NBD1 and
NBD2) of the outward-facing state are shown in white spheres.
TMD1 and TMD2 indicate the two transmembrane domains,
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Puriﬁcation and reconstitution studies for the character-
ization of ABC transporters have highlighted the eﬀects of
membrane composition on protein structure and func-
tion,397−412 while speciﬁc lipid species tightly bound to the
protein have been identiﬁed by mass spectrometry,413−415
crystallography, and cryo-EM studies.415−419 In this context,
molecular dynamics simulations have provided molecular
insights into the lipids organization and dynamics around
ABC transporters.
The transporter associated with antigen processing (TAP)
translocates antigenic peptides, derived from proteosomal
degradation, into the endoplasmic reticulum, for loading of
major histocompatibility class I molecules.420 Experimental
estimates found 22 lipids are required around TAP in a
nanodisc to bind an inhibiting protein.421 Atomistic simu-
lations showed that 22 lipids are indeed suﬃcient to surround
TAP, although their detailed structure diﬀered signiﬁcantly
from a control simulation in a bilayer.421
Other simulations studies employed MD simulations for a
more detailed characterization of lipid−protein interactions.
The E. coli ABC transporter McjD translocates microcin J25
(MccJ25), a 21 amino acids long peptide with antibacterial
activity.422,423 Mass spectrometry studies revealed the presence
of PG and PE lipids together with lipopolysaccharide tightly
bound to the transporter.415 Retention of PG lipids after
protein delipidation together with a higher ligand-induced
ATPase activity stimulated by PG lipids in comparison to other
lipids suggested a functional role for this negatively charged
lipid species.415 To investigate the molecular interactions
between McjD and lipids, 40 μs-long CG molecular dynamics
simulations using the Martini model were carried out in lipid
bilayers of POPE, POPG, and CL in diﬀerent ratios.415 The
negatively charged head groups of PG and/or CL were shown
to preferentially interact with arginine and lysine residues
located at the interface with the cytosolic side of the
membrane. In binary and ternary mixtures, these interactions
reduced the contacts between the protein and PE lipids,
although these zwitterionic lipids remained colocalized within
the same lipid shell (Figure 13).415 These ﬁndings support the
crystallization of McjD with a PG lipid molecule.415
Combining equilibrium and nonequilibrium simulations to
pull the MccJ25 substrate out of the occluded cavity of
McjD424 could also provide a tool to look at coupling of
conformational changes to lipid−protein interactions.
In a recent study,425 the results of Martini CG simulations
were converted to the atomistic level of detail to investigate the
protein−lipid interplay for P-glycoprotein, an ABC multidrug
transporter involved in cancer drug resistance.426 A homology
model of human P-glycoprotein with the TMD cavity open to
the cytosol and the NBDs in contact with each other was
embedded in a more complex membrane, consisting of POPE,
POPC, POPS, SM lipids, and cholesterol, to mimic the
composition of brain epithelial cell membranes.425 Multiple
replicas of the same system were simulated for 10 μs, followed
by an additional 100 ns of simulation time after converting the
system to the atomistic level of detail using the backward
Martini tool.135 This computational approach revealed ordered
rings of lipids around P-glycoprotein, similarly to what has
been proposed for McjD415 and smaller transmembrane
domains.427 PS lipids were identiﬁed, in particular, in the
ﬁrst lipid shell around the protein, due to positively charged
residues located at the water interface of the inner leaﬂet, as
observed for McjD,415 and in line with experimental ﬁndings
from mass spectrometry suggesting that P-glycoprotein
preferentially binds negatively charged lipids.413 The simu-
lations also provided insights on the interactions between P-
Figure 13. Lipid organization around the ABC transporter McjD. CG simulations of the McjD transporter were carried out in diﬀerent mixtures
(A−D) of POPE, POPG, and cardiolipin.415 Preferential interactions in the binary and tertiary mixtures with the headgroup of anionic lipids were
driven by electrostatic interactions with several positively charged residues. Shown are the headgroup number density maps for the four simulated
systems, with the densities of POPE, POPG, and cardiolipin in cyan, magenta, and yellow, respectively, for upper and lower leaﬂet. Adapted with
permission from ref 415. Copyright 2016 The American Society for Biochemistry and Molecular Biology, Inc.
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glycoprotein and cholesterol: multiple cholesterol binding
sites, deﬁned based on a distance cutoﬀ and contact time
duration, were retrieved on the protein surface, with a
prominent binding site located in a cleft formed by
transmembrane helices 10 and 12, which line one of the
entries to the main cavity of the transporter.425 The
distribution of cholesterol around the TMDs of ABCC4, also
known as MRP4, was also studied via atomistic MD
simulations in POPC:cholesterol mixtures. Increasing choles-
terol concentrations, reﬂected in higher thickness of the
membrane, reduced the degree of opening between the NBDs,
showing how the modulatory eﬀect of lipids might extend to
domains not embedded in the membrane.428
The presence of positively charged residues promoting
interactions with negatively charged lipids has also been
reported for the bacterial transporter TmrAB, an ABC exporter
from T. thermophilus with a broad spectrum of substrate
speciﬁcity.412 As for many other ABC transporters, TmrAB
function is modulated by the lipid composition, with negatively
charged lipids such as PG lipids essential for transport,412 and
found tightly bound to the transporter.414 To characterize lipid
binding sites, Noll et al. used atomistic molecular dynamics
simulations of TmrAB in POPE or POPG bilayers, on time
scales ranging from 0.5 to 2 μs. As previously discussed for
McjD and P-glycoprotein,415,425 the binding of either POPE or
POPG molecules to TmrAB was driven by clusters of
positively charged residues located at the interface region of
the inner or outer leaﬂet of the membrane.412
The interplay between ABC transporters and lipids is not
limited to protein function or structure modulation. Many
ABC transporters carry out transport of sterols, lipids, or lipid-
like molecules, and mutations in these transporters are linked
to several diseases, including, for instance, Tangier and
Stargardt disease.429 MD simulations can be used to character-
ize the details and pathways of lipids uptake into the main
cavity of the transporters. An early study where such events
were detected is the work of Ward et al.,116 who applied the
multiscale CG (MS-CG) method118 to develop CG potentials
suitable for the investigations of lipid−protein interactions
starting from atomistic simulations of the reference systems.
To test these potentials, the bacterial ABC exporter MsbA,
embedded in a DOPE:DOPC membrane, was used. During
the simulations of the conformational state with a large
intracellular opening, lipids were observed to diﬀuse into the
main cavity of the transporter, preventing further conforma-
tional changes toward a more closed state.116 MsbA is a lipid
ﬂippase that translocates lipopolysaccharide across the inner
membrane of Gram negative bacteria,430 and lipids entry into
the main cavity as detected in the simulations might have
mechanistic implications or even provide an example of entry
pathway possibly shared with lipopolysaccharide molecules.
This study also showed how simulations at a coarser resolution
could sample events (such as lipids uptakes into the
transporter cavity) not easily accessible at an atomistic scale,
while preserving the molecular and physical representation of
the system.116 Other CG models have shown a similar
distribution of lipids in the central cavity of ABC transporters.
Using the Martini model, for instance, Stansfeld et al.
developed an automated protocol to insert, in a POPC lipid
bilayer, crystal structures of membrane proteins, including
ABCB10, a mitochondrial ABC transporter.431 During the 100
ns-long simulation, lipids were shown to partition inside the
cavity of the transporter.431 The CgProt force-ﬁeld, also
derived from the MS-CG model,118 has been applied to study
lipid−protein interactions for P-glycoprotein in a POPE:POPC
bilayer containing 20% cholesterol.117 P-glycoprotein structure
and function are strongly modulated by sterols and lipids, and
lipids such as ﬂuorescently labeled PE, PC, and SM lipids have
been shown to be substrates of P-glycoprotein.426 The CgProt
simulations allowed the study of the transition from a
conformational state with a large intracellular opening (suitable
for substrates like lipids uptake) to a conformational state with
the cavity open to the opposite side of the membrane, while
lipids and cholesterol redistributed around the protein.117
Within the ﬁrst lipid shells near the protein, enrichment was
observed for PC lipids and cholesterol, while lipid diﬀusion
inside the central cavity was retrieved only for PC and PE
lipids. Although these studies captured lipids uptake events,
details on the time scale or the protein residues involved were
not described. Barreto-Ojeda et al. used the Martini model to
characterize such interactions.432 Here, the conformational
state of P-glycoprotein with a large intracellular opening (also
used in the CgProt simulations discussed above)117 was
embedded in lipid bilayers of diﬀerent ratios of POPE and
POPC lipids. In this state, access to the cavity is granted
through two diﬀerent portals, lined by transmembrane helices
4 and 6 on one side and 10 and 12 on the other.395 The 20 μs-
long simulations sampled several lipid uptake events for both
POPE and POPC species (Figure 14), evaluated based on the
presence of a lipid headgroup within a 8 Å cutoﬀ from the
residues inside the cavity, for at least 200 consecutive ns. A
diﬀerent probability of lipid uptake events was detected
between the two portals, reﬂecting the asymmetric con-
formation of the helices lining the portals. During the
simulations, as also found by Domicevica et al.,425 positively
charged residues located at the water−lipid interface in the
Figure 14. Lipid access to the central cavity of P-glycoprotein. CG
simulations of P-glycoprotein in diﬀerent mixtures of POPE and
POPC lipids were used to identify the residues involved in
interactions with lipids at the portals and inside the cavity.432 A.
Displayed are examples of pathways sampled by diﬀerent lipids to gain
access to (L1 to L4) and to leave the central cavity ((L1′ to L4′) during
the simulation time. P-glycoprotein is viewed from the extracellular
side. Reprinted with permission from ref 432. Copyright 2018
Barreto-Ojeda et al. B. Snapshot of P-glycoprotein with a POPC lipid
(PC1) located at portal 1 (yellow helices), a second lipid (PC2)
located at portal 2 (orange helices), and a third lipid (PC3) inside the
cavity. Highlighted are residues identiﬁed in the simulations as hot-
spots for lipid interactions at the portals (green spheres) and inside
the cavity (cyan spheres).
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inner leaﬂet favor interactions with the polar headgroup of the
lipids, recruiting them near the transmembrane helices at the
portals, whereas no signiﬁcant diﬀerence was observed in the
pattern of interactions of POPE and POPC lipids with the
protein. Inside the cavity, the lipids orient their tails toward the
upper and more hydrophobic region, while their headgroup
remains in contact with the more polar environment of the
cavity near the cytosolic interface, reminiscent of the cryo-EM
structure of MsbA in nanodisc in complex with a lip-
opolysaccharide molecule trapped in the cavity.417 The
residues identiﬁed as key players in P-glycoprotein for lipid−
protein interactions are conserved in related transporters such
as ABCB4, known to translocate PC lipids in hepato-
cytes.429,432 This highlights how the simulations results can
be of relevance for transporters for which high resolution
structures are not yet available. A recent simulation study from
Pan et al. targeted the eﬀects of the presence of drug molecules
inside the cavity on the dimerization motion of the NBDs.433
100 and 300 ns-long atomistic simulations of P-glycoprotein
were carried out in the presence (holo) and in the absence
(apo) of drugs. The two sets of systems, holo and apo, revealed
a diﬀerent closing motion, with the apo simulations
characterized by NBDs misaligned with respect to the
orientation required to form a proper dimer. This misalign-
ment appears correlated with the degree of lipid protrusion
through the portals. While this study emphasizes the coupling
between drug occupancy in the cavity and the motion of
TMDs and NBDs, it also highlights how lipids can have an
impact on the conformational transitions of the transporter.433
The studies described above provide details of lipid binding
or access to the main cavity of ABC transporters but do not
show full translocation events from the inner to the outer
leaﬂet, due to the large conformational changes required
during the transport cycle. Another limitation is the relatively
simple lipid mixture used in the simulations. Recently, the use
of the Martini model showed P-glycoprotein molecules
simulated in a plasma membrane mixture, highlighting, for
instance, the diﬀerent distribution of fully saturated and
polyunsaturated lipids around the two TMDs, with changes in
the membrane thickness proﬁle that shows region of increased
and decreased thickness, respectively.121 Moreover, the
simulation shows an enrichment in negatively charged lipids
(such as PIP, PI, and PA lipids) around the protein−lipid
interface in the inner leaﬂet, in line with the previously
mentioned studies that highlight a ring of positively charged
residues engaged in electrostatic interactions with lipid
headgroups. The reorganization of the lipids near the protein
also creates a clear pattern of negative curvature, possibly
linked to speciﬁc structural features of P-glycoprotein, for
instance the shorter extracellular end of TM3 and TM4
together with the presence of positively charged residues in
this region. The interplay between lipids and ABC transporters
is not limited to the TMDs, as lipids can aﬀect the dynamics of
the transporters and mutations at the NBDs can, in turn, aﬀect
substrate transport.434 Simulations have also suggested that
membrane defects near speciﬁc transmembrane helices could
be associated with a given conformational state of the cystic
ﬁbrosis transmembrane conductance regulator (CFTR), an
ABC transporter that functions as a chloride channel, which
would be a novel and uncommon role for lipid−protein
interactions.435
Figure 15. Examples of OMPs discussed in this review. From left to right: OmpA,439 the OmpF trimer,440 Hia,441 LptD and LptE,442 and BamA.443
The ﬁve POTRA domains of BamA are labeled P1−P5. Individual subunits are shown as cartoons and colored in light yellow, orange, and brown.
Upper and lower panels show a side view and a view from the extracellular side of the proteins, respectively. Out, extracellular side; Per, periplasm.
The membrane region is highlighted in gray.
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6. OUTER MEMBRANE PROTEINS
The cell envelope of Gram-negative bacteria consists of two
membranes, an outer membrane (OM) and an inner
membrane (IM), separated by the periplasm.436 The lipid
composition of the two leaﬂets of the OM is highly
asymmetric: the inner leaﬂet is composed of phospholipids,
mainly PE, PG, and CL, while the outer leaﬂet is composed of
lipopolysaccharide (LPS) molecules. LPS consists of Lipid A, a
glycolipid with six or seven saturated acyl tails connected to a
glucosamine disaccharide unit and a polysaccharide. The
polysaccharide is divided into a core sugar region, with an
inner and outer core layer, directly attached to Lipid A, and the
O antigen, consisting of repeating units of monosaccharides,
attached to the core region and extending into the extracellular
medium.437 LPS molecules are linked together by divalent
cations, which strongly bind to the several negatively charged
groups of the LPS molecules.437
Due to its composition, the OM is impermeable to
hydrophobic and large polar molecules. Beta-barrel trans-
membrane proteins, called outer membrane proteins (OMPs),
regulate the movement of a large range of molecules across the
bilayer, and can constitute up to half of the OM mass.437,438
OMPs diﬀer in diameter and can function as selective or
nonselective porins, as well as transporters, enzymes, or
receptors.437 Figure 15 illustrates a few examples of OMPs
discussed below.
6.1. OMPs in Simple Mixtures
The interplay between OMPs and the OM has been
extensively studied with MD simulations. Simulations in
simple phospholipids mixtures have been used to characterize
the hydrophobic mismatch between OMPs and the membrane
together with related lipid sorting eﬀects. Membrane thinning
over several nm away from the proteins coupled with
enrichment in shorter tails lipids has been shown, for instance,
for OmpA in phospholipid bilayers.444 The size and
concentration of OMPs aﬀect both protein and lipid diﬀusion.
A panel of OMPs including OmpA, NanC, FhuA, OmpF, and
LamB, which diﬀer in size and amino acid composition, were
also studied in lipid bilayers consisting of only POPE or a
mixture of POPE and POPG lipids, to approximate the
composition of the OM inner leaﬂet.445 CG simulations
carried out at varying protein densities, from 2 to 50% of the
membrane area covered by proteins, showed slower lipid
diﬀusion over 2 to 3 nm from the protein surface, with the
larger trimeric assemblies of OmpF having the strongest eﬀect
compared to the smaller, monomeric NanC.445 The slower
lipid diﬀusion near the protein was also shown to be diﬀerent
between the leaﬂets, with the lipids in the outer leaﬂet diﬀusing
slower than those in the inner leaﬂet. This eﬀect was correlated
with the higher content of charged residues on the outer
surface of the proteins, providing hot spots for electrostatic
interactions with lipids.445 Crowding was also responsible for
slower lipid and protein diﬀusion, with the largest proteins
(FhuA, for instance) forming extended clusters that led to the
compartmentalization of lipids.445 The analysis of the eﬀect of
crowding in larger bilayers of similar composition but with 256
OmpA molecules prompted the development of new computa-
tional tools for the visualization of lipid motion linked to
protein oligomerization.446
Lipid−protein interactions are important for protein
oligomerization as well. For instance, the free energy of
dimerization between NanC monomers has been calculated by
means of umbrella sampling and CG simulations.447 Dunton et
al. proposed that lipid−protein interactions can induce the
formation of metastable states, with the interface between the
two proteins separated by one, two, or three lipid molecules
that bridge the proteins together, stabilizing the dimers.447
The use of CG models for the study of the lipid−protein
interplay allows the simulations of large systems with high
protein concentrations, useful to address questions concerning
protein−protein interactions in the membrane as well as to
investigate how proteins modify physical properties of the
membrane. For OMPs, such studies have been applied to the
interactions of BtuB and OmpF with a POPE and POPG lipid
bilayer,448−450 (see also below for more details) as well as to
OmpF in vesicles of diameter ranging from 16 to 65 nm, with a
POPE and POPG mixture or DLPC and DSPC lipids, where
protein−protein interactions were linked to membrane
thinning and lipid sorting.451,452 BtuB and OmpF seem to
modulate membrane bending rigidity in diﬀerent ways. With
10 μs-long simulations where 28%, 37% and 40% of the
membrane area was covered by BtuB, OmpF or an equal
distribution of the two proteins, respectively, Fowler and
colleagues show how BtuB, a monomeric OMP, signiﬁcantly
reduces membrane stiﬀness.449 The OmpF trimer, on the other
hand, shows no comparable eﬀects, although it remains unclear
if this diﬀerent behavior between the two OMPs is due to their
oligomerization state or to the limited time scale (5 μs) of the
simulations.449
CG models have also been applied to lipid binding to OMPs
and inner membrane proteins (IMPs) as a function of
charge.453 Binding of POPG or POPC lipids to OmpF, the
ferripyoverdine receptor (FpvA) and VDAC (a mitochondrial
outer membrane protein covered in more detail below) as
examples of OMPs and to AmtB, MscL, and NavMS as
examples of IMPs was addressed at diﬀerent pHs using native
MS.453 Lipid binding to OmpF, the protein with the highest
local densities of charged residues among those tested in this
study, showed the greatest sensitivity to electronspray polarity
in the MS approach, while lipid binding to AmtB showed
minimal changes (see section 13.4 for more details on AmtB).
1 μs-long CG simulations of AmtB and OmpF in a
POPC:POPG 1:1 mixture were performed for diﬀerent
protonation states of both lipids and proteins and showed
increased binding of anionic POPG for the charged state of the
proteins, especially for OmpF. The analysis of lipid distribution
around the proteins between the diﬀerent protonation states
support a model where the location of basic residues along the
protein surface and their charge state aﬀect lipid binding
selectivity, in line with the native MS experiments.453
6.2. OMPs in Complex Mixtures
Given the asymmetric composition of the OM, more realistic
OM models for MD simulations required the development of
atomistic and CG force ﬁeld parameters for LPS, which
allowed the investigation of diﬀerent structural properties of
the OM.454−467 For instance, the coupling between the two
asymmetric leaﬂets, as well as the network of electrostatic
interactions between LPS molecules and the details of the
electroporation mechanism after applying varying external
electric ﬁelds have been studied using atomistic simulations.455
The role of the diﬀerent components of the LPS molecules,
crucial for the structural integrity of the membrane, has also
been investigated by means of atomistic simulations in
combination with NMR studies457 and using the Martini
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model as well.459 Experimental evidence of speciﬁc interactions
between LPS and OMPs,468−473 and the role of LPS in
regulating the assembly of several OMPs into trimers,473−477
highlights the importance of using more complex OM models
for proper characterization of OMPs dynamics and lipid−
protein interactions in computer simulations.
Atomistic simulations of E. coli FecA, an OM 22-stranded
beta-barrel, in a membrane composed of LPS in the outer
leaﬂet and PE, PG lipids, and CL in the inner leaﬂet
characterized conformational changes of extracellular loops
upon ligand binding and FecA-LPS interactions.478 The slower
diﬀusion rate of LPS in the outer leaﬂet allows for frequent but
short-lived hydrogen bonds between the core sugar region of
LPS molecules and speciﬁc FecA residues in the extracellular
loops, experimentally shown to be essential for FecA
function.478 Such interactions modify the loop dynamics
compared to control simulations of FecA in POPC
membranes, where no hydrogen bonds were retrieved between
the polar POPC headgroup and the selected protein
residues.478 Similarly, restrained loop dynamics has been
reported for other OMPs, including the outer membrane
protein phospholipase A OmpLA, and OmpA in atomistic,
asymmetric membranes with LPS in the outer leaﬂet and
phospholipids mixtures in the inner leaﬂet.458,479,480 Diﬀer-
ences in the interactions between OMPs and LPS or
phospholipids have also been described for the H. inf luenza
autotransporter Hia,479 which consists of three monomers,
each carrying four beta-strands and an α helix, that combine
together in a 12-stranded beta-barrel and three helices located
in the central pore.441,481 In atomistic simulations of Hia
embedded in an OM model with LPS and PE lipids in the
outer and inner leaﬂet, respectively, positively charged residues
of the helices interact with LPS molecules, possibly acting as
anchor points for the protein in the membrane.479 However, a
detailed characterization of the LPS−protein interactions is
limited by the short time scales of the simulations and the
slower diﬀusion of LPS.479 Balusek et al. used 300 ns-long
atomistic simulations to analyze conformational changes of
BtuB, a monomeric beta-barrel that translocates vitamin B12
through the OM, as a function of the membrane environment
and the presence of Ca2+ ions, required for transport.482 As
discussed above for other OMPs, the ﬂexibility of the
extracellular loops and several substrate-binding residues is
restrained in the presence of LPS molecules, while signiﬁcant
conformational changes are detected when LPS is missing from
the membrane environment. Comparisons between the
simulations carried out with and without Ca2+ ions also
show how Ca2+ binding not only stabilizes further an
extracellular loop important for substrate binding but also
drives speciﬁc structural rearrangements that are typical of
BtuB structures in complex with vitamin B12.482
MD simulations carried out in these more complex models
often highlight how the thickness proﬁle of the OM changes in
the proximity of the proteins, as previously shown for the
simpler mixtures. In particular, the simulations on OmpLA
show an overall thinner membrane for the complex model
compared to a phospholipids-only bilayer, due to the shorter
hydrophobic length of the LPS molecules.458 The more
pronounced smaller thickness near OmpLA is also not
uniformly distributed, reﬂecting lipid adaptation to the
asymmetric structure of the protein.458 Atomistic simulations
on OmpA reveal how the interactions between LPS and the
protein as well as protein−protein interactions can be
modulated by diﬀerent ionic strengths.480 CG simulations of
OmpA and OmpF show that the proteins perturb lipid
ordering and thickness over a radius of ca. 3 nm in a PE, PG,
and cardiolipin mixture, while in an asymmetric OM model
including LPS the proteins’ eﬀect on the bilayer properties is
not as pronounced.483 The diﬀerence is attributed to the
slower diﬀusion of the large LPS molecules, which in turn
reduces the diﬀusion of phospholipids in the opposite
leaﬂet.483
CG simulations of OmpF in asymmetric membranes with
lipid A or lipid A and the core sugar region moieties of LPS
further conﬁrm the interactions between lipid A and the core
region with the protein in the outer leaﬂet.464 Lipid A is found
distributed along the protein surface of monomers, with the
tails interacting with the hydrophobic residues of the beta-
barrel, while the head groups are engaged in electrostatic
interactions with the protein positively charged residues. The
so-called “corona” of lipid A around the protein does not
prevent the formation of dimer or trimers, and as proteins
oligomerize, protein−protein interactions replace lipid A-
protein interactions, with lipid A reorganizing around the
newly formed dimer or trimer.464
LPS and OMPs are essential to regulate proper homeostasis
of the OM and provide a barrier against antibiotics and
antibodies that hamper bacterial invasion. Depending on the
environmental conditions, Gram negative bacteria can express
diﬀerent forms of LPS, thus promoting diﬀerent interactions
Figure 16. Simulation snapshots of the OmpF trimer embedded in atomistic OM models of increasing complexity.484 PE, PG and cardiolipin types
of lipids of the inner leaﬂet are shown in blue, orange and magenta spheres; Lipid A is shown as pink spheres; a model of the LPS core is shown in
gray stick, and polysaccharides of the O-antigen are shown in orange sticks. Ca2+, K+ and Cl− ions are shown as cyan, green and magenta spheres.
Reprinted with permission from ref 484. Copyright 2016 Biophysical Society, by Elsevier Inc.
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with OMPs and possibly the accessibility of the proteins
extracellular loops, which are targeted by antibodies. To
address the question of how the LPS leaﬂet hampers antibodies
access to the OMPs, Patel et al. carried out atomistic
simulations of OmpF in OM models characterized by a
diﬀerent degree of complexity, depending on the presence and
type of the LPS core region and the O antigen, while the inner
leaﬂet is composed of a mixture of PE, PG lipids, and CL
(Figure 16).484 These simulations show at the molecular level
how the LPS sugars are eﬀective in blocking access to the
extracellular loops of OmpF: their exposure is mainly regulated
by the interactions between the core sugar region and speciﬁc
residues of the protein outer surface, without aﬀecting its
channel function.484 The degree of such exposure, however,
depends on the complexity of the OM model, which controls
the ﬂexibility of the core region as well as the O antigen, and in
turn the dynamics of the protein extracellular loops.484 A
similar approach has been applied to study the interactions
between the diﬀerent domains of LPS and the outer membrane
protein H (OmpH) of P. aeruginosa.485 Atomistic simulations
of OmpH in asymmetric membranes modeling P. aeruginosa
and E. coli OMs show how the complexity of the LPS domains
modulate the dynamics of the extracellular loops, as well as the
interactions between LPS and positively charged residues on
the outer leaﬂet surface of the protein. Although the E. coli OM
is thicker than the P. aeruginosa OM, no signiﬁcant diﬀerence
in thickness was retrieved near the protein in the simulations,
as a consequence of a reciprocal hydrophobic matching
between the membrane components and the protein.485
LPS is transported from the IM to the OM by a complex of
seven lipopolysaccharide transport (Lpt) proteins, namely
LptA through LptG.486 LptD, a beta-barrel protein, and LptE,
required for LptD folding and acting as a plug inside the barrel
(Figure 15), are responsible for the translocation of LPS across
the OM and its insertion in the outer leaﬂet.486 Structural and
functional assays combined with molecular simulations show
that the polar domains of LPS may be translocated while inside
the barrel, whereas the lipid A moiety exploits a lateral opening
in the barrel structure to maintain the acyl tails in contact with
the hydrophobic region of the OM.442,487,488 Dong and
colleagues applied a multiscale approach combining CG and
atomistic MD simulations of the LptD-LptE complex in a
DMPE-DMPG bilayer and at diﬀerent lateral pressures.442 The
barrel opening was observed at −65 bar, a lateral pressure for
which other beta-barrels, BtuB and FhaC, simulated as
controls, did not show any instability.442 This study guided
further experimental characterization and simulation studies
focused on speciﬁc residues required for LPS transport as well
as a series of hydrophobic residues predicted to facilitate the
projection of Lipid A acyl tails into the membrane.487 Using a
OM model with LPS molecules in the outer leaﬂet and PE
lipids in the inner leaﬂet, Botos et al. applied atomistic
simulations, in combination with structural and functional
studies, to address the role of conserved proline residues in the
beta-sheets responsible for the lateral opening.488 Simulations
of the WT LptD-LptE complex and the complex with alanine
mutations of the conserved proline residues showed a distinct
pattern of hydrogen bond interactions between the beta-sheets,
with less interactions for the WT complex, supporting
experimental ﬁndings and conﬁrming that the presence of
the proline residues is essential to facilitate the lateral opening
for LPS insertion.488
6.3. Beta-Barrel Assembly Machinery
Another macromolecular complex is required for proper
homeostasis of the OM, the beta-barrel assembly machinery
(BAM), which ensures proper folding and insertion of OMPs
in the OM.489 BAM consists of ﬁve proteins, the lipoproteins
BamB−E, and the beta-barrel BamA (Figure 15), whose
function is essential for ﬁnal insertion of OMPs in the OM. For
this, BamA, as previously described for LptD, requires a lateral
opening in its barrel architecture linked to an exit pore for
OMPs, as suggested by structural, functional and molecular
dynamics studies.443,490−492 The hydrophobic belt of BamA is
asymmetric, with the thinner portion located near the C-
terminal strand. In this region, μs-long atomistic simulations of
H. ducreyi and N. gonorrheae BamA in a DMPE bilayer have
shown a signiﬁcant decrease in lipid order and membrane
thickness as well as a lateral opening between the ﬁrst and the
last strands, providing access to the membrane from the barrel
interior.443 Additional simulations of BamA have further
characterized the weak points in the structure of the barrel
that allow separation between the strands and the formation of
an exit pore above the lateral opening, required for the
extracellular loops of the nascent OMP.491 Recently, atomistic
simulations of diﬀerent BamA proteins in lipid bilayers and in a
complex OM model, together with PMF calculations and
mutagenesis studies, have also linked a kinked conformation in
the C-terminal strand with the lateral opening of the barrel.492
While these studies helped develop a possible model for
BamA-mediated OMP insertion, alternative models also exist
(reviewed, for instance, by Kim et al. and Pavlova et al.).493,494
The N-terminus of BamA includes a large periplasmic
domain formed by ﬁve polypeptide transport-associated
(POTRA) motifs (Figure 15), whose degree of ﬂexibility
depends on the interactions with the other components of the
BAM complex.495 Using atomistic MD simulations, Fleming
and co-workers showed that the ﬂexibility of the POTRA
domains is also regulated by the interaction with the inner
leaﬂet of the OM.496 A complex model of the OM was used,
containing LPS molecules in the outer leaﬂet and a mixture of
PE, PG lipids and CL in the inner leaﬂet. The POTRA
domains partitioned into the membrane via hydrophobic as
well as hydrogen bond interactions, suggesting that the BAM
complex operates through a mechanism that requires the
coordination between multiple domains, as well as the lipid
matrix.496
CG simulations have been applied to understand the role of
BamA and protein−protein interactions in the turnover of
OMPs in the OM. Using ﬂuorescence microscopy, Rassam et
al. showed the existence of OMPs islands containing the BAM
complex, which are linked to an OMPs biogenesis gradient
through the cell, highest at the cell center.448 Within these
islands, of ca. 0.5 μm diameter, diﬀerent OMPs were identiﬁed.
Protein diﬀusion rates decreased as a function of protein
concentration and size and appear limited by protein−protein
interactions in protein cluster formation.448 To study protein−
protein interactions within the OMPs islands generated by the
BAM complex, CG MD simulations were applied to systems
containing PE and PG lipids and diﬀerent ratios of BtuB, a
monomer, and OmpF, a trimer, both identiﬁed within the
OMPs islands used in the experiments. The simulations
showed that the barrels engage in homologous and
heterologous protein−protein interactions, with aromatic
residues mainly involved in the latter.448 In a follow up
study, the same group considerably extended the length scale
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of the simulation systems and used the information derived
from OMPs clustering formation to derive a mesoscale model
of how OMPs interact in a crowded environment:450 Larger
clusters formed by diﬀerent OMPs fence smaller clusters of
proteins or single proteins, limiting their diﬀusion and creating
a coralling eﬀect that is proposed to be related to the insertion
of OMPs in the membrane via the BAM machinery.448,450
The simulation studies described above have targeted
diﬀerent aspects of the protein−lipid interplay for OMPs,
including membrane remodeling, protein stability, and
protein−protein interactions, and highlighted the progress in
modeling and simulating the complexity of the OM. However,
the interactions between OMPs and LPS are hampered by the
limited diﬀusion of LPS molecules on the time scale of even
CG simulations, which remains one of the main challenges in
this area.
Computer simulations can also address larger-scale ques-
tions about the structure of the bacterial envelope, which
requires models beyond atomistic or coarse-grained simu-
lations at the level of Martini. We highlight one example here,
based on elastic models derived from more detailed
simulations. The bacterial envelope (OM, cell wall and IM)
is a complex structure that allows the cell to respond to
changes in the osmotic pressure. Atomistic simulations of
diﬀerent OMPs embedded in a DMPC bilayer and subject to
external forces, have been applied to derive an elastic energy
model for OMPs, in which speciﬁc features of the barrel
structure allow OMPs to withstand stress, possibly contribu-
ting the structural stability of the OM.497 The calculation of
area compressibility from atomistic simulations of diﬀerent
models of the OM and the IM as well as of a model of the cell
wall have linked elastic properties of lipid and protein
components to the mechanical properties of the envelope as
a whole.498 This type of studies provides a framework where
structural properties of lipids and proteins are related to
macroscopic features of the cell envelope.
Figure 17. Lipid scrambling and structural rearrangements in N. haematococca TMEM16 as described by MD simulations. A. Snapshots showing,
from left to right, the structural rearrangements needed for lipid molecules to access the groove from the extracellular side. R432 initially interacts
with E313 but as lipids approach it switches to the interactions with E318.507 B. Snapshots showing, from left to right, lipid translocation from the
intracellular side to the extracellular side.507 The transmembrane region of TMEM16 is shown as white cartoons, while relevant residues involved in
key interactions and lipids molecules are shown as spheres and sticks, respectively. Adapted with permission from ref 507. Copyright 2018 Lee et al.
Licensed under Creative Commons Attribution 4.0. Panels in B are only a subset of those in the original ﬁgure. We thank G. Khelashvili and H.
Weinstein for providing the original ﬁgures.
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7. TMEM16 PROTEIN FAMILY AND OTHER LIPID
TRANSPORT PROTEINS
Lipid asymmetry across membrane leaﬂets is regulated by
several proteins that recognize diﬀerent lipid types and move
them between leaﬂets.499 We have previously described
GPCRs and ABC transporters for which experimental studies
and MD simulations have detailed lipid binding and/or
translocation events. This section discusses the TMEM16
protein family and a few other examples for which MD
simulations have contributed to a better understanding of their
role in shuttling lipids across membrane leaﬂets.
Bidirectional lipid transport is achieved by scramblases,
including the transmembrane protein 16 (TMEM16)
family.500 TMEM16 proteins include members that carry out
diverse Ca2+-activated functions, while sharing a common
structural architecture, with limited conformational changes.500
Some members function as Ca2+-activated anion channels,
others as Ca2+-activated lipid scramblases.500 Structural and
functional studies of N. haematococca TMEM16 showed the
presence of a hydrophilic groove exposed to the membrane
that could provide the lipid translocation pathway501 while
maintaining channel activity,502 thus proving that the dual
channel-scramblase function can be carried out by the same
protein.502 Similarly, the presence of the hydrophilic groove
has been characterized for other TMEM16 proteins, whose
details are reviewed by Whitlock et al. and more recently by
Falzone et al.503,504 Many of the mutations that aﬀect channel
function are part of or near the hydrophilic groove, supporting
the hypothesis that the TMEM16 pore is partially formed by
lipids.503 MD simulations on TMEM16 proteins have so far
addressed two main questions: how lipid scrambling occurs via
the hydrophilic groove and if lipids and ions can move along
the same pathway. A 1-μs long CG MD simulation of N.
haematococca TMEM16 in a DPPC lipid bilayer detected not
only lipid binding but also ca. 15 lipid translocation events
between the leaﬂets along the groove.431 This simulation,
however, did not characterize the details of lipid binding in the
groove. Using a hybrid continuum-atomistic model, Argudo et
al. and Bethel et al. described large membrane deﬂections
induced by hydrophobic and charged residues located on the
surface of N. haematococca TMEM16, with signiﬁcant bending
and membrane thinning located near the hydrophilic groove,
which persisted after neutralizing all of the charged residues in
the groove.90,505 Atomistic simulations of 120 and 400 ns, in a
POPC lipid bilayer, showed the same membrane deformation
proﬁle, further supporting the hypothesis that the thinning of
the membrane might provide a shorter pathway for lipid
translocation through the groove.505 The simulations also
identiﬁed, via density analyses, two interaction sites for the
phospholipids, located at the extracellular and cytoplasmic
ends of the groove.505 For these sites, the sequence alignment
of diﬀerent members of the TMEM16 family showed a smaller
degree of conservation for those TMEM16 proteins with no or
decreased scramblase activity, while they all share the same
membrane deformation proﬁle.505 A total of four lipid
translocation events were detected in independent simulations
and suggested a dipole-stacking mechanism for lipid access to
the groove and translocation.505 According to this mechanism,
lipids arrange in a dipole-like fashion, with the positively
charged choline group of one lipid interacting with the
negatively charged phosphate group of a second lipid,
eventually forming a single chain of lipid head groups inside
the groove, initiating at the cytosolic site.505 The energetic
barrier for lipid translocation was estimated to be small, ca. 1
kcal/mol; thus, lipids are stable in the groove, as a result of the
dipole-stacking and water molecules also contributing to the
interactions. Jiang et al. also used atomistic simulations, 1 μs-
long, to characterize lipid translocation in N. haematococca
TMEM16 with Ca2+ bound, embedded in an asymmetric
bilayer consisting of POPC lipids in the outer leaﬂet and a
POPC:POPS mixture in the inner leaﬂet.506 These simulations
showed the same membrane deformation proﬁle observed
before90,505 and identiﬁed a single chain of lipids in the groove
as described by Bethel et al.;505 however, the major interaction
sites between protein and lipids diﬀer from those previously
reported,505 with the exception of the extracellular site. The
new sites were further investigated with mutagenesis studies
and lipid scrambling assays conﬁrming their role as hot spots
for interactions with the lipids.506 The lipid scrambling
pathway of N. haematococca TMEM16 has also been studied
via mutations to tryptophan of 18 residues along the groove
and by assessing their eﬀects on scrambling rate constants.507
This study focuses mainly on the extracellular side of the
groove and highlights three regions with the strongest eﬀects
on lipid scrambling and ion permeation: (i) an extracellular
gate formed by charged residues, (ii) a constriction in the
central region of the pathway, and (iii) a group of four residues
located between the gate and the constriction (Figure 17).
From 2 to 4 μs long atomistic simulations of wild type and
selected tryptophan mutants of N. haematococca TMEM16 the
authors derived the structural rearrangements of these three
regions that enable lipid scrambling, resulting in a network of
interactions between residues and lipids that starts with the
opening of the extracellular gate.507 To further investigate the
sequence of events that enables a complete translocation of
lipids, Lee et al. applied the same iterative protocol previously
used for opsin216 and detected full lipid scrambling events from
the intracellular to the extracellular side, with lipid release in
the extracellular leaﬂet only after the opening of the gate
(Figure 17).
Electrophysiology experiments showed that high intra-
cellular Ca2+ concentrations stimulate both the scramblase
and channel activity of N. haematococca TMEM16.506
Additional MD simulations carried out at diﬀerent voltages
revealed that in the presence of Ca2+, lipid translocation events
as well as Na+ ion permeation followed the same pathway
along the hydrophilic groove, with longer residence time for
Na+ ions retrieved at locations near the newly identiﬁed lipid
interaction sites.506 POPC and POPS translocation events
showed distinct features, with the POPS headgroup being
more coordinated and for a longer time than POPC head
groups. In the absence of Ca2+ ions, however, a smaller number
of lipids accessed the groove. The simulations also captured
the eﬀects of Ca2+ ions on the conformational state of the
protein: in the absence of Ca2+ ions, as a consequence of
changes in electrostatic interactions, the intracellular end of the
hydrophilic groove (lined by transmembrane helices TM4 and
6), widens considerably, while at the extracellular end TM4
can be in close contact with TM6, closing the groove, although
for only less than 50% of the time.506
The computational studies described above have provided
many insights in the molecular mechanism of TMEM16
proteins, but several aspects of their molecular mechanism
remain to be elucidated. For instance, TMEM16 proteins have
been shown to be involved in the scrambling of diﬀerent lipid
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types,501,508−511 possibly with diﬀerent lipid speciﬁcity.509
Malvezzi et al. recently showed that TMEM16 proteins can
also scramble lipids conjugated with polyethylene glycol
molecules, thus bearing head groups signiﬁcantly larger than
the width of the groove.512 These ﬁndings indicate that
TMEM16 proteins enable lipid scrambling outside the
hydrophilic groove as well, as part of a mechanism where the
groove would trigger those membrane deformations that lower
the energy barrier for lipid scrambling inside505,506,513 and
outside the groove as well.512 This dual mechanism for lipid
scrambling has also been veriﬁed for GPCR scramblases.512 In
the near future, we expect MD simulations to be able to target
the molecular details of this new mechanism for lipid
scrambling. Further studies are also required to elucidate the
complex interplay between TMEM16 and lipids, as cholesterol,
fatty acids and PIP lipids have been shown to regulate protein
activity.500
MD simulations have also provided some insights into the
mechanism of lipid transport and scramblase activity of
MlaA514 and PLSCR1,515 respectively. Additional structural
data for PLSCR1 and information on possible interactions with
other proteins and structural changes in MlaA are however
needed to fully elucidate their mechanism of action.
8. P-TYPE ATPASES
P-type ATPases constitute a family of membrane pumps that
use the energy derived from ATP hydrolysis to ﬂip lipids,
transport ions and generate electrochemical gradients across
biological membranes.516 Diﬀerent from previously discussed
ABC transporters, their mechanism requires phosphorylation
and dephosphorylation of a conserved aspartate residue during
the transport cycle.516 P-type ATPases are divided into ﬁve
classes (P1 to P5), further organized into subfamilies, and
share a common architectural core with three cytoplasmic
domains (namely the Actuator, A, domain; the Phosphor-
ylation, P, domain; the Nucleotide, N, binding domain) and a
six helixes transmembrane domain, the so-called Transport
domain, followed by additional transmembrane helices forming
the Support domain.516 During the catalytic cycle, P-type
ATPases switch between two main conformational states,
namely the E1 state, with the binding sites for the ions to be
expelled exposed to the cytoplasmic side, and the E2 state,
where the ion binding sites are open to the opposite side of the
membrane.516,517 Current models based on structural data,
mutagenesis and transport studies propose that the pumps are
phosphorylated in the E1 state (E1-P), to then switch to a
phosphorylated E2 state (E2-P), in turn dephosphorylated to
return to the E1 state. These conformational changes require
large motions of the cytoplasmic domains, coupled with
changes of speciﬁc transmembrane helices in the transport
domain to allow ion transport.516
Ca2+-ATPases (members of the P2A class) transport Ca2+
ions from the cytosol into the lumen of organelles or outside
the cell. The Sarco(endo)plasmic Reticulum Ca2+-ATPase
(SERCA) located in the endoplasmic reticulum drives the
reuptake of Ca2+ from the cytosol, required for muscle
contraction, in exchange for H+.516 Several MD simulations
studies have focused on Ca2+ and H+ ion exchange and
possible pathways.518−520 SERCA activity is, however, heavily
modulated by lipids.521 A membrane thickness of ca. 30 Å is
required for maximum ATPase activity, although the hydro-
phobic belt of the protein is considerably shorter.521−525 In
MD simulation studies of SERCA in PC lipid bilayers with acyl
tails of diﬀerent length, lipids adapt to the protein surface in a
dynamic manner, depending on the conformational state in the
starting structure.522,526 The thinning of the bilayer is not
uniformly distributed around the protein but highly localized
to match the hydrophobic and hydrophilic residues on the
surface522 and linked to changes in the lipids tilt angle and
structure of the acyl chains.526 Autzen et al. applied CG and
atomistic MD simulations to address the interactions between
SERCA and cholesterol, for which both speciﬁc and non-
speciﬁc interactions with the protein have been postulated.527
From 30 independent CG simulations in a POPC:cholesterol
bilayer, Autzen et al. detected cholesterol enrichment near the
protein, identifying putative cholesterol interaction sites.
However, phospholipids were shown to compete with
cholesterol for binding to the same pockets, which makes it
diﬃcult to explain how cholesterol might regulate SERCA via
speciﬁc interactions. Moreover, the binding pocket of
thapsigargin, a SERCA inhibitor, was postulated to be a
potential cholesterol site due to shared structural features, but
neither CG nor atomistic simulations found a stable binding
mode, supporting the hypothesis of nonspeciﬁc interactions as
the main mechanism for cholesterol regulation of the pump.
The studies above provide snapshots of local lipid
adaptation around SERCA but do not describe the full
complexity of the protein−lipid interplay. Many structural
studies show several lipid binding sites, some of which are
speciﬁc for a given conformational state while others are state
independent, with distinct regulatory and structural roles
(compared and analyzed by Drachmann et al.).528 More
recently, Norimatsu et al. using X-ray solvent contrast
modulation have revealed new details on how lipids actively
contribute to the activity of the pump.529 Stable interactions
with lipid headgroups were identiﬁed for speciﬁc arginine and
lysine residues that act as anchor points for lipids through the
entire transport cycle. To account for the perpendicular
movement of selected transmembrane helices during transport,
changes in the tilt of the entire protein, up to 18°, are required
to preserve the interactions with the anchor points in the
diﬀerent conformational states, together with local variations in
lipid thickness. At the same time, more dynamic interactions
with lipids, diﬀerent for diﬀerent conformational states, were
suggested with other positively charged residues and with
tryptophan residues, important to drive the proper orientation
of the protein with respect to the membrane through the
catalytic cycle. Combined, protein tilt changes, stable
interactions with lipids via the anchor points and more
dynamic interactions with the supporting residues result in an
eﬀective mechanism that couples ion translocation with the
large movements of the transport domain and the cytosolic
domains.529,530
The Na+,K+-ATPase (a P2C ATPase) resides in the plasma
membrane and extrudes Na+ ions while counter-transporting
K+ ions.531 As for SERCA, ATP hydrolysis and movement of
ions across the membrane are coupled with conformational
transitions between phosphorylated or dephosphorylated
states, E1 and E2, which contain ion binding sites of diﬀerent
aﬃnity and exposed to opposite sides of the membrane.532 The
Na+,K+-ATPase consists of three subunits, namely the alpha
subunit, carrying the three cytoplasmic domains and the
transport domain with ten transmembrane helices, the one
transmembrane helix beta subunit, and the FXYD subunit.533
Nonspeciﬁc lipid−protein interactions, including membrane
thickness and ﬂuidity linked to cholesterol concentration,
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modulate protein activity (reviewed by Cornelius et al.).531
The speciﬁcity of the interactions between the pump and lipid
headgroups, tails and cholesterol has been widely investigated
via biochemical, kinetic and structural studies, which revealed
how lipids can stabilize, stimulate, or inhibit the pump.531 In
particular, expression of recombinant Na+,K+-ATPase in Pichia
pastoris and puriﬁcation studies in controlled lipid environ-
ments revealed a stabilizing eﬀect of (18:0/18:1) PS lipids and
cholesterol via speciﬁc interactions,534 while neutral polyunsa-
turated phospholipids (18:0/20:4 or 18:0/22:6 PC or PE)
stimulate the ATPase activity promoting the transition
between the E1-P and E2-P states.535,536 Anionic and
polyunsaturated neutral lipids bind at distinct sites, namely
site A for stabilizing lipids and site B for stimulating
lipids.535−538 Cholesterol contributes to the thermal stability
of the pump via direct interactions with phosphatidylserine at
site A,536 while saturated PC and SM lipids inhibit the pump in
a cholesterol dependent manner, leading to the hypothesis of a
third lipid binding site (site C).536 The stoichiometry of lipid
binding to site A and B has been further characterized by
native mass spectroscopy combined with mutagenesis stud-
ies.539 Additional details and analysis of structural data are
described in Cornelius et al.531 MD simulations have yet to
address the speciﬁcity of the interactions described above and
are so far limited to local perturbations of the lipids. While
investigating the mechanism of response of a dye to the
conformational transitions of the Na+,K+-ATPase, Garcia et al.
showed, by means of atomistic simulations, the diﬀerent
thickness proﬁles induced by diﬀerent conformational states of
the pump on a DOPC membrane (Figure 18).540 However, in
a more realistic membrane environment, the thickness proﬁle
also correlates with the local lipid distribution, as shown by CG
simulations of the pump in a generic plasma membrane
model.121 It has also been hypothesized that the N-terminal
domain of the protein could exert an autoinhibitory eﬀect by
controlling the transition between states via interactions with
anionic lipids.540−542 MD simulations of the E2 state with a
modeled N-terminal domain and embedded in a POPC:POPS
bilayer showed how the interaction with the membrane might
be driven by electrostatic interactions between positively
charged residues of the N-terminus and POPS lipids.541 With a
similar simulation approach applied to both the phosphory-
lated E1 and E2 states, Nguyen et al. found that the
interactions with the membrane are diﬀerent between the
phosphorylated states and stronger for the phosphorylated
E1.542
The plasma membrane Ca2+ pump (PMCA) is a P2B-
ATPase whose activity is also modulated by lipids.543−545
Atomistic simulations of a PMCA model based on SERCA in
bilayers consisting of DOPC or DMPC lipids showed how
lipids adapt to the protein hydrophobic belt.545 In this case, the
shorter DMPC showed a better hydrophobic matching than
the longer DOPC,545 contrary to what Sonntag et al. described
for SERCA, where the shorter 14 carbons lipids used in their
study provided less favorable coverage,522 probably reﬂecting
diﬀerent structural features of the two ATPases.
P4-ATPases share the same catalytic mechanism of P2-
ATPases like SERCA but use ATP as a source of energy to ﬂip
lipids from the extracellular or luminal leaﬂet to the
cytoplasmic leaﬂet of membranes.546 Among diﬀerent models
proposed for the mechanism of action of P4-ATPases is the
presence of a hydrophilic groove along the protein surface.
This groove would allow the interaction with the lipid
headgroup during ﬂipping, while the acyl tails remain in
contact with the hydrophobic region of the membrane,
similarly to what has been previously discussed for TMEM16
proteins.546 Atomistic MD simulations on homology models of
the ATP8A2 P4-ATPase supported this model by showing
how water molecules occupy diﬀerent locations of the groove
depending on the conformational state of the pump.547 Full
lipid translocation events, however, yet remain to be described
in simulations, limited by the time scale of protein conforma-
tional changes that are required for transport or experimental
conformations that can be use to construct a plausible reaction
coordinate to describe the transport process.
The Cu(I)-transporting P-type (CopA) ATPase couples
ATP hydrolysis with the transport of Cu(I). It shares the
overall architecture of other P-type ATPases, with an
additional cytosolic domain required for Cu(I) transport, and
two additional transmembrane helices, MA and MB.548 In in
vitro studies, the lipid composition greatly aﬀects the activity of
the enzyme, with increased ATPase activity induced by more
disordered membranes as well as by the anionic lipids PG and
especially CL.549 A combination of CG and atomistic
simulations of CopA from Legionella pneumophila (LpCopA)
in a PE, PG, and CL mixture revealed a preference for anionic
lipids in close proximity of the protein.549 Anionic lipids,
however, are not uniformly distributed and preferential hot-
spots for PG and CL are identiﬁed from the simulations, with
prominent cardiolipin interactions located at the C-terminal
side of MB. Further analyses of the protein−lipid contacts
highlight how for CL and PG lipids the interactions mainly
involve their head groups, with contributions from the acyl tails
in the case of PG lipids, while for the more abundant PE lipids
headgroup and tails equally contribute. Combined, the in vitro
Figure 18. Membrane deformation around the Na+,K+-ATPase pump.
MD simulations revealed distinct local perturbations of membrane
thickness for two conformational states of the pump, linked to speciﬁc
transmembrane helices.540 A. Snapshots of the pump in the E1 (left)
and E2 (right) state. B. Thickness deviations proﬁles obtained from
the last 50 ns of the simulations for the E1 (left) and E2 (right) state
of the pump. Transmembrane helices linked to thickness changes are
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and in silico approach applied by Autzen et al. shows a clear
modulatory eﬀect of the lipid composition on the activity of
LpCopA, exerted through direct interactions with speciﬁc lipid
types.549
9. ATP SYNTHASES
The synthesis of ATP from ADP and inorganic phosphate is
achieved by ATP synthases, rotary motors which utilize
electrochemical gradients across membranes as their source of
energy.550−552 One of the most studied ATP synthases is the
F0F1-ATP synthase, found in chloroplasts, yeasts, bacteria, and
the inner membrane of mitochondria. F0 is the transmembrane
and F1 the catalytic domain, connected by a central and a
peripheral stalk.551,553,554 MD simulations have been used
extensively to study the free energy landscape and conforma-
tional coupling of the diﬀerent subunits of these mo-
tors551,555,556 and, recently, have targeted the interactions
with the surrounding membrane, discussed below.
In mitochondria, the F0F1-ATP synthase forms dimers
arranged in rows along the tips of the cristae, contributing to
the morphology of the membrane and optimization of ATP
synthesis.557−559 To explain the experimental observation that
the formation of rows of dimers is not due to protein−protein
interactions, Davies et al. applied CG simulations of one, two,
and four F0F1 dimers in a POPC bilayer.
557 A single dimer
induced a strong curvature in the surrounding membrane,
which in turn promoted the association of dimers into rows
and the formation of a sharp ridge in the membrane. A
decrease in the membrane elastic energy rather than direct
dimer−dimer contacts would then be the driving force for the
formation of rows of F0F1 dimers along the curved edges of
cristae (Figure 19).557 In a follow up study, the authors used
free energy calculations to quantify the energetics of dimer
association and further prove that direct dimer−dimer
interactions are not required.560 Instead, dimers sense each
other over a large distance, ca. 40 nm, via membrane
deformations that are enough to promote spontaneous
association of multiple dimers. This proposed mechanism
has signiﬁcant implications, as it has been suggested to be
linked to the structural organization of the cristae.560
The local lipid composition and, in particular, the role and
eﬀects of CL should also be considered for the mechanism of
the ATP synthase, as CL contributes to the morphology of
mitochondrial membranes383 and directly interacts with ATP
synthases.76,561−564 Duncan et al. used CG simulations to
investigate the molecular details of such interactions, targeting
the c-ring in the F0 domain in a POPE, POPC, and cardiolipin
bilayer.386 The c-ring consists of multiple replicas of a two-
helix hairpin subunit and functions as a rotor coupled with ion
transfer. The simulation results on the bovine c8-ring, the S.
cerevisiae c10-ring, and the I. tartaricus c11-ring showed CL
molecules within the ﬁrst two lipid shells at 0.6 and 0.9 nm,
with interaction patterns remarkably similar across the diﬀerent
c-rings (Figure 20). Multiple CL molecules can interact and
cluster around speciﬁc residues, especially in the inner leaﬂet,
where the residence time was longer than that of phospholipids
and longer than their residence time in the outer leaﬂet. The
longest residence time of ca. 600 ns was detected for the c11-
ring, indicating that during the 4 μs-long simulations CLs
frequently exchange at the interaction sites. As mentioned
above, CLs are required for proper function of the ATP-
synthase, but tightly bound lipids could hamper the rotation
mechanism of the c-ring. Based on their simulations, Duncan
et al. suggest that the transient yet selective binding of CL
would beneﬁt the mechanism of the rotor by acting as a
lubricant.386
10. AQUAPORINS
Aquaporins (AQPs) represent a family of ubiquitous channels
crucial for the regulation of ﬂow of water and other solutes
across membranes.565 As the time scale for water permeation
Figure 19. Mitochondrial membrane shaping induced by ATP
synthase dimers. CG MD simulations showed how ATP synthase
dimers (yellow surface) contribute to the formation of mitochondrial
cristae via curvature eﬀects.560 A, one dimer; B, two dimers; C, four
dimers. Adapted with permission from ref 557. Copyright 2012
Davies et al.
Figure 20. Selective binding of cardiolipin around c-rings of diﬀerent
size, as detected from MD simulation studies.386 A. Location of
cardiolipin headgroup densities, determined based on radial
distribution function analyses, around the c-rings are shown as
spheres, color-coded accordingly to speciﬁc residues involved in the
interactions. The size of the spheres reﬂects the intensity of the
density signal. B. Time-averaged lipid density. Density for POPC and
POPE headgroups is shown in gray, and density for cardiolipin
headgroup is shown in pink. Reprinted with permission from ref 386.
Copyright 2016 Duncan et al.
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across these tetrameric channels is on the order of ns and thus
within comfortable reach of equilibrium MD simulations,
computational studies have been extensively applied to
characterize the mechanism of the channels and their
selectivity for diﬀerent solutes.566 The availability of several
high-resolution AQP structures enabled a systematic analysis of
lipid-interaction sites via a multiscale approach, combining CG
and atomistic simulations.567 A similar pattern of interactions
was found from the simulations of a total of 40 structures of
diﬀerent AQPs used as input structures for independent
simulations: Preferential electrostatic interactions, although
transient in nature, were identiﬁed between the lipid phosphate
groups and positively charged residues. As AQPs are found in
membranes of diﬀerent lipid composition, the conservation of
these residues would endow the channels with a similar lipid−
protein interface evolved to ensure nonspeciﬁc yet recurring
interactions.567
The structures of AQP0 solved by electron crystallography
revealed the ﬁrst shell of lipids interacting with AQP0
tetramers.56,57,568 Comparisons of the 2D crystals obtained in
DMPC568 and E. coli polar lipids56 revealed minimal changes
in the organization of the lipid acyl tails around the AQP0
tetramers, while diﬀerences were detected for the lipid head
groups, suggesting that the interactions with the protein for the
ﬁrst layer of lipids is mainly driven by hydrophobic contacts.
Aponte-Santamaria et al. embedded a single tetramer and the
2D crystal organization of four tetramers in DMPC bilayers
and performed 100 ns-long simulations.569 Time-average lipid
density analyses described at the molecular level forces driving
the lipid tail localization on the surface of AQP0. This appears
to be guided primarily by surface complementarity and
impacted by the degree of ﬂexibility of the protein. Although
polar and positively charged residues allow for electrostatic
interactions with the lipid headgroups, in silico mutagenesis of
such residues and additional simulations retrieved the same
lipid distribution around the protein surface as for the WT
systems, ruling out their role as speciﬁc lipid-interaction
sites.569 In a follow up study from the same group, the eﬀects
of temperature, phase transition, and protein mobility on lipid
localization were further investigated, with protein mobility
shown to have the strongest eﬀect (Figure 21).570 Lipids
adapted to the protein hydrophobic belt, resulting in an
increased thickness as well as in localized, gel-like regions with
higher order, linked to diﬀerent features of the protein surface.
Lipid headgroups, however, although not the major players in
controlling lipid organization around AQP0 tetramers,56,568,569
do aﬀect crystal packing, as shown by the analysis of AQP0 2D
crystals obtained in the presence of anionic lipids (DMPG,
DMPS, or DMPA). The headgroup of these lipids interact with
diﬀerent protein residues, thus altering the interactions
between tetramers.57
Other simulation studies have targeted diﬀerent aspects of
the interplay between AQPs and lipids. MD simulations of
AQP5 with a PS lipid bound to the central pore revealed that
the bound lipid does not modify the water ﬂow through the
channel but alters, instead, gas permeation.571 Simulations of
an AqpZ monomer were also used as part of a study to
describe the eﬀects of surface tension on phase transition of
DPPC lipids.572 Compared to the pure lipid bilayer, AqpZ has
a stabilizing eﬀect on the lipids, with a thinning of the
membrane that persists at diﬀerent surface tensions near the
protein. In the gel phase reduced lipid order was observed,
while in the liquid phase the protein hampered lipid
diﬀusion.572 A previous simulation study targeted, at the
atomistic level, the interactions between AQP0 and mem-
branes consisting of DMPC lipids or DMPC lipids and
cholesterol.573 Over 25 to 100 ns of simulation time,
cholesterol engaged in both stacking interactions with aromatic
residues and hydrogen bonds with polar residues on the
surface of AQP and strengthened the hydrogen bonds between
DMPC headgroups and the protein.573 The use of CG
simulations has enabled the study of the interactions with more
complex lipids and membranes. Gu et al. investigated the
behavior of gangliosides in μs-long atomistic and CG
simulations, highlighting possible interactions with AQP1.574
Gangliosides form small clusters and interact directly or via
Figure 21. Organization of lipids around AQP0. To study the eﬀect of temperature, lipid phase, and protein mobility on the reorganization of lipids
around AQP0, Briones et al. performed MD simulations using diﬀerent simulation setups and found that protein mobility has the strongest eﬀect
on lipid packing in close proximity of the protein.570 Displayed are lipid densities around AQP0 monomers as a function of simulation conditions.
Reprinted with permission from ref 570. Copyright 2017 Briones et al. Licensed under Creative Commons Attribution 4.0.
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other lipids with the protein, establishing extended hydrogen
bond interaction networks. The lipid organization around
AQP1 derived from CG simulations using a generic plasma
membrane revealed a more complex lipid redistribution: small,
highly localized islands of cholesterol enrichment are sym-
metrically distributed near the monomers interface, while
broader distributions are found for polyunsaturated and
saturated lipids, with signiﬁcant diﬀerences between upper
and lower leaﬂets.121 Despite local diﬀerences in lipid
distribution between four simulated tetramers, this simulation
study showed a highly symmetric curvature proﬁle induced by
the proteins, outlining a complex landscape of possible
interactions with lipids and the need for further character-
ization of the lipid−protein interplay and its eﬀect on protein
function.
11. RECEPTOR TYROSINE KINASES AND CYTOKINE
RECEPTORS
Bitopic membrane proteins are characterized by one trans-
membrane helix that connects the extracellular domain to the
intracellular domain, including a juxtamembrane region, and
are usually active as homodimers or heterodimers. Diﬀerent
types of cell receptors are bitopic proteins, including receptor
tyrosine kinases (RTKs) and cytokine receptors, large families
of membrane proteins essential for signal transduction (Figure
22A).575,576 To date, there is no high-resolution experimental
structure of a full length RTK or cytokine receptor, but
structures are available for the separate domains as well as for
dimeric transmembrane domains.577 Experimental and compu-
tational eﬀorts have extensively targeted the dynamics and
energetics of the transmembrane dimers, and experimental
ﬁndings on the membrane-mediated modulation of these
proteins have prompted a number of studies targeting
interactions with the lipids as well.577,578 In atomistic and
CG studies addressing helix−helix association of RTKs
(epidermal growth factor ErbB and ephrin, Eph, receptors),
membrane thickness has been shown to aﬀect dimer stability
and preferentially select speciﬁc dimer conformations, which
also depend on lipid composition.579,580 Computational
approaches have also been used to assemble full-length models
of the epidermal growth factor receptor (EGFR or ErbB-1)
starting from experimental structures of the individual domains
and to characterize their interactions with the mem-
brane.581−583 Atomistic μs-long simulations of the trans-
membrane dimers extracted from these models revealed a
diﬀerent degree of opening of the dimer depending on the lipid
composition.581 Larger openings were detected in a DMPC
bilayer compared to a POPC:POPS mixture, as a consequence
of diﬀerent helix tilting in membranes of diﬀerent thickness.
The PS lipids not only selectively stabilized the transmembrane
dimer in the inactive state but also enhanced the conforma-
tional coupling between all of the protein domains via strong
electrostatic interactions with the juxtamembrane region of
EGFR.581 As anionic lipids are involved in the signaling
cascade mediated by EGFR, MD simulations studies have
focused on the interactions between PIP lipids and the
juxtamembrane region.584 In a multiscale approach combining
atomistic and CG simulations, Abd Halim et al. showed PIP2
lipids clustering near a group of positively charged residues of
the juxtamembrane region. For a construct where mutations
were introduced in place of the basic residues, a signiﬁcant
decrease in PIP2-protein contacts was observed, together with
Figure 22. Lipid−protein interactions in RTKs and cytokine receptors as detected in MD simulations. A. General structure of an RTK. B. The
transmembrane helix and juxtamembrane region of EphA2 receptor, colored according to the extent of the interactions with PIP lipids.585 A and B
are reprinted with permission from ref 585. Licensed under Creative Commons Attribution 4.0. C. Snapshots after 5 μs of simulation time (left,
upper leaﬂet; right, lower leaﬂet) of a plasma membrane model with multiple transmembrane segments of a cytokine receptor.591 GM3, PIP lipids
and sodium ions are shown in magenta, yellow and blue spheres, respectively. D. Extent of the interactions from blue to red for PIP lipids and
cholesterol with the transmembrane helix of the receptor. C and D are reprinted with permission from ref 591. Copyright 2014 Koldso et al.
Licensed under Creative Commons Attribution 4.0.
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00451
Chem. Rev. XXXX, XXX, XXX−XXX
AH
changes in the structure of the dimer.584 Computer simulations
also showed how this pattern of interactions between anionic
lipids and the juxtamembrane domain is a feature not only of
EGFR but of many other RTKs as well. Hedger et al. applied a
multiscale approach similar to that of Abd Halim and
colleagues to a panel of 58 RTKs, retrieving clustering of PS
or PIP lipids around speciﬁc and conserved juxtamembrane
residues, driven by electrostatic interactions (Figure 22A,B).585
Anionic lipids are not the only lipids known to modulate
RTK activity. For EGFR, for instance, the interactions between
GM3 gangliosides and the extracellular domain aﬀect the
dimerization mechanism and prevent the activation of the
kinase domain.586 CG simulations provided more details on
the interactions between EGFR, PIP and GM3 lipids.587 While
the contacts between PIP lipids and the juxtamembrane region
persist over several μs of simulation time, the interactions of
the GM3 lipids in the extracellular side are dynamic, although
always localized around positively charged residues. The free
energy proﬁles of lipid association to WT and mutant
transmembrane dimers revealed weaker interactions with
GM3 lipids than with PIP lipids. This may be linked to
receptor localization in raft-like domains enriched in ganglio-
sides in the upper leaﬂet and to a speciﬁc role of PIP lipids in
the cytoplasmic leaﬂet in modulating receptor dimerization.587
A simulation-based multiscale approach also showed how
anionic lipids have an eﬀect on the conformation of the
extracellular domain of RTKs.588 The interactions with PG
lipids anchored the large and ﬂexible membrane-proximal
ﬁbronectin domain 2 (FN2) of the extracellular domain of
ephrin (Eph) receptors to the membrane surface, which may
be involved in receptor clustering for signal transduction.588
The extracellular domain of RTKs plays a signiﬁcant role in the
conformational coupling of the diﬀerent receptor domains not
only via substrate binding, but also through N-glycosylation.
Simulation studies have suggested how N-glycosylation triggers
a diﬀerent pattern of interactions with the membrane, which
may be relevant for kinase activation.589 A recent computa-
tional study on the EphA2 receptor targeted in particular the
interactions between the kinase domain, the juxtamembrane
region and the membrane.590 In combination with liposome
pull-down experiments, the simulations showed the ability of
the kinase domain to interact with the membrane mediated by
PIP lipids, resulting in two main orientations of the kinase
domain.590
The studies described above highlighted the interactions of
the juxtamembrane region with anionic lipids. Here, this
pattern of interactions is inﬂuenced by the presence of the
kinase domain, with decreased PIP lipid clustering when the
kinase domain contacts the juxtamembrane region. This study
combined with previous modeling of the full EphA2
receptor588 provides new insights on the possible conforma-
tional coupling of the extracellular, transmembrane, and
cytosolic domains of the receptor, relevant for receptor
activation and inactivation.590 Other membrane properties
might be relevant as well. CG simulations of EGFR in a plasma
membrane model, for instance, described large membrane
perturbations in terms of thickness and curvature induced by
the 2 transmembrane helices and possibly by interactions with
the extracellular and juxtamembrane domains.121 While at the
CG level changes in the conformational state of the receptor
are not addressed, this study shows that the eﬀect of the
protein on lipids goes beyond lipid sorting near the protein and
speciﬁc interactions with selected protein residues, and extends
to signiﬁcant changes on membrane properties.
Cytokine receptors represent another family of membrane
receptors involved in signal transduction upon homo- or
heterodimerization.576 Simulation studies revealed a pattern of
interactions with anionic lipids similar to RTKs: CG and
atomistic simulations identiﬁed both zwitterionic and
negatively charged lipids in the ﬁrst few shells near the
protein, but with enhanced clustering of anionic lipids close to
charged residues of the juxtamembrane region.427 The
interactions between lipids and cytokine receptors were
studied in a complex mixture of lipids asymmetrically
distributed between leaﬂets (Figure 22C).591 This membrane
model included, among others, ganglioside GM3 and anionic
lipids, which clustered and colocalized with the cytokine
receptors as discussed above for EGFR, as well as cholesterol,
for which preferred interaction sites were identiﬁed (Figure
22D).591
The increasing complexity of the membrane composition
used in simulations and the use of the CG representation of
the system combined with atomistic studies have helped
identifying conserved lipid interaction sites and conﬁrmed the
role of the membrane in modulating proteins’ conformational
state. Currently, one major limitation is related to the large size
of these dimers and their ﬂexibility, which hinder sampling and
limit the time scale on full-length models.
12. INTEGRINS AND L-SELECTIN
Integrins and selectins are diﬀerent families of cell adhesion
molecules. Integrins are heterodimeric receptors involved in
cell adhesion and migration and regulate signaling cascades in
many cellular processes.592 The intracellular domain of
integrins associate with several cytosolic proteins that, in
turn, mediate the interactions with the actin cytoskeleton.593
Active and inactive conformations of these heterodimers
(consisting of an α and a β subunit) are associated with
diﬀerent orientations of the transmembrane helices, in turn
controlled by the interactions with talin on the intracellular
side or with ligands on the extracellular domain.592 MD
simulations have targeted the packing of the transmembrane
helices, highlighting the role of a speciﬁc motif in heterodimer
stability594−596 and showing how the free energy of association
of integrin transmembrane domains depends on the speciﬁc
subunits involved in the heterodimer, relevant for integrin
activation.597 Below we describe in more detail simulations
studies that addressed interactions with the membrane.
Talin connects integrin receptors with the cytoskeleton.
Integrin activation involves the interaction between talin, the
membrane, and the β subunit of the receptor, which results in
conformational changes in the extracellular domains of
integrins.598 Anionic lipids are important players in this
mechanism.598−601 MD simulations have been extensively
used to describe the interactions between talin and the
membrane, highlighting the role of anionic lipids in triggering
the interactions with several basic residues of talin.602−604
Multiscale approaches combining CG and atomistic simu-
lations or atomistic simulations alone of integrin trans-
membrane helices, with or without talin, revealed how talin
modulates the interactions between the helices, controlling the
switch between integrin conformational states.603,605,606 The
results of atomistic MD simulations suggested that the
interplay between PIP2 lipids and talin contributes to the
activation of the integrin heterodimer by breaking an interhelix
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salt-bridge and promoting transmembrane helix separation.607
The residues involved in the salt-bridge are highly conserved,
and the interaction is required to form a stable helix−helix
complex that prevents integrin activation.608,609 Using a
combination of biophysical and simulation methods, Schmidt
et al. evaluated the eﬀects of zwitterionic and anionic lipids on
the salt-bridge: anionic lipids do interfere with the salt-bridge
interaction but at the same time are able to stabilize the
transmembrane complex by bridging the helices together,
resulting in more stable contacts compared to zwitterionic
lipids.599 Microsecond-long atomistic simulations also sug-
gested an alternative mechanism of tail-mediated integrin
activation that does not require the transmembrane helices to
separate.610 While these studies used the transmembrane
domain of the receptor with or without talin or talin alone,
Kalli et al. addressed lipid−protein interactions for a full
integrin receptor in complex with talin, in three lipid bilayers
with diﬀerent ratios of PC, PE, PS, SM lipids, and cholesterol
between leaﬂets.611 The simulations identiﬁed residues that
speciﬁcally interact with PS lipids, which also promote stable
interactions of talin with the membrane, in line with previous
studies postulating the critical role of electrostatic interactions
in the formation of the complex with talin. The interactions
with PS lipids, together with higher cholesterol density near
the transmembrane domains, resulted in changes in lipid
organization near the receptor, with slower lipid diﬀusion
extending for up to 2.8 nm from the receptor.611
Integrin clustering in the membrane has been hypothesized
to be part of the signaling transduction mechanism, although
some controversy remains.612 MD simulations proposed that
integrin clustering in the membrane might be driven mainly by
the β subunit, which induces a less tight lipid packing in its
immediate surrounding, compared to the α subunit.613
Selectins are a group of three glycoproteins, namely P-, E-,
and L-selectin, expressed in diﬀerent types of cells,
characterized by an extracellular region containing a lectin
type domain, an EGF type domain and a series of short
repeats; a single transmembrane spanning helix, and a short
intracellular domain.614 L-Selectin, expressed on leukocytes,
acts as the membrane receptor for ezrin/radixin/moesin
(ERM) proteins, which connect L-selectin to the cytoskele-
ton.614 Sun and colleagues have used MD simulations to study
the role of anionic lipids in triggering the formation of the
complex between the cytosolic domain of L-selectin and the N-
terminal subdomain of ERM (FERM).615 Here either PS or
PIP2 lipids were found to enhance the binding strength of
FERM to the membrane, with PIP2 providing the largest
driving force. Moreover, PIP2 induced a conformational
change of L-selectin, which allowed the formation of the
heterocomplex by merging of PIP2 clusters around FERM and
L-selectin, highlighting once again the role of PIP lipids in
signal transduction.615
The studies discussed above describe the molecular details
of membrane reorganization associated with lipid−lipid and
lipid−protein interactions and provide further evidence on the
role of lipids as active players in signal transduction.
13. SLC TRANSPORTERS
The solute carrier transporters (SLCs) superfamily is
comprised of a large number of membrane proteins involved
in the transport of a wide range of substrates, including ions,
amino acids, neurotransmitters, drugs, sugars, and lipids.616 As
defects in SLCs underlie many diseases, SLCs represent a class
of attractive drug targets.617 Lipids can aﬀect the folding of
SLCs, modulate their activity, and contribute to the stability of
protein oligomers.44,618 Below we review the application of
MD simulations to study the role of lipids in SLCs. Following
other literature, we classify SLCs into four main categories
based on their structural fold, namely (i) the major facilitator
superfamily (MFS) fold, (ii) the LeuT fold, (iii) other inverted
repeat folds, and (iv) other folds, including all of the remaining
SLCs.616 Importantly, in SLC families many proteins with low
sequence identity adopt the same fold (often LeuT-like or
MFS). To connect fold-based classiﬁcation to SLC-family
based classiﬁcation we show examples of SLC families grouped
by fold.619,620
13.1. MFS Fold (SLC2, SLC15−19, and SLC37 Family of
Transporters)
The MFS is the largest superfamily of SLCs. MFS members
transport nutrients, metabolites, toxins, drugs, and other
substrates across membranes623 and are characterized by a
structural architecture of two 6 transmembrane helices
bundles, each containing two symmetric inverted repeats.616
One of the ﬁrst structures was the lactose permease, LacY
(Figure 23). In an early simulation study, Lensink et al.
simulated LacY in three diﬀerent bilayers (POPE, POPC, and
POPG).624 The authors proposed that the PE-dependence of
LacY for lactose transport is related to speciﬁc interactions
between highly conserved aspartic acid and (non-, mono-, and
dimethylated) POPE amine groups. The phospholipid head
groups are stabilized by interactions with a conserved lysine.
Lensink et al. concluded that lipid-mediated salt-bridges are
important determinants of LacY state stabilization. This
Figure 23. MFS fold and the LeuT fold in the SLC superfamily. Left.
LacY structure621 in the inward-facing state with the two repeats
(Rep1 and Rep2) shown in light yellow and orange cartoons. The side
chains of residues known to interact with the sugar substrate are
represented in white spheres. Right. Structure of a LeuT dimer,622
with the Na+ ions represented as blue spheres and the Leu substrate as
white spheres. For one monomer, the two repeats are shown in light
yellow and orange cartoons, while the second monomer is shown as a
white surface. The top panels represent a side view of the proteins,
with the membrane region highlighted in gray. The bottom panels
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mechanism of lipid-speciﬁc transporter function modulation
was tested in a FRET study by Suaŕez-Germa ̀ et al.625 The D/
C mutation of the conserved aspartate identiﬁed by MD
studies was experimentally proven to considerably change
LacY selectivity for lipids. Recently, Martens et al. combined
hydrogen−deuterium exchange mass spectrometry (HDX-MS)
with simulations and showed how the speciﬁc interactions
between PE lipid headgroups and conserved charged residues
(including the aspartate describe above) regulate the
conformational equilibrium of the transporter.626 The HDX-
MS experiments show not only how mutations that abolish the
interactions at these charged positions promote the inward-
facing state of LacY but also how PE lipids support the opening
on the intracellular side. The same experimental approach
applied to the xylose transporter XylE resulted in similar
ﬁndings. Atomistic simulations showed speciﬁc interactions
between the conserved charged residues of both transporters,
LacY and XylE, in the inward-facing state and PE lipids, but
not for PC headgroups, in line with the HDX-MS experiments.
Moreover, the XylE simulations in the presence of PC lipids
revealed a closing motion at the intracellular side of the
transporter, further validated by additional HDX-MS studies.
Combined, these results depict a complex mechanism for the
transport cycle, possibly valid for other homologous SLCs,
where the switching between outward- and inward-facing states
should be described as a function of the interactions with
lipids.626 μs-long atomistic simulations carried out on the
ANTON supercomputer also show how PE lipids might be
involved in substrate uptake on the periplasmic side of LacY,
highlighting further the complex interplay between the
transporter and lipids.627
Some of the best characterized MFS transporters are the
glucose transporters (GLUTs), which transport glucose and
other sugars across membranes via an alternating access
mechanism, possibly combined with the accessibility of
multiple substrate-binding sites.628,629 Iglesias-Fernandez et
al. used atomistic MD simulations to study how the structure
of GLUT1 is aﬀected by the bilayer structure, following
experimental ﬁndings of decreased transport in the gel
phase.630 The simulations of two opposite protein conforma-
tions showed how the protein responds to diﬀerent lipid
environments, as in the gel phase the access to the central
glucose binding site becomes narrower, with no continuous
pathway from the extracellular to the intracellular side.630 CG
simulations have provided a ﬁrst characterization of the lipid
distribution around the transporter embedded in a complex
mixture, showing an enrichment of polyunsaturated and fully
saturated lipids in the lower and upper leaﬂet, respectively.121
As the activity of GLUTs is regulated by the composition of
the membrane, molecular simulations in the future are
expected to yield further insight into the speciﬁcity of such
interactions, especially with anionic lipids and cone-shaped
lipids.631
13.2. LeuT Fold (SLC5, SLC6, SLC7, and SLC11−13
Families)
The leucine transporter (LeuT) fold consists of two inverted
repeats of 5 transmembrane helices (Figure 23).632 LeuT has
been extensively characterized from a functional and structural
point of view and has served as a model to guide studies on
other SLCs that share the same fold, including the neuro-
transmitter:sodium symporters (NSSs).633 The role of the
membrane and detergent molecules in modulating its structure
and function has been addressed with both experimental and
computational approaches. Following up on experimental
studies showing how detergent concentration alters the
stoichiometry of substrate binding, MD simulations of LeuT
in micelles revealed that this is due to detergent molecules
occupying the secondary substrate binding site (S2).634 The
substrate or agonist binding to the site S2 was proposed to be
an essential part of the allosteric regulation of the transport
cycle in NSS family. Simulations of LeuT in a POPE:POPG
lipid environment mixed with increasing ratios of detergent
were also carried out to mimic protein solubilization in
detergent and investigate the behavior of lipids that remain
bound to the protein.635 Penetration of detergent into the
secondary substrate binding site occurs at high detergent
concentrations and depends on the type of detergent, which
has implications for the use of detergents in studies of NSSs.
Moreover, at higher concentration, lipids within the ﬁrst shells
predominantly occupying site S2 may obstruct the substrate
access to primary binding site S1 and hence impair transport
function.635 It has been shown previously that detergent
binding to site S2 (octylglucosides) results in the functionally
blocked (transport-incompetent) form of the transporter.636
Atomistic simulations of LeuT in a POPC bilayer and in a
POPE:POPG mixture detailed membrane thinning around
speciﬁc helices important for transport as a result of
hydrophobic mismatch, depending on the protein conforma-
tional state.637 A lysine residue in TM7 was mainly responsible
for the membrane defect and water penetration deeper in the
membrane, both of which were abolished in simulations with
the corresponding alanine mutant.637 LeuT is highly dynamic
during its transport cycle, and some controversy remains
regarding the biological relevance of its crystallographic
inward-open state in the membrane environment.633 MD
simulations of LeuT in a POPC bilayer and in detergent
micelles showed how this state is preferred in the micelle
environment, due to a better compensation of the hydrophobic
mismatch and higher mobility of the TM1A segment.638 In the
bilayer, on the other hand, the dynamics of this segments is
limited, thus restricting the opening of the inner vestibule
compared to the crystallographic state.638
LeuT is the bacterial homologue of NSSs, such as the
transporter for dopamine (DAT), serotonine (SERT), and
others, which couple the sodium gradient with the reuptake of
neurotransmitter from the synaptic cleft in an alternating
access mechanism.639 The mechanism of transport of DAT
and SERT is regulated by interactions with lipids, including
PIP2 lipids and cholesterol.640−644 Direct interactions between
PIP2 lipids and DAT involve electrostatic interactions with
positively charged residues located at the N-terminus,640 as
supported by atomistic simulations and self-consistent mean
ﬁeld model calculations to quantify the interaction energy of
the DAT N-terminus with PIP2 lipids.640,645 The above-
mentioned simulations were carried out on a model of the
DAT N-terminus. Khelashvilli et al. also carried out
equilibrium atomistic simulations of a model of human DAT
embedded in a membrane enriched in PIP2 lipids, showing
spontaneous conformational changes between diﬀerent
states.646 Electrostatic interactions between PIP2 lipids, the
DAT N-terminus and the intracellular loop 4 were identiﬁed as
the triggering event to induce the conformational transition
from an outward-facing to an inward-facing state and release of
sodium from the second binding site, highlighting the role of
lipids as active players in the mechanism of transport.646 The
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comparison of extensive molecular dynamics simulations of
DAT in membranes with and without PIP2 lipids highlighted
how the diﬀerent patterns of interactions between the N-
terminus and the protein surface are directly linked to sodium
release as they regulate the opening and closing of intracellular
gates and water access to the binding site.647,648 As the N- and
C-termini are segments typical of eukaryotic NSSs, these
ﬁndings support the hypothesis that lipid-mediated regulation
is diﬀerent for NSSs and their bacterial homologues.649
The conformational transitions and function of NSSs are
also regulated by cholesterol. Diﬀerent populations of DATs
are associated with cholesterol-depleted or cholesterol-rich
domains.642,650−654 In cholesterol-rich domains, outward-
facing states of the transporter are preferred and stabilized
over inward-facing states, promoting binding of DAT blockers
such as cocaine;642 cholesterol depletion shifts the equilibrium
toward inward-facing states.653 Furthermore, cholesterol
modulation encompasses interactions between cholesterol
and speciﬁc sites on DAT,652,653 as also recently suggested
by experimental structures, reporting diﬀerent cholesterol
binding sites.655−657 Similar considerations apply to other
NSSs, including SERT.643,644,658−661 MD simulations at the
atomistic and CG level of detail have explored the speciﬁc
interactions between cholesterol and the suggested binding
sites in NSSs. The crystal structure of DAT showed cholesterol
bound to a groove lined by TM1a, TM5, and TM7.655 CG
simulations on a SERT homology model in mixtures with
increasing cholesterol concentrations identiﬁed six binding
sites,662 including CRAC/CARC motifs and the crystallo-
graphic cholesterol site in DAT. In particular, Ferraro et al.
suggested that cholesterol modulates the interactions at the
intracellular gate of the transporter, stabilizing the outward-
facing conformation.662 The cholesterol crystallographic site of
DAT was also reproduced by CG simulations of DAT
embedded in a plasma membrane model.121 The stabilizing
eﬀect of cholesterol on the conformational state of the
transporter was further addressed by Laursen et al., who
combined biochemical studies and CG simulations of the
Figure 24. Cholesterol interaction sites in NSSs obtained from CG simulations.663 Shown are diﬀerent views of the selected NSSs with the
cholesterol sites identiﬁed based on occupancy maps obtained in the presence of 20% cholesterol. The maps are drawn at occupancy values at least
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human SERT structure to show that cholesterol binding to the
site identiﬁed in DAT is crucial in regulating the conforma-
tional transitions between states, favoring an outward-facing
conformation.658 Extensive CG and atomistic simulations
recently added further support to this, showing a common
behavior across DAT, SERT and the norepinephrine trans-
porter (NET).663 The CG simulations showed that two
cholesterol sites described in DAT crystal structures655,657 are
common to all of the NSSs used in this study (Figure 24). A
comparison of these sites with the sequences of CRAC/CARC
motifs revealed that such motifs are not essential for
cholesterol binding.663 The μs-long atomistic simulations
showed that the site lined by TM1a, TM5, and TM7655 is
the most stable and hampers the transition to an inward-facing
state. Considering the degree of conservation of this site, this
simulation study suggests the existence of a common
cholesterol-based regulation mechanism, possibly extending
to other species.663
The interplay between LeuT or NSSs and lipids extends
further, as lipids also contribute to protein oligomerization, as
shown by cardiolipin and phospholipid binding to the dimer
interface of LeuT.618 A combination of diﬀerent simulation
techniques showed that in a pure POPC bilayer SERT forms
symmetric dimers preferably via its transmembrane helix 12.664
This dimerization, however, is highly dependent on membrane
composition as simulations performed in mixtures of POPC
with cholesterol or with PIP2 lipids show marked diﬀerences
and a higher energy barrier for SERT dimerization.664 PIP2
lipids were not found at the TM12 dimer interface, suggesting
that they do not act as a bridge between SERT monomers. As
experimental data show that PIP2 lipid concentration regulates
the equilibrium of protein oligomerization,665 further studies
are needed to clarify the direct interactions of PIP2 lipids and
their role in protein oligomerization.
13.3. Other Inverted Repeat Folds (SLC9, SLC10, and SLC4
Families)
Na+/H+ antiporters regulate sodium level and pH via an
alternating access mechanism as in other SLCs. The structures
of E. coli NhaA and T. thermophilus NapA (Figure 25)
represent diﬀerent states of the transport cycle, and reveal a
core region for ion translocation that adopt diﬀerent
conformations while the dimerization interface remains
unchanged.666,669 Landreh et al. applied mass spectrometry
and MD simulations to investigate the role of lipids in protein
dimerization for NhA, NapA, and the human homologue
NHA2.670 The mass spectrometry (MS) study highlighted the
high dimer stability of NapA (Figure 25) and NHA2 together
with a limited amount of bound lipids, while NhaA was found
primarily as a monomer and with bound cardiolipin.670
Atomistic simulations of a NapA dimer in POPE lipids
attributed the higher dimer stability of NapA to the tight
packing of lipids at the interface between the core and the
helices of the dimer interface, where membrane thinning was
observed as a consequence of hydrophobic mismatch.670
Additional simulations of NapA, with and without tightly
bound PE lipids, were carried out in vacuum to mimic the MS
conditions. Lipids in these regions prevented protein helices
from unfolding, and established interactions with the protein
that persisted at higher temperatures, overall increasing dimer
stability.670 The lower dimerization strength of NhaA was also
reported by Gupta et al., who found evidence of cardiolipin
binding in NhaA dimers at the interface between monomers,
and an increase in the amount of monomers following loss of
bound cardiolipin.618 These ﬁndings support the hypothesis
that cardiolipin stabilizes the dimeric form by bridging the two
monomers together. In contrast, NapA dimers are stable
without cardiolipin, as the glue-like mechanism is provided by
an N-terminal segment not present in NhaA.618
The E. coli UraA/H+ symporter couples the uptake of uracil
with H+ across membranes (Figure 25).671 By means of CG
Figure 25. Representative structures of other inverted repeat folds in the SLC superfamily. Left. NapA dimer,666 with the ion translocation domain
in light yellow cartoons and the dimerization domain in orange cartoons. The second monomer is shown as a white surface. Aspartate 157 required
for ion binding is highlighted in white spheres. Center. The UraA structure,667 with the gate and the core domains in orange and light yellow
cartoons, respectively, and the Ura substrate highlighted in white spheres. Right. The structure of a Band 3 dimer,668 with the gate and core domain
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and atomistic simulations, Kalli et al. investigated the
symporter interaction with lipids using a membrane model
mimicking the composition of E. coli membranes, consisting
primarily of PE, PG and cardiolipin.672 The anionic lipids
associated more readily with the protein, driven by electrostatic
interactions. While PG lipids distributed more evenly on the
protein surface, three main interaction sites were identiﬁed for
cardiolipin headgroups, further conﬁrmed with additional
simulations after in-silico mutagenesis of the residues involved
in the interactions.
UapA is a uric acid/xanthine H+ symporter. Structural
studies on UapA from Aspergillus nidulans showed the
preference of the symporter to form homodimers,673 with
protein oligomerization important for function and protein
localization on the fungal plasma membrane.673,674 Using mass
spectrometry, Pyle et al. identiﬁed PC, PE and PI lipids as lipid
classes that copurify with the protein, although only PI and PE
were able to promote the formation of a functional dimer after
protein delipidation, suggesting a speciﬁc eﬀect of PI and PE
lipids in mediating the interactions at the dimer interface.675 5
μs-long CG MD simulations of UpaA in diﬀerent mixtures of
PC, PE, and PI lipids revealed diﬀerent patterns of interactions
between PI lipids and PE and PC lipids, with frequent contacts
between PI lipids and positively charged residues at the
cytosolic side of the dimer interface. A combination of
mutagenesis studies and in vivo assays showed that mutations
at these position do not aﬀect protein traﬃcking nor substrate
binding but do alter transport.675 While this study highlights
the role of lipids in maintaining a functional dimer, further
studies are required to characterize possible interaction sites
and the regulatory role of lipids on the function of the
symporter.
Band 3 (AE1, SLC4A1) catalyzes the electroneutral
exchange of bicarbonate ions with chloride ions in red blood
cell membranes.676,677 Band 3 is found primarily as a dimer.
The transmembrane domain of each monomer consists of 14
transmembrane helices, organized into two inverted repeats of
7 helices forming a core and a gate domain (Figure 25).676
Several experimental studies provide evidence that phospho-
lipids and cholesterol aﬀect structure, function, and localization
of the transporter,678−682 and other members of the SLC4
family are directly regulated by phosphoinositides, e.g., the
PIP2-induced stimulation of NBCe1-A (SLC4A4) activity.683
The interactions between Band 3 and cholesterol and
phospholipids were recently addressed by Kalli et al. in a
computational study that combines CG and atomistic
simulations.684 At the coarse grain level of detail, Band 3 was
simulated in 8 diﬀerent membrane environments, with varying
ratios of cholesterol, PC, PE, SM, PS, and PIP2 lipids. Speciﬁc
interaction sites were identiﬁed for anionic lipids and
cholesterol: PS and PIP2 lipids coordinate with several
positively charged residues, with lipid density from PIP2
molecules being more localized than PS lipid density.
Cholesterol also interacted consistently with the same protein
residues, independently from its concentration. The simulation
results suggest that lipids and cholesterol might modulate the
interaction between the two monomers, as cholesterol
molecules, together with acyl tails of PS lipids, ﬁll the cavity
between the two monomers preventing changes at their
interface. The molecular details of Band 3−lipid interactions
described by the work of Kalli et al. provide a range of
hypotheses that could be tested further experimentally to
address the role of speciﬁc residues and lipids in modulating
Band 3 activity.
13.4. Other Folds
Additional folds found in SLCs include, but are not limited to,
those shown by mitochondrial ADP/ATP carriers, whose
interactions with cardiolipins have been described above
together with the respiratory proteins and proton carriers.616
The uncoupling protein 1 (UCP1) dissipates the proton
gradient across the inner mitochondrial membrane by moving
protons into the mitochondrial matrix, thus uncoupling the
proton electrochemical gradient with the synthesis of ATP.685
With a combination of NMR, functional, and MD simulation
studies, Zhao et al. characterized the binding of fatty acid
molecules to UCP1, required for protein activation, and
identiﬁed speciﬁc residues engaged in electrostatic interactions
with the fatty acid.686
The ammonium channel AmtB from E. coli is the most
characterized member of the ammonium transporter/methyl-
ammonium permease/rhesus (Amt/Mep/Rh) protein fam-
ily.688 AmtB is found as a trimer, with each monomer
consisting of a transmembrane domain of 11 membrane-
spanning helices (Figure 26).688 Ion-mobility mass spectrom-
etry (IM-MS) has shown how the trimer stability is linked to
PG lipids tightly associated with the protein, while X-ray
crystallography has identiﬁed at least 8 sites speciﬁc for the
interactions with PG headgroups.75 The eﬀects of PG lipids
binding on AmtB function have recently been investigated with
solid supported membrane electrophysiology (SSME) and MD
simulations.689 The SSME measurements carried out on AmtB
reconstituted in POPA/POPC and POPA/POPC/POPG
liposomes show that PG lipids are required for proper
transport activity. 700 ns-long atomistic simulations of the
AmtB trimer in POPA/POPC and POPA/POPC/POPG
Figure 26. Ammonium channel AmtB. The three monomers of
AmtB687 are shown in light yellow, orange, and brown cartoons, with
the sites for NH3 and NH4 binding highlighted by blue and red
spheres, respectively. The upper panel is the side view of the protein,
with the membrane region highlighted in gray. The bottom panel is
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mixtures retrieved the crystallographic PG binding sites and
identiﬁed new ones, highlighting how PG lipids preferentially
bind at the interface between monomers, with no signiﬁcant
structural changes except in a short periplasmic loop. This
study supports the hypothesis that PG lipids might act as a
bridge in controlling the interactions between monomers.689
However, there is more to the complex interplay between
AmtB and lipids, as speciﬁc lipid binding can allosterically
regulate not only the interactions of AmtB with other
proteins78 but also the interactions with other lipid types690
14. VIRAL PROTEINS
The general virus infection cycle is divided into the early stage
(entry process) and the late stage (assembly, budding, and
release processes of virus particles). The genome of many
circulating human pathogens such as human immunodeﬁ-
ciency virus (HIV) and Ebola virus are enveloped, i.e., contain
a lipid bilayer covering the protein capsid. For the infection to
occur, the genome is delivered to the host cytoplasm by
inducing the fusion of the viral envelope with the cell
membrane. In all known cases, the membrane fusion reaction
that allows viral entry is accomplished by viral surface
glycoproteins, including one key factor that is generally
denoted as the fusion protein.691 Initial steps involve
interactions of a viral fusion peptide with the membrane of
the target cell, a biophysical process that has received
considerable attention using model peptides but that is outside
the scope of this review692−697 The ﬁnal step of fusion involves
the merging of the viral and host membrane and depends
critically on their lipid composition. Lipids contribute to fusion
through their physical, mechanical, and/or chemical proper-
ties.698 Speciﬁc interactions between viral envelope glyco-
proteins, including fusion peptides, and lipids, including
cholesterol, ceramides, and glycophospholipids, have been
the subject of several excellent reviews and will not be
discussed in more detail here.699−702
Enveloped viruses generally acquire their envelope by
budding at the plasma membrane or internal compartments
depending on the virus type. Therefore, all of the viral
membranes originate from cellular membranes, but they
diverge in protein and lipid composition. Overall, the release
of an infectious mature virion requires traﬃcking and assembly
of its vital components to the budding site, induction of
membrane curvature and scission of the virion from the cellular
membrane. This is accomplished with the help of glycoproteins
on the viral membrane envelope as in the case of inﬂuenza, or
by inner structural proteins such as Gag proteins in HIV as
well as complexes from the host, for example the endosomal
sorting complex required for transport machinery.703,704 The
lipid compositions of infected cell membranes and budded
viral membranes are diﬀerent, indicating lipid sorting in virus
release699,705,706 Viruses modify lipid synthesis and reorganiza-
tion of cellular membranes for virus assembly and exit. They
can also promote the active synthesis of lipids to provide
membranes for the viral envelope. Quantitative analyses of viral
lipidomes at the individual molecular species level have
become possible by means of mass spectrometry, but
diﬃculties involved in cellular membrane puriﬁcation
complicates the understanding of lipid sorting and membrane
remodeling during viral budding. Lipids such as cholesterol,
sphingolipids, phospholipids, and PIP2 participate in both
early and late steps in the replication of a large number of
enveloped viruses.707−712
A combination of X-ray crystallography with cryo-electron
microscopy (cryo-EM) and cryo-electron tomography has
provided many high-resolution static structures of capsids and
envelopes.713 Meanwhile, MD simulations have been widely
used to explore the conformational dynamics and stability of
the viral capsids and organization of viral envelopes. In the
following two sections, we will consider large-scale MD
simulations that focus on structural stability and integrity of
enveloped virions and viral membrane fusion and budding with
and from host cells, respectively.
14.1. Viral Membrane Structural Stability and
Organization
There are considerable challenges in simulating a model of a
complete virion envelope. Compared to MD simulation of
proteins and lipid bilayers, enveloped viruses impose greater
structural complexity due to asymmetric bilayers and large
assemblies of proteins.714,715 Knowledge of a viral lipidome is a
critical step in building a computational model of an enveloped
virion. Although it is possible for viruses to select their own
unique lipid species, the lipid composition of the envelopes is
usually approximated based on the lipid composition of the
host cell membrane. Other crucial pieces of information are the
structures and copy numbers of proteins embedded within the
lipid bilayer. To date, several structures of the extra-membrane
domains of such proteins have been determined but, in most
cases, complete structures of the proteins including their
transmembrane (TM) domains are lacking.715 Thus, a more
speculative modeling approach based on domain prediction
and/or structural data is required.716
The interplay between lipid environments and inﬂuenza
virus has been an interesting subject for several computational
studies.692,717−719 The inﬂuenza virus triggers annual epi-
demics, occasional pandemics, and is considered a signiﬁcant
worldwide health problem. The viral proteins hemagglutinin
(HA) and neuraminidase (NA) are targeted to lipid rafts,
causing the merger and extension of the raft domains. This
clustering of HA and NA may cause a deformation of the
membrane and the initiation of the virus membrane fusion and
budding events.720,721 Many simulation studies have addressed
the eﬀect of HA on membrane deformation, as recently
reviewed by Boonstra et al.722 To understand the structural
dynamics of the entire inﬂuenza A membrane envelope, Reddy
et al. used CG MD simulations on the microsecond time
scale.718 The Martini CG force ﬁeld was used to simulate the
viral membrane model with POPS:DOPE:ether-linked
DOPE:cholesterol:hydroxylated sphingomyelin:Forssman gly-
colipids as the experimentally determined lipidome, an unusual
complexity compared to most simulations currently in the
literature. A high concentration of inﬂuenza A integral
membrane proteins, the HA trimers, NA tetramers, and the
TM domain of M2 tetramers were incorporated in the vesicle,
together forming the complete virion model. The ﬁnal model
contained >5 M particles and is relatively crowded where the
fractional volume of the proteins occupies ca. 15% of the viral
membrane area. In the absence of glycolipids, a stable lipid
population is maintained in each leaﬂet while the presence of
glycolipids leads to a broader lipid distribution pointing to
possible lipid mixing between the leaﬂets. The biologically
realistic and complex membrane model in this study points to
subdiﬀusive anomalous diﬀusion of inﬂuenza proteins where
M2 protein diﬀuses slower than the other two larger proteins.
This is mainly due to the larger cross-sectional area of TM
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domains and the strong interaction of M2 proteins with
surrounding lipids. In another CG MD study, the interactions
between HA in domain forming membranes with various local
concentrations of HA was investigated.719 The system
incorporated Martini representations of the crystal structure
of the HA ectodomain and models of TM and cytoplasmic
domains, DPPC, DLiPC, and cholesterol and explicit solvent.
After 12 μs of simulation, the proteins aggregated through their
bulky ectodomains without forming contacts among TM
domains. HA preferentially partitioned to the liquid ordered
(Lo) and liquid disordered (Ld) domain borders, initiating the
formation of lipid nanoassemblies of DPPC and cholesterol
within the protein clusters. In another study, lipid bilayers
containing POPC, DOPE, cholesterol, and the model receptor
(GD1a) with varying concentrations of GD1a and cholesterol
were used to show that inﬂuenza virus binding aﬃnity for
membranes is sensitive to membrane spatial organization and
sterol composition in the membrane.723 GD1a clusters form
and dissolve repeatedly within 18 μs of simulation.
Dissociation rates of multimers based on a Bayesian
formulation suggest that increasing cholesterol concentration
decreases GD1a-GD1a oﬀ rates and stabilizes GD1a clusters,
thus increasing viral binding aﬃnity.
Stability of the Dengue virions from the ﬂavivirus family has
also been studied by MD simulations.724−726 Dengue virions
are characterized by a relatively smooth surface, with a
diameter of approximately 500 Å. In addition to the RNA
genome, there are three structural proteins that occur in
stoichiometric amounts in the particle: the core, membrane
(M), and envelope (E).727 Reddy et al. used CG MD
simulations to build a model of the complete envelope of
Dengue virus by combining the cryo-EM structures of the
membrane proteins with the virus-infected insect cell
membrane lipid composition,728 resulting in a model
containing 7 diﬀerent lipid types, three M proteins and three
E proteins. In total, the model has 750 TM helices that occupy
18% of the membrane surface area, resulting in a degree of
crowding close to that of a mammalian cell. The size and shape
of the model was stable during 5 μs simulation and comparable
to the cryo-EM image of the Dengue virion. Due to the
crowded nature and the extensive interactions of the proteins
with the lipid headgroups, the lipids diﬀuse anomalously,
similar to the inﬂuenza A simulations. In a separate eﬀort,
Figure 27. Interactions between protein and lipids. (A) Initial (top) and ﬁnal (bottom) back-mapped coordinates of a representative E/M dimer
(DENVimpl) complexed with lipids. The E protein ectodomains (red, yellow, and blue corresponding to domains I, II, and III, respectively) and E
protein TM/stem regions (purple) as well as entire M protein (green) are shown in cartoon representation, with lipids shown in CPK format. (B)
The percentage contacts, averaged over 200 ns, between lipid phosphate groups and residues mapped onto the E/M protein heterodimer for the
three complete dengue envelope systems, together with a list of the residues in the E/M proteins that contacted lipid phosphates in >80% of frames
analyzed across all systems. A contact was recorded if a given amino acid was within 0.45 nm of a phosphate particle. Arginine/lysine residues are
excluded from this analysis and are instead shown in C. (C) The basic residues that made a contact with a lipid phosphate in >80% of the
simulation frames across all systems. Basic residues in the E and M proteins are shown in orange and pink, respectively, while the protein is
represented in white molecular surface format. Reproduced with permission from ref 724. Copyright 2018 Elsevier.
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Marzinek et al. developed a model of the Dengue virion
containing various phospholipids, obtaining a system that is
consistent morphologically with experimental observations.724
The arrangements of envelope protein complexes were
relatively unstable in pure zwitterionic phospholipid vesicles
compared to a more realistic mixed-membrane model,
suggesting that anionic lipids may be required for both
stability and fusion of viral particles. The simulations also
suggest that the ectodomain and stem regions of the E and M
proteins are involved in inducing lipid curvature. Moreover,
several His residues interacted with lipid head groups at the
interface, which may change their ionization state upon
exposure to the acidic environment of the endosome and
initiate envelope fusion (Figure 27).
In another study, Wewer et al. used the Martini force ﬁeld to
study glycosylated E3M3 hexamer proteins of Zika and
Dengue viruses embedded in a PC:PL:PE:PS:SM mem-
brane.729 It has been proposed that PS and PE lipids are the
key lipids for viral recognition by host proteins. Therefore,
understanding the lateral distribution of lipids and lipid−
protein interactions in Zika and Dengue membranes might be
useful for understanding the requirements for host entry. The
authors found that Zika and Dengue virus leave diﬀerent
footprints on the lipid distribution of the membrane. As for the
distribution of lipids around the proteins, PE and PS were
densely populated around both viral proteins, relative to SM
and PC, while PE lipids were more enriched around the
Dengue proteins and PS lipids were closer to the Zika proteins.
Additional examination of the protein sequences suggests
speciﬁc lipid binding sites on M proteins of both viruses. The
viral membrane became thinner around the Zika hexamer
compared to the Dengue hexamer, while M proteins from both
viruses induced positive curvature in the lower monolayer of
their associated membranes.
MD simulations have also been used to investigate the
interaction of lipids with nonstructural proteins from Dengue
virus.730,731 Nonstructural proteins are key viral factors that
induce membrane curvature and thereby contribute to the
formation of the membranous replication complex. Lin et al.
modeled the nonstructural protein 4A (NS4A) in a POPC
lipid bilayer by combining a docking approach and MD
simulations to develop a reasonable model for the structure of
the membrane-embedded and attached parts of the NS4A
protein.732 The model induces membrane curvature after 200
ns of all atom simulations in a structure-dependent manner
with a radius similar to the estimated radius of a replication
vesicle. In another study by Fajardo-Sanchez et al., all-atom
MD simulations were employed to understand interactions of
the PepC segment of Dengue virus with artiﬁcial short-chain
phospholipid membrane mimicks.733
HIV is an enveloped retrovirus, which buds primarily from
the plasma membrane of infected T cells.734 Diﬀerent
simulation approaches have evaluated the protein packing
and assembly in HIV virions.735,736 Of particular interest is the
interaction between lipids and Gag polyproteins. The HIV Gag
polypeptide contains all of the structural proteins required to
form the mature, infectious virion. Charlier et al. studied PIP2
membrane anchoring of HIV myristoylated MA protein that
lies at the N-terminal of the Gag protein precursor using CG
MD simulations.737 Before the MA protein reaches the
membrane, the myristoyl group spontaneously releases from
its initial hydrophobic pocket which costs ∼5 kcal/mol
energetically as estimated by umbrella sampling. After adopting
a stable orientation at the membrane surface, MA conﬁnes
PIP2 lipids around its surface where the PIP2 head groups
bind to its highly basic region in agreement with NMR data,
but without ﬂipping of their acyl chain into the MA protein.
Such a conﬁnement induces a lateral segregation of PIP2 in
domains and is consistent with a PIP2 enrichment of the viral
envelope relative to the host cell membrane.
The structural characteristics, molecular assembly and ion
conductivity of Hepatitis virus proteins in various lipid
compositions have also been studied by means of MD
simulations.738−740 The Hepatitis C virus p7 viroporin is a
potential drug target that controls the permeability of the
membrane to ions and facilitates virus production, analogous
to M2 from inﬂuenza A virus. Chandler et al. used monomeric
p7 to build oligomeric models with 4 to 7 subunits in hydrated
POPC lipid bilayers.741 Hexamers and heptamers with
optimized intersubunit contacts are the most structurally
stable and retained their symmetry. In the simulations, the
heptameric pore is always accessible to solvent, whereas the
hexameric pore is blocked occasionally. This may suggest that
cell membranes contain transiently open p7 hexamers
combined with always open p7 heptamers. In response to
varying lipid environments, the ﬂexible p7 hexamer in thinner
DHPC bilayers retains a highly tilted conformation in
agreement with cryo-EM observations while they adopt the
more upright conformation in thicker POPC bilayers.
14.2. Viral Membrane Fusion, Assembly, and Budding
MD simulations have proven to be beneﬁcial in studying
speciﬁc protein−lipid dynamics that control membrane fusion,
membrane bending followed by virus budding, and ﬁnal
membrane scission, in which the virion is detached from the
cellular membrane.693,694,742−758 Soares et al. used all atom and
CG MD simulations to investigate the eﬀects of protein−
protein and protein−membrane interactions in the generation
of membrane-bending forces in the Dengue virus envelope
proteins.759 Their bilayer model incorporates POPC:POPE:-
POPS:cholesterol with the lipid ratios from Dengue virus,
derived from the mosquito lipidome. The structural organ-
ization of three heterotetrameric EM proteins (EM3 unit)
serves as an anisotropic bending unit for the Dengue virus
envelope, because it is able to locally decrease the thickness of
the membrane with its short transmembrane helices and
impose a speciﬁc radius of curvature to the membrane. This
suggests that the EM3 unit may be the main determinant of the
viral particle size. The simulations show that the EM15 system
which includes ﬁve EM3 assemblies and corresponds to one-
sixth of the viral envelope induces complete vesiculation of an
open membrane patch. The pentagonal arrangement of ﬁve
EM3 units inﬂicts a speciﬁc curvature on the membrane,
breaking its initial symmetry and creating stress in the
membrane. The resulting elastic energy is minimized by the
systematic migration of lipids from the lower into the upper
layer. Overall, the vesiculation process studied in this work
suggests an explanation for the role of the envelope proteins of
Dengue virus in the mechanism of membrane shaping.
Rogers et al. used atomistic and continuum-level simulations
to study the energetics involved in Dengue virus assisted
membrane fusion.760 The system consisted of the E protein
trimers and a membrane of uniformly mixed POPG:POPC
lipids. The potential of mean force (PMF) of association of the
viral protein and the membrane displays a broad minimum.
POPG lipids exert a strong attractive force on E proteins to
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produce an irreversible surface-associated protein−membrane
contact. Continuum calculations in combination with the all-
atom PMF resulted in an estimated binding free energy of −15
kcal/mol per trimer, which represents an upper bound to
membrane bending energy necessary for membrane−mem-
brane fusion.
15. C99 AND γ-SECRETASE
The product of β-secretase cleavage of the full-length amyloid
precursor protein (APP) is a 99 residues long transmembrane
helix (C99) with an intracellular domain, which is further
cleaved in fragments of diﬀerent length by γ-secretase to form
the ﬁnal Aβ peptides.761 NMR and EPR spectroscopy studies
combined with mutagenesis assays identiﬁed the tandem
glycine motif of the helix as the interaction site for cholesterol,
in a 1:1 ratio, with an asparagine and a glutamate residue on
the extracellular end of the helix coordinating the polar group
of cholesterol.762 The tandem glycine motif induces a kink in
the helix that together with cholesterol binding has been
suggested to facilitate the interaction between C99 and the γ-
secretase.762 MD simulations also suggested that cholesterol
binding is sensitive to the protonation state of this glutamate
and an aspartate at this end of the helix, with the neutral state
of their side chains stabilizing the C99-cholesterol complex.763
Furthermore, MD simulations studies have provided additional
molecular details on the interactions of cholesterol with C99,
suggesting alternative binding modes to interact with the
glycine motif,412,764 as well as the existence of multiple binding
sites.412 The sensitivity to cholesterol of diﬀerent Aβ peptides
has also been addressed by simulations describing diﬀerent
cholesterol hot-spots depending on their length.765−767
Cholesterol bound at the tandem glycine motif might compete
with helix dimerization,768 but other sites have also been
proposed to promote helix−helix interactions.769 More in
general, the lipid environment and composition greatly aﬀect
helix orientation and dimerization of precursors of diﬀerent
lengths,770,771 an aspect that has been addressed with MD
simulations as well. Simulations in detergent micelles and lipid
bilayers captured diﬀerent dimeric states and helix orientations,
linked to the diﬀerent curvature in bilayers and micelles;772−774
simulations of C99 (residues 23−55) monomers and
homodimers in bilayers of diﬀerent composition highlighted
the diﬀerent kink and tilt angle of the helix as a function of
membrane thickness, favoring diﬀerent dimeric structures.775
The length of the precursor also impacts its structure in the
membrane, as shown by simulations of a full-length C99
(residues 1−99) monomer in implicit membranes of diﬀerent
thickness, where diﬀerent secondary structure elements for the
N-terminus were found depending on membrane thickness.776
Using CG simulations and comparing raft-like with nonraft
environments, Sun et al. showed that cholesterol not only
aﬀects C99 dimerization, but also alters dimer stability and
C99 partitioning in lipid domains.777 In raft-like membranes,
C99 preferentially partitioned at the boundary of liquid
ordered and disordered phases. Dimerization was signiﬁcantly
impacted, resulting in structural deformations of the dimer
compared to a nonraft membrane. As γ-secretase only cleaves
monomeric C99 and considering the greater risk of developing
Alzheimer diseases with increasing levels of cholesterol, the
dimer destabilization observed in the presence of a raft-like
environment might be linked to the molecular details leading
to the formation of Aβ peptides.777 Audagnotto et al. used CG
and atomistic simulations to investigate C99 dimerization in a
simple POPC bilayer and in a complex, synaptic plasma
membrane (SPM) model with 32 lipid types, showing that the
motifs involved in helix dimerization are diﬀerent in the two
membrane environments, resulting in diﬀerent dimer stabil-
ity.778
Recently, MD simulations have also been used to study how
the membrane aﬀects APP recruitment by the γ-secretase,779 a
multiprotein complex formed by presenilin (PSEN1),
presenilin enhancer 2, nicastrin, and anterior pharynx-defective
1 (APH-1).780 Audagnotto et al. used a CG approach to
simulate a shorter fragment of C99 that includes the
transmembrane helix as well as a full model of the γ-secretase
embedded in the synaptic plasma membrane (SPM) model
described above.779 The formation of a liquid ordered and
disordered phase was observed in the simulations, with the
ordered phase preferred in proximity of the convex face of the
γ-secretase.779 In the complex membrane, APP seems to
preferentially partition in raft-like, cholesterol-rich domains
when not interacting with the secretase, and in nonraft
domains when in proximity of the secretase. In line with what
was discussed above, APP dimerization was detected only for
low cholesterol concentrations, due to the inhibiting eﬀect of
cholesterol in helix−helix association. In a diﬀerent study, MD
simulations of the PSEN1 component of the γ-secretase
suggested an additional role for lipids in regulating the
cleavage, as a PE molecule was observed to enter the catalytic
site and form stable interactions.781
16. MISCELLANEA
For members of many other protein families, computer
simulations, often in combination with experiments, have
provided details on how lipids interact with proteins and
possibly modulate protein function. Below we describe studies
of a variety of membrane proteins that do not ﬁt neatly in the
larger groups previously described, recognizing this distinction
is somewhat arbitrary and based both on biological grounds
and the volume of simulation studies devoted to particular
proteins.
16.1. Glycophorin A
Glycophorin A (GpA) is a major sialoglycoprotein from
erythrocytes. Its main biological interest is derived from its
glycosylation, but the transmembrane part of the protein is
widely used as a model system for membrane protein
thermodynamics. Several experimental structures are available
from solution NMR in micelles,782 X-ray diﬀraction,783 and
solid state NMR,784 showing a consistent well-deﬁned helical
dimer structure.577 Combined with an abundance of
thermodynamic experimental data, see for instance Fleming
et al.,785 including on sets of mutants, this has made GpA a
popular model system for simulation methods development
and testing.786 With currently available computer resources
potentials of mean force calculations of helices in fully detailed
atomistic models have become readily accessible, which
enables their use in testing and developing computational
models. A recent example is the free energy of association of
two GpA transmembrane helices in explicit lipids.787 Although
the structure of the dimer remained stable and close to the
experimental structures, somewhat surprisingly the force ﬁeld
used predicted that the dimer was metastable. Minor changes
to interaction parameters that govern all lipid−protein
interactions, not speciﬁc to GpA, can modulate the stability.
This highlighted a second problem, in that the experimental
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values vary over a broad range.787 Simulations using the coarse-
grained Martini model correctly predicted that the dimer is the
most stable thermodynamic state, but the detailed structure
cannot be reproduced with a coarse-grained model. Overall,
this important paper highlights both strengths and weaknesses
in simulation approaches and in experimental data, and
emphasizes the need for careful studies on model systems,
and ﬁnancial support for such work from granting agencies, to
improve computational models and the interpretation of
experimental results for more complex systems of biological
interest.
16.2. Membrane Fluidity Sensors
There are several proteins able to sense membrane ﬂuidity for
which simulations have provided more details on their
mechanism of action. Two examples are the thermosensor
DesK, which responds to changes in thickness as a
consequence of changes in temperature,788 and the tran-
scription factor Mga2, for which the degree of lipid saturation
preferentially selects dimers with diﬀerent helix orientations.789
16.3. Lysosome-Associated Proteins
Atomistic simulations supported the identiﬁcation of a
ceramide interaction motif in the lysosome-associated protein
transmembrane 4B (LAPTM4B),790 required for recruiting
amino acid transporters to the lysosomal membrane in a
ceramide-dependent fashion.791 In particular, Zhou et al.,
based on a comparison with previously identiﬁed sphingolipid-
binding motifs, identiﬁed residues in transmembrane helix
(TM) 3 of LAPTM4B involved in ceramide interactions,
which were conﬁrmed by in vitro and in vivo assays.790
Atomistic MD simulations of POPC bilayers containing several
copies of TM3 showed that TM3 was able to trigger insertion
of ceramide micelles, a phenomenon that was not observed
when TM3 was replaced in a control simulations by the
WALP23 peptide. A ﬂexible region in the helix together with
the presence of an aspartate residue in the middle of TM3 is
responsible for changes in helix kink and preferential
interactions with ceramide, while nearby acidic residues
control helix tilting, to facilitate ceramide intake. These
conformational changes may be important for interactions
with the amino acid transporters.790
16.4. AcrAB-TolC Eﬄux Pump
Gram-negative bacteria use multidrug eﬄux pumps that span
both the inner membrane (IM) and the outer membrane
(OM) to extrude antibiotics out of the cell.792,793 We review
lipid−protein interactions of such pumps, which are large
complexes that consist of multiple proteins including an OMP.
AcrABZ-TolC is the best-studied example. It is a tripartite
complex formed by AcrB in the IM, controlling substrates
speciﬁcity; TolC, embedded in the OM; AcrA, a periplasmic
membrane fusion protein (MFP) connecting AcrB with TolC;
and AcrZ, a small protein with modulating eﬀects on AcrB.794
MD simulations have also been applied to characterize the
dynamics of individual components (mainly AcrB and TolC)
of the pump, as well as of the entire pump and their interfaces
and substrate interactions.793,795 Hsu et al. used CG MD
simulations to investigate the eﬀect of the full AcrABZ-TolC
complex on lipid organization in the presence of nearby
proteins, namely AqpZ and LacY in the IM and OmpA in the
OM.565 Membrane reshaping is observed in both the IM and
the OM in terms of curvature eﬀects, which diﬀer depending
on the type of protein present and their concentration.
Similarly, lipid sorting eﬀects, and in particular cardiolipin
enrichment over PE and PG lipids, were also observed to be
protein-dependent, highlighting the complexity of the interplay
between lipids and bacterial proteins.565
16.5. EmrE
EmrE is an ion-coupled, small multidrug transporter from E.
coli that confers resistance to many cationic drugs.796 EmrE
oligomerization is regulated by the lipid environment, as
shown by Brewster angle microscopy797 and FRET measure-
ments,798 but the interplay with the membrane extends further
as physical properties of the lipids are modiﬁed upon ligand-
binding to EmrE, as shown by diﬀerential scanning calorimetry
and solid state NMR studies.799 MD simulations showed that
ligand-binding alters the interaction of lipids with selected Trp
residues and highlighted a preference for PE lipids in a PE/PG
mixture, based on hydrogen-bond patterns.800
16.6. VDAC
In addition to the OMPs described in a previous section above,
lipid−protein interactions of other beta-barrel pores have been
addressed with computer simulations. This is the case for
Voltage-Dependent Anion-Channels (VDACs) and several
toxins (discussed below). VDACs are located in the
mitochondrial outer membrane and are related to ancient
porins present in bacteria.801 VDACs are the major pathway
for metabolite and ion transport across the mitochondrial outer
membrane.802 The channel is formed by a 19-stranded β-barrel
connected by loops and an N-terminal helix inside.803−805
Lipids contribute to the regulation of VDAC gating.806
Villinger and colleagues, using NMR spectroscopy, Gaussian
network model analysis, and molecular dynamics simulations,
showed how the dynamics of the channel is tightly regulated by
mutations or changes in the protonation state of glutamate 73,
whose side chain projects toward the lipids.807 MD simulations
revealed signiﬁcant changes in membrane thickness near the
protein, creating, when the glutamate is negatively charged, a
membrane defect that extends up to the bilayer middle.807
VDAC is also one of the few examples of cholesterol
interactions with β-barrel proteins. Molecular docking
combined with MD simulations suggested that sterols are
essential for VDACs’ structure and dynamic.808 This work
suggested a model in which 1 to 5 cholesterol molecules bind
to the channel, consistent with previous binding studies of
VDAC in detergent.803 The authors performed 15 atomistic
molecular dynamic simulations, averaging 37 ns, in which the
criterion to select the most favorable poses was based on the
sustained residency of cholesterol in the sites808 Additionally,
the channels were simulated in a POPC bilayer with
cholesterol bound in ﬁve hypothetical sites identiﬁed
previously by Hiller et al.803 and compared with equivalent
systems without cholesterol in simulations of 1.4 μs in total.
NMR studies on the mammalian VDAC1 suggested the
existence of a shell of tightly bound phospholipids around the
protein.809 Electrophysiology studies have also shown that
protein-sterol interactions may be involved in both voltage
dependence and selectivity of the plant VDAC (PcVDAC from
Phaseolus coccineus).810 Mlayeh et al. combined electro-
physiological studies in planar bilayers with MD simulations
to characterize the eﬀect of phosphatidylethanolamine (PE)
and ion concentration on PcVDAC.811 This study suggested
that ionic interactions formed by acidic residues with PE head
groups have an impact on VDAC ion selectivity.
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16.7. Beta-Barrel Toxin Channels
Examples of beta-pore-forming toxins are anthrax toxin, α-
hemolysin and actinoporins. The anthrax toxin from B.
anthracis consists of the so-called lethal factor, edema factor
and protective antigen (PA).812 PA, after binding to speciﬁc
receptors and cleavage-based activation, assembles into a
heptameric prepore that binds lethal and edema factors for
endocytosis and delivery into the endosomal compartment.812
The acidic pH of the late endosome triggers conformational
changes in the prepore that lead to the insertion of the channel
in the endosomal membrane to release lethal and edema
factors in the cytoplasm.812 The membrane environment
aﬀects diﬀerent stages of this mechanism.812,813 Using model
membranes measurements and atomistic MD simulations,
Kalu and colleagues recently showed how lipids have a strong
impact on channel properties including its insertion in the
membrane, gating, and selectivity, possibly linked to lipid-
induced structural changes in the ﬁnal PA pore.813
α-Hemolysin (αHL) is a pore-forming toxin from S. aureus
that in its monomeric form interacts with host membranes to
assemble into an heptameric structure whose stem domain
forms a beta-barrel pore across the lipid bilayer.814 Although
there is evidence that lipids aﬀect the mechanism of αHL, a
systematic analysis of the interplay with the membrane is not
yet available.815 Guros et al. applied MD simulations to study
the structure and conductance of αHL in a pure POPC bilayer
and a pure 1,2-diphytanoyl-sn-glycero-3-phospho-choline,
DPhPC, membrane, for direct comparisons with previous
experimental data.815 Lipids and protein adapt to each other,
with lipids creating a negative curvature to match the protein
hydrophobic proﬁle while the protein changes its tilt in the
membrane. There is, however, a diﬀerence in this mutual
adaptation between the POPC and the DPhPC bilayers. More
prominent eﬀects are detected in the thicker POPC bilayer,
where decreased thickness and negative curvature near the
protein force some loops to bend inward, thus occluding the
channel, or outward, thus destabilizing nearby lipids
organization. In the methyl-branched DPhPC bilayer, with a
thickness that better matched the hydrophobic proﬁle of the
protein, protein tilt and distortions as well as the negative
curvature of the membrane are less evident. Due to the
changes in the structure of the pore, in POPC lipids αHL
shows a reduced ionic current, highlighting, in line with
experimental reports, coupling between protein function,
structure and the lipid environment.815
Actinoporins are toxins from sea anemones that assemble
into beta-barrels, similar to αHL. Family members include
fragaceatoxin, equinatoxin, and sticholysin. Recent struc-
tures816 have enabled simulations to study details of pore
formation.817,818 As most actinoporins appear to require
speciﬁc lipids, these toxins may be of further methodological
interest, in addition to their intrinsic biological and
biotechnological importance.
16.8. Tetraspanin
The structure of tetraspanin CD81, a cell surface protein with
four transmembrane (TM) helices, is characterized by a conic
shape, with a large separation between TM1−2 and TM3−4,
and capped by the extracellular loop (closed state).819 A bound
cholesterol molecule is located in the gap between the two sets
of helices. Binding assays together with mutagenesis studies
showed that the pocket between TM1−2 and TM3−4 is
speciﬁc for cholesterol. Several μs-long MD simulations of
CD81 showed how the dynamics of the protein may be
regulated by cholesterol: in the apo state, the protein switched
from a closed to a fully open conformation with dissociation of
the extracellular loop. In the presence of cholesterol, the closed
conformation was preserved, and only one cholesterol
unbinding event was captured, followed by a transition to
the open state. Combined, these ﬁndings have important
mechanistic implications as they describe a binding site speciﬁc
for cholesterol that could be possibly targeted by drugs and
supports a cholesterol-regulated mechanism for the inter-
actions between the CD81 extracellular loop with other
proteins (Figure 28).819
16.9. Undecaprenyl Pyrophosphate Phosphatase
Undecaprenyl pyrophosphate phosphatase (UppP/BacA) is an
integral membrane protein essential in the synthesis of the cell
wall. UppP dephosphorylates undecaprenyl pyrophosphate to
its monophosphate form, which is then used as a carrier for
sugars and glycan chains across membranes.820 A combination
of molecular modeling and MD simulations helped the
characterization of the binding site for undecaprenyl
pyrophosphate in the UppP of E. coli.821
16.10. Photosystem II
The protein complex photosystem II (PSII), embedded in the
thylakoid membrane, is a key component of the photosynthetic
machinery. PSII functions as a homodimer, where each
monomer consists of 27 subunits in plants and 20 in
cyanobacteria. A large number of cofactors endow PSII with
its light-harvesting and water-splitting capabilities. To provide
a dynamical view on this large and important protein complex,
van Eerden et al. developed a CG model of PSII from
cyanobacterium Thermosynechococcus vulcanus based on the
Martini force ﬁeld.822 The complex was embedded in a realistic
thylakoid membrane composed of a mixture of phosphatidyl-
glycerol (PG) and the glycolipids digalactosyl-diacylglycerol
(DGDG), monogalactosyl-diacylglycerol (MGDG), and sulfo-
quinovosyl-diacylglycerol (SQDG). Based on cumulative
simulations of more than 500 μs of the full PSII dimer in
the thylakoid membrane, the authors identiﬁed the exchange
pathways of the electron carriers plastoquinone (PLQ) and
Figure 28. Cholesterol-regulated mechanism of CD81. Cholesterol
regulates CD81 equilibrium between the capped state (left) and the
open state (right). The conformational transition between these states
was studied with MD simulations, and it is believed to be an
important regulatory step for the interactions between CD81 and
other protein, such as CD19 (modeled in the picture).819 Reprinted
with permission from ref 819. Copyright 2016 Elsevier Inc.
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plastoquinol (PLQol).823 The long time scale allowed the
observation of many spontaneous entries of PLQ into PSII, as
well as the unbinding of the reduced carrier PLQol from the
exchange cavity inside the complex. The simulations point to a
promiscuous diﬀusion mechanism in which three channels
function as both entry and exit channels. The exchange cavity
Figure 29. Lipid−protein interactions in the photosystem II. A. Examples of two lipid diﬀusion events from the stromal (left) and luminal (right)
leaﬂet through the plastoquinone exchange cavity. The two lipids are colored relatively to the time the diﬀusion events took place. B−D. Binding
sites for (B−C) MGDG (headgroup in red) and (D) SQDG (headgroup in yellow) lipids identiﬁed in the simulations. Chlorophyll molecules are
shown in green. Adapted with permission from ref 822. Copyright 2017 Biophysical Society. Licensed under Creative Commons Attribution 4.0.
Figure 30. Cardiolipin interaction sites on the SecYEG complex. CG simulations of the SecYEG-SecA complex embedded in lipid bilayers with
diﬀerent concentrations of cardiolipins identiﬁed speciﬁc protein residues responsible for stable interactions with cardiolipins.826 A. CG
representation of the complex, with SecY in pink, SecE in tan, SecG in green, and SecA in light blue. Residues involved in the interactions with
cardiolipins are highlighted as spheres and colored from yellow to red according to occupancy values determined from the simulations. The newly
identiﬁed sites 1 and 2 are marked. B. Selected frames from the CG simulations were back-mapped to an atomistic representation to highlight site 1
and 2 with cardiolipin molecules bound. C. Cytoplasmic view of the SecYEG complex in B. SecA is not shown for clarity. Adapted with permission
from ref 826. Copyright 2018 Corey et al.
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itself serves as a PLQ reservoir. The thylakoid lipids also play a
dynamic role in this process, as they can leave and enter the
exchange cavity, allowing exchange of cocrystallized lipids with
the bulk membrane (Figure 29A). Interestingly, the
simulations predict an accumulation of MGDG and SQDG
lipids in the annular shell around the protein, at distinct
binding sites (Figure 29B−D). The biological relevance of this
ﬁnding, however, remains unclear.822
16.11. Sec Translocon
Post-translational or cotranslational translocation of most
proteins across membranes is achieved by the Sec translocon,
a complex of proteins found in eukaryotes, bacteria, and
archaea.824 In bacteria, the Sec translocon consists of SecY,
SecE, and SecG, which form a transmembrane complex, also
associated with the SecA ATPase motor for post-translational
protein translocation. SecY forms a central pore for proteins to
be translocated fueled by ATP hydrolysis via SecA and by the
proton motive force.824,825 Using CG MD simulations of the
SecYEG-SecA complex, Corey and colleagues, in addition to a
known cardiolipin binding site involving SecA, identiﬁed two
new sites as possible cardiolipin interaction sites (Figure 30),
and further conﬁrmed their ﬁndings with native MS and
FRET.826 The speciﬁc binding of cardiolipin to these sites is
shown to regulate the energetics of the translocon by
Figure 31. Corradi et al. used CG MD simulations to investigate lipid reorganization around diﬀerent membrane proteins embedded in a plasma
membrane model.121 Each system consisted of 4 copies of a given membrane protein, and ca. 6000 lipid molecules of more than 60 diﬀerent types.
A. Snapshots at 30 μs of four selected systems, namely AQP1, COX1, Kv1.2, and P-gp, viewed from the extracellular side. Fully saturated and
polyunsaturated lipids are shown in white and black licorice, respectively, while all other lipid types are shown as a transparent surface. Diﬀerent
lipid distribution around the proteins is reﬂected in diﬀerent thickness proﬁles, averaged between 25 and 30 μs of simulation time and over the 4
protein copies of a given system. B. Unique lipid composition is found around ten diﬀerent proteins in the plasma mixture. The total number of
lipids found within 0.7 nm cutoﬀ is reported in parentheses as average number of lipids obtained from the four protein copies of each system,
between 25 and 30 μs of simulation time.
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00451
Chem. Rev. XXXX, XXX, XXX−XXX
AV
stimulating SecA ATPase activity as well as translocation
induced by the electrochemical gradient of protons, while
nonspeciﬁc cardiolipin interactions with the complex could
drive SecYEG dimerization.826
In bacteria, the YidC insertase promotes protein insertion
into the inner membrane via a mechanism that does not
require ATP, and can work independently from the Sec
translocon or in conjunction with it.827 Atomistic simulations
of the YidC instertase of E. coli revealed the changes in
membrane thickness induced by the shorter transmembrane
helices of the enzyme.828
The time scale associated with protein ribosomal translation
and the complexity of the mechanism of the systems here
described have prompted the development of a 2D coarse
model of the Sec translocon,829 which has been successfully
used to predict the topology of nascent proteins and to provide
a link between protein expression levels and protein integration
in the membrane mediated by the translocon.829−831 Recently,
a 3D representation of the 2D model has been developed, at a
level of detail much coarser than the Martini force ﬁeld.832
This model still describes critical features of the system,
including an explicit representation of the nascent protein and
the lateral gate of the translocon, modeled in diﬀerent
conformations, in an implicit membrane. This type of
biological events are, at the present time, still inaccessible to
the current atomistic and Martini CG simulations techniques.
The continuous development of such coarser models will allow
simulations to address other aspects of protein insertion via the
Sec translocon, including the role of the membrane.
17. DISCUSSION
As the hundreds of papers referenced in the main body above
demonstrate, computer simulations have been applied to a
large number of proteins and lipids, addressing a wide range of
questions. Although the volume of papers did not allow a
critical detailed discussion of each paper, we would like to
conclude with a number of more general points. Technically, it
has become fairly straightforward to set up and run atomistic
simulations of a single protein with a high-quality known
structure in a simple lipid mixture and obtain reasonable
simulation lengths (microseconds, as a general guideline) on
modest computational resources, starting from a few desktop
computers with high-end gaming graphics hardware, although
the state of the art requires custom hardware like ANTON or
large-scale super computers. This presents a huge opportunity,
as such simulations can become routine ingredients of broader
functional studies, which is already happening in the literature.
Below we outline the current state of the ﬁeld as well as
challenges and future directions.
17.1. Diversity in Lipid−Protein Interactions
Broadly speaking, the literature reviewed above supports a
wide range of roles for lipid−protein interactions, studied by
an equally wide range of experimental and computational
approaches that in some of the most interesting cases are
combined to span the whole spectrum from detailed local
interactions to functional biological relevance. Lipid composi-
tion and lipid−protein interactions modulate the physical
properties of membranes. An obvious example are the
mechanosensitive channels, where lipid−protein interactions
directly transfer a tension from the membrane to the protein,
which then undergoes a structural change. Lipid compositions
may also change the equilibrium between conformational
states, as shown for instance in several GPCRs and ion
channels.
Moving toward more speciﬁc interactions, simulations of
many proteins have noticed an enrichment or depletion of
speciﬁc lipids near a protein. A striking example is a recent set
of simulations of 10 diﬀerent proteins in a very complex
membrane environment, using the Martini model on a time
scale of 30−50 μs, that showed a lipid environment diﬀerent
from bulk and diﬀerent between all proteins (Figure 31)121 but
the general feature has been observed in a variety of simpler
systems. Part of this phenomena may just be a local adjustment
of the membrane to the speciﬁc thickness and more detailed
chemical features of a speciﬁc protein, but these enrichment or
depletion eﬀects may also play an important role in organizing
the membrane at larger scales.
Simulations have also observed strongly localized speciﬁc
lipids near a variety of proteins. A noteworthy example is the
binding of cholesterol to GPCRs, but examples are found
throughout this review. In many cases, the biological
signiﬁcance of this remains to be investigated, but in many
examples protein function depends on the speciﬁc lipids
identiﬁed, and in some cases the same lipids are observed in
high-resolution structures that include lipid density. We have
also highlighted some areas where there is detailed
experimental data on the importance of speciﬁc lipid−protein
interactions, notably in P-type ATPases and potassium
channels, where further simulations might be useful to provide
further details at the molecular level.
In the most speciﬁc case, certain lipids play a key role that
has been well-established experimentally, and simulations have
made it possible to identify the speciﬁc features of lipid−
protein interactions and resulting protein structures involved in
the mechanism of the protein. The most obvious examples of
this are inwardly rectifying potassium channels that depend on
interactions of PIP lipids with conserved residues in the
channel for their activation. In another class of proteins, lipids
are actually the substrates, such as in lipid ﬂippases and
scramblases or are intimately involved in the transport of other
substrates.
Finally, at a much larger scale, lipids mediate interactions
between proteins that lead to large scale organization of
protein complexes and membranes. The most obvious
examples in this review are the respiratory complexes bridged
by cardiolipin and the organization of ATPases in rows by
indirect interactions through lipids. In the accompanying
review on large-scale membrane models,111 we further expand
on this topic.
17.2. Challenges
The main critical elements in molecular dynamics simulations
are an appropriate choice of force ﬁeld and the ability to obtain
enough sampling to draw meaningful conclusions. After
reviewing the literature, we argue that the most common
problems are currently indeed a lack of sampling, leading to
poorly justiﬁed conclusions, limitations in the accuracy of force
ﬁelds, and stretching the interpretation of simulation results to
argue they support a functional mechanism that cannot be
directly inferred from the simulations. The latter is not a
simulation challenge per se but is related to the more general
diﬃculty of interpreting functional assays in terms of molecular
interactions at the lipid−protein level.
Sampling involves both sampling over lipid and protein
diﬀusion, lipid−protein interactions as well as lipid-mediated
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protein−protein interactions, and internal dynamics of
proteins that may change conformation depending on their
lipid environment and interactions. As computer speed
increases sampling almost automatically improves, as shown
by the roughly 5 orders of magnitude increase in scope of
computer simulations in the past 25 years. We also anticipate
algorithmic advances that speed up simulations of lipid−
protein interactions. Simulations are not fundamentally limited
by the maximum time scale they can reach in equilibrium
simulations. Techniques such as Hamiltonian replica exchange
might be used to increase sampling in complex membrane
systems, as they have elsewhere,130 as might practical methods
that combine Monte Carlo moves with molecular dynamics to
enable entire lipids to swap place rather than wait for lipids to
swap places by diﬀusion. A recent example of this is the work
of Fathizadeh and Elber,833 building on several previous
advances that have not been widely used for practical reasons.
A tighter integration of coarse-grained and atomistic
simulations might also increase sampling, although there is
currently no rigorous way to do this (e.g., PACE force ﬁeld)834
and balancing interactions between diﬀerent levels of
resolution within one calculation remains challenging.835
Another approach that has proven very powerful in processes
such as protein folding is the use of Markov state models and
other collective variable methods that can combine large
numbers of short simulations of the order of hundreds of
nanoseconds or microseconds to describe dynamics on time
scales of seconds. A recent application of peptide−protein
complex formation showed that a particular class of Markov
models combined with machine learning correctly identiﬁed
complex structures as well as the kinetics associated with
complex formation, a problem somewhat similar to lipid−
protein interactions.836
In addition to sampling, the quality of force ﬁelds is a key
technical requirement for the accuracy and usefulness of
simulations. Current force ﬁelds for biomolecular simulation
are quite sophisticated and generally well-tested, but every time
simulations cover new ground in simulation time or system
complexity areas where improvements are required become
clear. A recent example in simulations of soluble proteins is the
overstabilization of unfolded states, relevant for protein folding
and the nature of intrinsically disordered proteins.837 Although
the disagreement between experiment and simulation in this
area was quite dramatic, once both experiment and simulation
were able to probe detailed structural properties of these
diﬃcult-to-study states of proteins, relatively minor adjust-
ments to water−protein interaction parameters equally
dramatically improved the agreement. In lipid−protein
interactions a similar phenomenon was observed by Domanski
et al., who showed that the widely used CHARMM force ﬁeld
actually described the stable glycophorin A dimer as a
metastable state.787 A small adjustment to lipid−protein
interaction parameters, without aﬀecting either the lipid
properties or the protein internal dynamics, is in principle
suﬃcient to improve the thermodynamic description.787 This
study also highlighted a perhaps more serious problem, as a
review of experimental data gave a range of between −16 and
−51 kJ/mol for the stability of the glycophorin A dimer with
the same reference state.787,838 This is an unacceptably large
range of uncertainty for many purposes, both for biophysical
understanding of protein stability and as parametrization or
validation goal for simulations. Sandoval-Perez et al. tested
several force ﬁelds to describe membrane proteins, focusing on
the membrane−water interface.839 They compare the con-
servation of the secondary structure of transmembrane
proteins, the positioning of transmembrane peptides relative
to the lipid bilayer, the insertion depth of side chains of
unfolded peptides absorbed at the membrane interface, and the
ability to reproduce experimental insertion energies of Wimley-
White peptides at the membrane interface.839 Only the
Wimley-White experiments give unambiguous quantitative
data on the thermodynamics of lipid−protein interactions
but are limited to side-chain partitioning at the interface and to
a single lipid type. This type of force ﬁeld comparison is useful
as it highlights areas of strength and weakness but also
highlights the lack of quantitative experimental data on lipid−
protein interactions in more complex systems. One example is
the relative balance between lipid−lipid, lipid−protein and
protein−protein interactions. Both atomistic840 and Martini
simulations841 overestimate the strength of protein−protein
interactions, leading to artiﬁcial aggregation of proteins.
Martini 3.0 improves this balance111 but quantitative
experimental data to calibrate these interactions remains a
challenge. Similarly, hydrophobicity scales based on residue
substitutions in small beta-barrel proteins from Fleming
provide thermodynamic data for side chain partitioning in
bilayers but in the context of membrane protein folding using
an experimental approach that is only available in one lipid
type, for now.842 Although aspects of these systems are readily
accessible for simulations, a direct comparison with relative
protein stabilities for diﬀerent mutants requires assumptions
about the unfolded state, for which there is no structural data
available. We have highlighted some model systems for lipid−
protein interactions in this section, as these are particularly
relevant for the topic of this review. In addition, lipid and
protein parameters themselves are under continuous develop-
ment. While simulations of soluble proteins are quite mature,
aspects of membrane proteins might require further develop-
ment as more experimental data becomes available, for
instance from multiple conformations obtained from electron
microscopy data. It is also quite possible that further testing of
the description by current force ﬁelds of membrane protein
conformations and dynamics will show that they already
adequately describe these propertie. Diﬀusion times in lipid
mixtures almost guarantee that microsecond time scale
simulations are essential to explore lipid mixtures, a time
scale that has only been readily available for a few years. We
expect signiﬁcant eﬀort in studying lipid mixtures in the next
few years, perhaps highlighting areas where lipid parameters
need to be adjusted to accurately represent lipid mixtures.
In many of the papers reviewed above, and in the ﬁeld of
lipid−protein interactions in general, simulations and experi-
ments are used hand in hand. Simulations give exquisite detail
but are subject to the limitations described above. Experi-
ments, broadly speaking, require signiﬁcant interpretation to
translate from experimental observables to a molecular-level
model of the system of interest. The range of experiments that
has been applied or can be applied to lipid−protein
interactions is too extensive to discuss here, but it may be
useful to consider how to optimize the combined use of
simulations and experiments. Experiments that yield quantita-
tive measurements of molecular properties that can be directly
calculated from simulations are essential to develop and
validate simulation methods. Such experiments include de-
tailed structural and dynamic measurements on lipids and
lipid−protein systems by NMR and diﬀraction, thermody-
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namic measurements, and potentially a host of other data.
They might also include in the future data on the organization
of complex membrane mixtures, from, e.g., NanoSIMS
(secondary ion mass spectrometry)843 and super-resolution
imaging,844 as simulations increase to larger length scales and
experiments increase their resolution to directly overlap with
the size of simulation systems. Experiments that yield data on
direct interactions between lipids and proteins are also
essential. Some of these include cryo electron microscopy,
mass spectrometry, and quantitative experiments using SMALP
and related polymers.845 Challenges in this area may lie in
deﬁning the quantitative nature of these experiments, as they
currently appear to be in a gray zone between qualitative and
quantitative. Lastly, experiments that modify lipid composi-
tions to perturb properties of membrane proteins that can be
functionally assayed are of direct biological relevance, the real
goal of studying lipid−protein interactions but are diﬃcult to
link directly to simulations or details of interactions, in most
cases.
18. CONCLUSIONS
Simulations using a combination of approaches have given
insight in a wide range of lipid−protein interactions. Despite a
range of challenges, including technical computational
challenges, the nature of experimental data, and challenges
linking functional experimental data to local molecular
interactions, the vast majority of papers does give interesting
new insights in lipid−protein interactions and provides a
molecular picture with a variety of scenarios involving these
interactions, together with hypotheses that can be tested
experimentally, such as, for instance, protein residues involved
in lipid binding with consequences for protein function. Given
the accessibility of current computational techniques and the
strong overlap of achievable time scales in simulations and
biologically relevant time scales, we expect this ﬁeld to
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C.; Sobrino, F. Lipid Involvement in Viral Infections: Present and Future
Perspectives for the Design of Antiviral Strategies; IntechOpen: Rijeka,
Croatia, 2013; pp 291−321.
(700) Lorizate, M.; Krausslich, H. G. Role of Lipids in Virus
Replication. Cold Spring Harbor Perspect. Biol. 2011, 3, a004820.
(701) Teissier, E.; Pecheur, E. I. Lipids as Modulators of Membrane
Fusion Mediated by Viral Fusion Proteins. Eur. Biophys. J. 2007, 36,
887−899.
(702) Chlanda, P.; Zimmerberg, J. Protein-Lipid Interactions
Critical to Replication of the Influenza a Virus. FEBS Lett. 2016,
590, 1940−1954.
(703) Brown, R. S.; Wan, J. J.; Kielian, M. The Alphavirus Exit
Pathway: What We Know and What We Wish We Knew. Viruses
2018, 10, 89.
(704) Votteler, J.; Sundquist, W. I. Virus Budding and the Escrt
Pathway. Cell Host Microbe 2013, 14, 232−241.
(705) Waheed, A. A.; Freed, E. O. The Role of Lipids in Retrovirus
Replication. Viruses 2010, 2, 1146−1180.
(706) Chan, R. B.; Tanner, L.; Wenk, M. R. Implications for Lipids
During Replication of Enveloped Viruses. Chem. Phys. Lipids 2010,
163, 449−459.
(707) Takahashi, T.; Suzuki, T. Function of Membrane Rafts in Viral
Lifecycles and Host Cellular Response. Biochem. Res. Int. 2011, 2011,
245090.
(708) Brugger, B.; Glass, B.; Haberkant, P.; Leibrecht, I.; Wieland, F.
T.; Krausslich, H. G. The Hiv Lipidome: A Raft with an Unusual
Composition. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 2641−2646.
(709) Lorizate, M.; Sachsenheimer, T.; Glass, B.; Habermann, A.;
Gerl, M. J.; Krausslich, H. G.; Brugger, B. Comparative Lipidomics
Analysis of Hiv-1 Particles and Their Producer Cell Membrane in
Different Cell Lines. Cell. Microbiol. 2013, 15, 292−304.
(710) Gerl, M. J.; Sampaio, J. L.; Urban, S.; Kalvodova, L.;
Verbavatz, J. M.; Binnington, B.; Lindemann, D.; Lingwood, C. A.;
Shevchenko, A.; Schroeder, C.; et al. Quantitative Analysis of the
Lipidomes of the Influenza Virus Envelope and Mdck Cell Apical
Membrane. J. Cell Biol. 2012, 196, 213−221.
(711) Ivanova, P. T.; Myers, D. S.; Milne, S. B.; McClaren, J. L.;
Thomas, P. G.; Brown, H. A. Lipid Composition of Viral Envelope of
Three Strains of Influenza Virus - Not All Viruses Are Created Equal.
ACS Infect. Dis. 2015, 1, 399−452.
(712) Kerviel, A.; Thomas, A.; Chaloin, L.; Favard, C.; Muriaux, D.
Virus Assembly and Plasma Membrane Domains: Which Came First?
Virus Res. 2013, 171, 332−340.
(713) Rossmann, M. G. Structure of Viruses: A Short History. Q.
Rev. Biophys. 2013, 46, 133−180.
(714) Reddy, T.; Sansom, M. S. Computational Virology: From the
inside Out. Biochim. Biophys. Acta, Biomembr. 2016, 1858, 1610−
1618.
(715) Huber, R. G.; Marzinek, J. K.; Holdbrook, D. A.; Bond, P. J.
Multiscale Molecular Dynamics Simulation Approaches to the
Structure and Dynamics of Viruses. Prog. Biophys. Mol. Biol. 2017,
128, 121−132.
(716) Kasson, P.; DiMaio, F.; Yu, X.; Lucas-Staat, S.; Krupovic, M.;
Schouten, S.; Prangishvili, D.; Egelman, E. H. Model for a Novel
Membrane Envelope in a Filamentous Hyperthermophilic Virus. eLife
2017, 6. DOI: 10.7554/eLife.26268
(717) Durrant, J. D.; Bush, R. M.; Amaro, R. E. Microsecond
Molecular Dynamics Simulations of Influenza Neuraminidase Suggest
a Mechanism for the Increased Virulence of Stalk-Deletion Mutants. J.
Phys. Chem. B 2016, 120, 8590−8599.
(718) Reddy, T.; Shorthouse, D.; Parton, D. L.; Jefferys, E.; Fowler,
P. W.; Chavent, M.; Baaden, M.; Sansom, M. S. P. Nothing to Sneeze
At: A Dynamic and Integrative Computational Model of an Influenza
a Virion. Structure 2015, 23, 584−597.
(719) Parton, D. L.; Tek, A.; Baaden, M.; Sansom, M. S. P.
Formation of Raft-Like Assemblies within Clusters of Influenza
Hemagglutinin Observed by Md Simulations. PLoS Comput. Biol.
2013, 9, e1003034.
(720) Risselada, H. J.; Marelli, G.; Fuhrmans, M.; Smirnova, Y. G.;
Grubmuller, H.; Marrink, S. J.; Muller, M. Line-Tension Controlled
Mechanism for Influenza Fusion. PLoS One 2012, 7, e38302.
(721) Rossman, J. S.; Lamb, R. A. Influenza Virus Assembly and
Budding. Virology 2011, 411, 229−236.
(722) Boonstra, S.; Blijleven, J. S.; Roos, W. H.; Onck, P. R.; van der
Giessen, E.; van Oijen, A. M. Hemagglutinin-Mediated Membrane
Fusion: A Biophysical Perspective. Annu. Rev. Biophys. 2018, 47, 153−
173.
(723) Goronzy, I. N.; Rawle, R. J.; Boxer, S. G.; Kasson, P. M.
Cholesterol Enhances Influenza Binding Avidity by Controlling
Nanoscale Receptor Clustering. Chem. Sci. 2018, 9, 2340−2347.
(724) Marzinek, J. K.; Holdbrook, D. A.; Huber, R. G.; Verma, C.;
Bond, P. J. Pushing the Envelope: Dengue Viral Membrane Coaxed
into Shape by Molecular Simulations. Structure 2016, 24, 1410−1420.
(725) Vanegas, J. M.; Heinrich, F.; Rogers, D. M.; Carson, B. D.; La
Bauve, S.; Vernon, B. C.; Akgun, B.; Satija, S.; Zheng, A. H.; Kielian,
M.; et al. Insertion of Dengue E into Lipid Bilayers Studied by
Neutron Reflectivity and Molecular Dynamics Simulations. Biochim.
Biophys. Acta, Biomembr. 2018, 1860, 1216−1230.
(726) Sharma, K. K.; Marzinek, J. K.; Tantirimudalige, S. N.; Bond,
P. J.; Wohland, T. Single-Molecule Studies of Flavivirus Envelope
Dynamics: Experiment and Computation. Prog. Biophys. Mol. Biol.
2018, DOI: 10.1016/j.pbiomolbio.2018.09.001.
(727) Kuhn, R. J.; Zhang, W.; Rossmann, M. G.; Pletnev, S. V.;
Corver, J.; Lenches, E.; Jones, C. T.; Mukhopadhyay, S.; Chipman, P.
R.; Strauss, E. G.; et al. Structure of Dengue Virus: Implications for
Flavivirus Organization, Maturation, and Fusion. Cell 2002, 108,
717−725.
(728) Reddy, T.; Sansom, M. S. P. The Role of the Membrane in the
Structure and Biophysical Robustness of the Dengue Virion Envelope.
Structure 2016, 24, 375−382.
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00451
Chem. Rev. XXXX, XXX, XXX−XXX
BR
(729) Wewer, C. R.; Khandelia, H. Different Footprints of the Zika
and Dengue Surface Proteins on Viral Membranes. Soft Matter 2018,
14, 5615−5621.
(730) Fajardo-Sanchez, E.; Galiano, V.; Villalain, J. Spontaneous
Membrane Insertion of a Dengue Virus Ns2a Peptide. Arch. Biochem.
Biophys. 2017, 627, 56−66.
(731) Oliveira, E. R.; de Alencastro, R. B.; Horta, B. A. The
Mechanism by Which P250l Mutation Impairs Flavivirus-Ns1
Dimerization: An Investigation Based on Molecular Dynamics
Simulations. Eur. Biophys. J. 2016, 45, 573−580.
(732) Lin, M. H.; Hsu, H. J.; Bartenschlager, R.; Fischer, W. B.
Membrane Undulation Induced by Ns4a of Dengue Virus: A
Molecular Dynamics Simulation Study. J. Biomol. Struct. Dyn. 2014,
32, 1552−1562.
(733) Fajardo-Sanchez, E.; Galiano, V.; Villalain, J. Molecular
Dynamics Study of the Membrane Interaction of a Membranotropic
Dengue Virus C Protein-Derived Peptide. J. Biomol. Struct. Dyn. 2017,
35, 1283−1294.
(734) Briggs, J. A. G.; Wilk, T.; Welker, R.; Krausslich, H. G.; Fuller,
S. D. Structural Organization of Authentic, Mature Hiv-1 Virions and
Cores. EMBO J. 2003, 22, 1707−1715.
(735) Ayton, G. S.; Voth, G. A. Multiscale Computer Simulation of
the Immature Hiv-1 Virion. Biophys. J. 2010, 99, 2757−2765.
(736) Lin, M. H.; Chen, C. P.; Fischer, W. B. Patch Formation of a
Viral Channel Forming Protein within a Lipid Membrane - Vpu of
Hiv-1. Mol. BioSyst. 2016, 12, 1118−1127.
(737) Charlier, L.; Louet, M.; Chaloin, L.; Fuchs, P.; Martinez, J.;
Muriaux, D.; Favard, C.; Floquet, N. Coarse-Grained Simulations of
the Hiv-1 Matrix Protein Anchoring: Revisiting Its Assembly on
Membrane Domains. Biophys. J. 2014, 106, 577−585.
(738) Holzmann, N.; Chipot, C.; Penin, F.; Dehez, F. Assessing the
Physiological Relevance of Alternate Architectures of the P7 Protein
of Hepatitis C Virus in Different Environments. Bioorg. Med. Chem.
2016, 24, 4920−4927.
(739) Shukla, A.; Dey, D.; Banerjee, K.; Nain, A.; Banerjee, M. The
C-Terminal Region of the Non-Structural Protein 2b from Hepatitis a
Virus Demonstrates Lipid-Specific Viroporin-Like Activity. Sci. Rep.
2015, 5, 15884.
(740) Briggs, E. L. A.; Gomes, R. G. B.; Elhussein, M.; Collier, W.;
Findlow, I. S.; Khalid, S.; McCormick, C. J.; Williamson, P. T. F.
Interaction between the Ns4b Amphipathic Helix, Ah2, and Charged
Lipid Headgroups Alters Membrane Morphology and Ah2 Oligo-
meric State - Implications for the Hepatitis C Virus Life Cycle.
Biochim. Biophys. Acta, Biomembr. 2015, 1848, 1671−1677.
(741) Chandler, D. E.; Penin, F.; Schulten, K.; Chipot, C. The P7
Protein of Hepatitis C Virus Forms Structurally Plastic, Minimalist
Ion Channels. PLoS Comput. Biol. 2012, 8, No. e1002702.
(742) Baker, M. K.; Gangupomu, V. K.; Abrams, C. F. Character-
ization of the Water Defect at the Hiv-1 Gp41 Membrane Spanning
Domain in Bilayers with and without Cholesterol Using Molecular
Simulations. Biochim. Biophys. Acta, Biomembr. 2014, 1838, 1396−
1405.
(743) Akabori, K.; Huang, K.; Treece, B. W.; Jablin, M. S.;
Maranville, B.; Woll, A.; Nagle, J. F.; Garcia, A. E.; Tristram-Nagle, S.
Hiv-1 Tat Membrane Interactions Probed Using X-Ray and Neutron
Scattering, Cd Spectroscopy and Md Simulations. Biochim. Biophys.
Acta, Biomembr. 2014, 1838, 3078−3087.
(744) Vitiello, G.; Falanga, A.; Petruk, A. A.; Merlino, A.; Fragneto,
G.; Paduano, L.; Galdiero, S.; D’Errico, G. Fusion of Raft-Like Lipid
Bilayers Operated by a Membranotropic Domain of the Hsv-Type I
Glycoprotein Gh Occurs through a Cholesterol-Dependent Mecha-
nism. Soft Matter 2015, 11, 3003−3016.
(745) Guardado-Calvo, P.; Atkovska, K.; Jeffers, S. A.; Grau, N.;
Backovic, M.; Perez-Vargas, J.; de Boer, S. M.; Tortorici, M. A.;
Pehau-Arnaudet, G.; Lepault, J.; et al. A Glycerophospholipid-Specific
Pocket in the Rvfv Class Ii Fusion Protein Drives Target Membrane
Insertion. Science 2017, 358, 663−667.
(746) Del Vecchio, K.; Frick, C. T.; Gc, J. B.; Oda, S. I.; Gerstman,
B. S.; Saphire, E. O.; Chapagain, P. P.; Stahelin, R. V. A Cationic, C-
Terminal Patch and Structural Rearrangements in Ebola Virus Matrix
Vp40 Protein Control Its Interactions with Phosphatidylserine. J. Biol.
Chem. 2018, 293, 3335−3349.
(747) Shukla, A.; Padhi, A. K.; Gomes, J.; Banerjee, M. The Vp4
Peptide of Hepatitis a Virus Ruptures Membranes through Formation
of Discrete Pores. J. Virol. 2014, 88, 12409−12421.
(748) Huang, Q.; Chen, C. L.; Herrmann, A. Bilayer Conformation
of Fusion Peptide of Influenza Virus Hemagglutinin: A Molecular
Dynamics Simulation Study. Biophys. J. 2004, 87, 14−22.
(749) Lague, P.; Roux, B.; Pastor, R. W. Molecular Dynamics
Simulations of the Influenza Hemagglutinin Fusion Peptide in
Micelles and Bilayers: Conformational Analysis of Peptide and Lipids.
J. Mol. Biol. 2005, 354, 1129−1141.
(750) Hung, H. M.; Hang, T. D.; Nguyen, M. T. Multiscale
Simulations on Conformational Dynamics and Membrane Inter-
actions of the Non-Structural 2 (Ns2) Transmembrane Domain.
Biochem. Biophys. Res. Commun. 2016, 478, 193−198.
(751) Hu, Y.; Patel, S. Thermodynamics of Cell-Penetrating Hiv1
Tat Peptide Insertion into Pc/Ps/Chol Model Bilayers through
Transmembrane Pores: The Roles of Cholesterol and Anionic Lipids.
Soft Matter 2016, 12, 6716−6727.
(752) Apellaniz, B.; Rujas, E.; Carravilla, P.; Requejo-Isidro, J.;
Huarte, N.; Domene, C.; Nieva, J. L. Cholesterol-Dependent
Membrane Fusion Induced by the Gp41 Membrane-Proximal
External Region-Transmembrane Domain Connection Suggests a
Mechanism for Broad Hiv-1 Neutralization. J. Virol. 2014, 88, 13367−
13377.
(753) Worch, R.; Krupa, J.; Filipek, A.; Szymaniec, A.; Setny, P.
Three Conserved C-Terminal Residues of Influenza Fusion Peptide
Alter Its Behavior at the Membrane Interface. Biochim. Biophys. Acta,
Gen. Subj. 2017, 1861, 97−105.
(754) Mavioso, I. C. V. C.; de Andrade, V. C. R.; Carvalho, A. J. P.;
do Canto, A. M. T. M. Molecular Dynamics Simulations of T-2410
and T-2429 Hiv Fusion Inhibitors Interacting with Model
Membranes: Insight into Peptide Behavior, Structure and Dynamics.
Biophys. Chem. 2017, 228, 69−80.
(755) Risselada, H. J. Membrane Fusion Stalks and Lipid Rafts: A
Love-Hate Relationship. Biophys. J. 2017, 112, 2475−2478.
(756) Victor, B. L.; Lousa, D.; Antunes, J. M.; Soares, C. M. Self-
Assembly Molecular Dynamics Simulations Shed Light into the
Interaction of the Influenza Fusion Peptide with a Membrane Bilayer.
J. Chem. Inf. Model. 2015, 55, 795−805.
(757) Ruiz-Herrero, T.; Hagan, M. F. Simulations Show That Virus
Assembly and Budding Are Facilitated by Membrane Microdomains.
Biophys. J. 2015, 108, 585−595.
(758) Hollingsworth, L. R.; Lemkul, J. A.; Bevan, D. R.; Brown, A.
M. Hiv-1 Env Gp41 Transmembrane Domain Dynamics Are
Modulated by Lipid, Water, and Ion Interactions. Biophys. J. 2018,
115, 84−94.
(759) de Oliveira Dos Santos Soares, R.; Bortot, L. O.; van der
Spoel, D.; Caliri, A. Membrane Vesiculation Induced by Proteins of
the Dengue Virus Envelope Studied by Molecular Dynamics
Simulations. J. Phys.: Condens. Matter 2017, 29, 504002.
(760) Rogers, D. M.; Kent, M. S.; Rempe, S. B. Molecular Basis of
Endosomal-Membrane Association for the Dengue Virus Envelope
Protein. Biochim. Biophys. Acta, Biomembr. 2015, 1848, 1041−1052.
(761) Chen, G. F.; Xu, T. H.; Yan, Y.; Zhou, Y. R.; Jiang, Y.;
Melcher, K.; Xu, H. E. Amyloid Beta: Structure, Biology and
Structure-Based Therapeutic Development. Acta Pharmacol. Sin.
2017, 38, 1205−1235.
(762) Barrett, P. J.; Song, Y. L.; Van Horn, W. D.; Hustedt, E. J.;
Schafer, J. M.; Hadziselimovic, A.; Beel, A. J.; Sanders, C. R. The
Amyloid Precursor Protein Has a Flexible Transmembrane Domain
and Binds Cholesterol. Science 2012, 336, 1168−1171.
(763) Panahi, A.; Bandara, A.; Pantelopulos, G. A.; Dominguez, L.;
Straub, J. E. Specific Binding of Cholesterol to C99 Domain of
Amyloid Precursor Protein Depends Critically on Charge State of
Protein. J. Phys. Chem. Lett. 2016, 7, 3535−3541.
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00451
Chem. Rev. XXXX, XXX, XXX−XXX
BS
(764) Nierzwicki, L.; Czub, J. Specific Binding of Cholesterol to the
Amyloid Precursor Protein: Structure of the Complex and Driving
Forces Characterized in Molecular Detail. J. Phys. Chem. Lett. 2015, 6,
784−790.
(765) Di Scala, C.; Troadec, J. D.; Lelievre, C.; Garmy, N.; Fantini,
J.; Chahinian, H. Mechanism of Cholesterol-Assisted Oligomeric
Channel Formation by a Short Alzheimer Beta-Amyloid Peptide. J.
Neurochem. 2014, 128, 186−195.
(766) Di Scala, C.; Yahi, N.; Lelievre, C.; Garmy, N.; Chahinian, H.;
Fantini, J. Biochemical Identification of a Linear Cholesterol-Binding
Domain within Alzheimer’s Beta Amyloid Peptide. ACS Chem.
Neurosci. 2013, 4, 509−517.
(767) Lockhart, C.; Klimov, D. K. Cholesterol Changes the
Mechanisms of a Beta Peptide Binding to the Dmpc Bilayer. J.
Chem. Inf. Model. 2017, 57, 2554−2565.
(768) Song, Y. L.; Hustedt, E. J.; Brandon, S.; Sanders, C. R.
Competition between Homodimerization and Cholesterol Binding to
the C99 Domain of the Amyloid Precursor Protein. Biochemistry
2013, 52, 5051−5064.
(769) Yan, Y.; Xu, T. H.; Harikumar, K. G.; Miller, L. J.; Melcher,
K.; Xu, H. E. Dimerization of the Transmembrane Domain of
Amyloid Precursor Protein Is Determined by Residues around the
Gamma - Secretase Cleavage Sites. J. Biol. Chem. 2017, 292, 15826−
15837.
(770) Lu, J. X.; Yau, W. M.; Tycko, R. Evidence from Solid-State
Nmr for Nonhelical Conformations in the Transmembrane Domain
of the Amyloid Precursor Protein. Biophys. J. 2011, 100, 711−719.
(771) Song, Y.; Mittendorf, K. F.; Lu, Z.; Sanders, C. R. Impact of
Bilayer Lipid Composition on the Structure and Topology of the
Transmembrane Amyloid Precursor C99 Protein. J. Am. Chem. Soc.
2014, 136, 4093−4096.
(772) Dominguez, L.; Foster, L.; Meredith, S. C.; Straub, J. E.;
Thirumalai, D. Structural Heterogeneity in Transmembrane Amyloid
Precursor Protein Homodimer Is a Consequence of Environmental
Selection. J. Am. Chem. Soc. 2014, 136, 9619−9626.
(773) Dominguez, L.; Meredith, S. C.; Straub, J. E.; Thirumalai, D.
Transmembrane Fragment Structures of Amyloid Precursor Protein
Depend on Membrane Surface Curvature. J. Am. Chem. Soc. 2014,
136, 854−857.
(774) Lemmin, T.; Dimitrov, M.; Fraering, P. C.; Dal Peraro, M.
Perturbations of the Straight Transmembrane Alpha-Helical Structure
of the Amyloid Precursor Protein Affect Its Processing by Gamma-
Secretase. J. Biol. Chem. 2014, 289, 6763−6774.
(775) Dominguez, L.; Foster, L.; Straub, J. E.; Thirumalai, D. Impact
of Membrane Lipid Composition on the Structure and Stability of the
Transmembrane Domain of Amyloid Precursor Protein. Proc. Natl.
Acad. Sci. U. S. A. 2016, 113, E5281−E5287.
(776) Pantelopulos, G. A.; Straub, J. E.; Thirumalai, D.; Sugita, Y.
Structure of App-C991−99 and Implications for Role of Extra-
Membrane Domains in Function and Oligomerization. Biochim.
Biophys. Acta, Biomembr. 2018, 1860, 1698−1708.
(777) Sun, F.; Chen, L.; Wei, P.; Chai, M.; Ding, X.; Xu, L.; Luo, S.
Z. Dimerization and Structural Stability of Amyloid Precursor
Proteins Affected by the Membrane Microenvironments. J. Chem.
Inf. Model. 2017, 57, 1375−1387.
(778) Audagnotto, M.; Lemmin, T.; Barducci, A.; Dal Peraro, M.
Effect of the Synaptic Plasma Membrane on the Stability of the
Amyloid Precursor Protein Homodimer. J. Phys. Chem. Lett. 2016, 7,
3572−3578.
(779) Audagnotto, M.; Lorkowski, A. K.; Dal Peraro, M.
Recruitment of the Amyloid Precursor Protein by Gamma-Secretase
at the Synaptic Plasma Membrane. Biochem. Biophys. Res. Commun.
2018, 498, 334−341.
(780) Bai, X. C.; Yan, C.; Yang, G.; Lu, P.; Ma, D.; Sun, L.; Zhou, R.;
Scheres, S. H. W.; Shi, Y. An Atomic Structure of Human Gamma-
Secretase. Nature 2015, 525, 212−217.
(781) Kong, R.; Chang, S.; Xia, W. M.; Wong, S. T. C. Molecular
Dynamics Simulation Study Reveals Potential Substrate Entry Path
into Gamma-Secretase/Presenilin-1. J. Struct. Biol. 2015, 191, 120−
129.
(782) MacKenzie, K. R.; Prestegard, J. H.; Engelman, D. M. A
Transmembrane Helix Dimer: Structure and Implications. Science
1997, 276, 131−133.
(783) Trenker, R.; Call, M. E.; Call, M. J. Crystal Structure of the
Glycophorin a Transmembrane Dimer in Lipidic Cubic Phase. J. Am.
Chem. Soc. 2015, 137, 15676−15679.
(784) Smith, S. O.; Eilers, M.; Song, D.; Crocker, E.; Ying, W. W.;
Groesbeek, M.; Metz, G.; Ziliox, M.; Aimoto, S. Implications of
Threonine Hydrogen Bonding in the Glycophorin a Transmembrane
Helix Dimer. Biophys. J. 2002, 82, 2476−2486.
(785) Fleming, K. G.; Engelman, D. M. Specificity in Trans-
membrane Helix-Helix Interactions Can Define a Hierarchy of
Stability for Sequence Variants. Proc. Natl. Acad. Sci. U. S. A. 2001, 98,
14340−14344.
(786) Wassenaar, T. A.; Pluhackova, K.; Moussatova, A.; Sengupta,
D.; Marrink, S. J.; Tieleman, D. P.; Bockmann, R. A. High-
Throughput Simulations of Dimer and Trimer Assembly of
Membrane Proteins. The Daft Approach. J. Chem. Theory Comput.
2015, 11, 2278−2291.
(787) Domanski, J.; Sansom, M. S. P.; Stansfeld, P. J.; Best, R. B.
Balancing Force Field Protein-Lipid Interactions to Capture Trans-
membrane Helix-Helix Association. J. Chem. Theory Comput. 2018,
14, 1706−1715.
(788) Cybulski, L. E.; Ballering, J.; Moussatova, A.; Inda, M. E.;
Vazquez, D. B.; Wassenaar, T. A.; de Mendoza, D.; Tieleman, D. P.;
Killian, J. A. Activation of the Bacterial Thermosensor Desk Involves a
Serine Zipper Dimerization Motif That Is Modulated by Bilayer
Thickness. Proc. Natl. Acad. Sci. U. S. A. 2015, 112, 6353−6358.
(789) Covino, R.; Ballweg, S.; Stordeur, C.; Michaelis, J. B.; Puth,
K.; Wernig, F.; Bahrami, A.; Ernst, A. M.; Hummer, G.; Ernst, R. A
Eukaryotic Sensor for Membrane Lipid Saturation. Mol. Cell 2016, 63,
49−59.
(790) Zhou, K.; Dichlberger, A.; Martinez-Seara, H.; Nyholm, T. K.
M.; Li, S.; Kim, Y. A.; Vattulainen, I.; Ikonen, E.; Blom, T. A
Ceramide-Regulated Element in the Late Endosomal Protein
Laptm4b Controls Amino Acid Transporter Interaction. ACS Cent.
Sci. 2018, 4, 548−558.
(791) Blom, T.; Li, S. Q.; Dichlberger, A.; Back, N.; Kim, Y. A.;
Loizides-Mangold, U.; Riezman, H.; Bittman, R.; Ikonen, E. Laptm4b
Facilitates Late Endosomal Ceramide Export to Control Cell Death
Pathways. Nat. Chem. Biol. 2015, 11, 799−806.
(792) Venter, H.; Mowla, R.; Ohene-Agyei, T.; Ma, S. T. Rnd-Type
Drug Efflux Pumps from Gram-Negative Bacteria: Molecular
Mechanism and Inhibition. Front. Microbiol. 2015, 6, 377.
(793) Travers, T.; Wang, K. J.; Lopez, C. A.; Gnanakaran, S.
Sequence- and Structure-Based Computational Analyses of Gram-
Negative Tripartite Efflux Pumps in the Context of Bacterial
Membranes. Res. Microbiol. 2018, 169, 414−424.
(794) Du, D.; Wang, Z.; James, N. R.; Voss, J. E.; Klimont, E.;
Ohene-Agyei, T.; Venter, H.; Chiu, W.; Luisi, B. F. Structure of the
Acrab-Tolc Multidrug Efflux Pump. Nature 2014, 509, 512−515.
(795) Vargiu, A. V.; Ramaswamy, V. K.; Malloci, G.; Malvacio, I.;
Atzori, A.; Ruggerone, P. Computer Simulations of the Activity of
Rnd Efflux Pumps. Res. Microbiol. 2018, 169, 384−392.
(796) Schuldiner, S. Emre, a Model for Studying Evolution and
Mechanism of Ion-Coupled Transporters. Biochim. Biophys. Acta,
Proteins Proteomics 2009, 1794, 748−762.
(797) Nathoo, S.; Litzenberger, J. K.; Bay, D. C.; Turner, R. J.;
Prenner, E. J. Visualizing a Multidrug Resistance Protein, Emre, with
Major Bacterial Lipids Using Brewster Angle Microscopy. Chem. Phys.
Lipids 2013, 167, 33−42.
(798) Dutta, S.; Morrison, E. A.; Henzler-Wildman, K. A. Emre
Dimerization Depends on Membrane Environment. Biochim. Biophys.
Acta, Biomembr. 2014, 1838, 1817−1822.
(799) Banigan, J. R.; Leninger, M.; Her, A. S.; Traaseth, N. J.
Assessing Interactions between a Polytopic Membrane Protein and
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00451
Chem. Rev. XXXX, XXX, XXX−XXX
BT
Lipid Bilayers Using Differential Scanning Calorimetry and Solid-
State Nmr. J. Phys. Chem. B 2018, 122, 2314−2322.
(800) Padariya, M.; Kalathiya, U.; Baginski, M. Structural and
Dynamic Insights on the Emre Protein with Tpp(+) and Related
Substrates through Molecular Dynamics Simulations. Chem. Phys.
Lipids 2018, 212, 1−11.
(801) Shoshan-Barmatz, V.; Keinan, N.; Zaid, H. Uncovering the
Role of Vdac in the Regulation of Cell Life and Death. J. Bioenerg.
Biomembr. 2008, 40, 183−191.
(802) Zaid, H.; Abu-Hamad, S.; Israelson, A.; Nathan, I.; Shoshan-
Barmatz, V. The Voltage-Dependent Anion Channel-1 Modulates
Apoptotic Cell Death. Cell Death Differ. 2005, 12, 751−760.
(803) Hiller, S.; Garces, R. G.; Malia, T. J.; Orekhov, V. Y.;
Colombini, M.; Wagner, G. Solution Structure of the Integral Human
Membrane Protein Vdac-1 in Detergent Micelles. Science 2008, 321,
1206−1210.
(804) Ujwal, R.; Cascio, D.; Colletier, J. P.; Faham, S.; Zhang, J.;
Toro, L.; Ping, P. P.; Abramson, J. The Crystal Structure of Mouse
Vdac1 at 2.3 Angstrom Resolution Reveals Mechanistic Insights into
Metabolite Gating. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 17742−
17747.
(805) Bayrhuber, M.; Meins, T.; Habeck, M.; Becker, S.; Giller, K.;
Villinger, S.; Vonrhein, C.; Griesinger, C.; Zweckstetter, M.; Zeth, K.
Structure of the Human Voltage-Dependent Anion Channel. Proc.
Natl. Acad. Sci. U. S. A. 2008, 105, 15370−15375.
(806) Rostovtseva, T. K.; Bezrukov, S. M. Vdac Regulation: Role of
Cytosolic Proteins and Mitochondrial Lipids. J. Bioenerg. Biomembr.
2008, 40, 163−170.
(807) Villinger, S.; Briones, R.; Giller, K.; Zachariae, U.; Lange, A.;
de Groot, B. L.; Griesinger, C.; Becker, S.; Zweckstetter, M.
Functional Dynamics in the Voltage-Dependent Anion Channel.
Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 22546−22551.
(808) Weiser, B. P.; Salari, R.; Eckenhoff, R. G.; Brannigan, G.
Computational Investigation of Cholesterol Binding Sites on
Mitochondrial Vdac. J. Phys. Chem. B 2014, 118, 9852−9860.
(809) Eddy, M. T.; Ong, T. C.; Clark, L.; Teijido, O.; van der Wel,
P. C. A.; Garces, R.; Wagner, G.; Rostovtseva, T. K.; Griffin, R. G.
Lipid Dynamics and Protein-Lipid Interactions in 2d Crystals Formed
with the Beta-Barrel Integral Membrane Protein Vdac1. J. Am. Chem.
Soc. 2012, 134, 6375−6387.
(810) Mlayeh, L.; Chatkaew, S.; Leonetti, M.; Homble, F.
Modulation of Plant Mitochondrial Vdac by Phytosterols. Biophys. J.
2010, 99, 2097−2106.
(811) Mlayeh, L.; Krammer, E. M.; Leonetti, M.; Prevost, M.;
Homble, F. The Mitochondrial Vdac of Bean Seeds Recruits
Phosphatidylethanolamine Lipids for Its Proper Functioning. Biochim.
Biophys. Acta, Bioenerg. 2017, 1858, 786−794.
(812) Young, J. A. T.; Collier, R. J. Anthrax Toxin: Receptor
Binding, Internalization, Pore Formation, and Translocation. Annu.
Rev. Biochem. 2007, 76, 243−265.
(813) Kalu, N.; Atsmon-Raz, Y.; Momben Abolfath, S.; Lucas, L.;
Kenney, C.; Leppla, S. H.; Tieleman, D. P.; Nestorovich, E. M. Effect
of Late Endosomal Dobmp Lipid and Traditional Model Lipids of
Electrophysiology on the Anthrax Toxin Channel Activity. Biochim.
Biophys. Acta, Biomembr. 2018, 1860, 2192−2203.
(814) Berube, B. J.; Wardenburg, J. B. Staphylococcus Aureus Alpha-
Toxin: Nearly a Century of Intrigue. Toxins 2013, 5, 1140−1166.
(815) Guros, N. B.; Balijepalli, A.; Klauda, J. B. The Role of Lipid
Interactions in Simulations of the Alpha-Hemolysin Ion-Channel-
Forming Toxin. Biophys. J. 2018, 115, 1720−1730.
(816) Tanaka, K.; Caaveiro, J. M. M.; Morante, K.; Gonzalez-Manas,
J. M.; Tsumoto, K. Structural Basis for Self-Assembly of a Cytolytic
Pore Lined by Protein and Lipid. Nat. Commun. 2015, 6.
DOI: 10.1038/ncomms7337
(817) Mesa-Galloso, H.; Delgado-Magnero, K. H.; Cabezas, S.;
Lopez-Castilla, A.; Hernandez-Gonzalez, J. E.; Pedrera, L.; Alvarez,
C.; Tieleman, D. P.; Garcia-Saez, A. J.; Lanio, M. E.; et al. Disrupting
a Key Hydrophobic Pair in the Oligomerization Interface of the
Actinoporins Impairs Their Pore-Forming Activity. Protein Sci. 2017,
26, 550−565.
(818) Ermakova, E.; Kurbanov, R.; Zuev, Y. Coarse-Grained
Molecular Dynamics of Membrane Semitoroidal Pore Formation in
Model Lipid-Peptide Systems. J. Mol. Graphics Modell. 2019, 87, 1−
10.
(819) Zimmerman, B.; Kelly, B.; McMillan, B. J.; Seegar, T. C. M.;
Dror, R. O.; Kruse, A. C.; Blacklow, S. C. Crystal Structure of a Full-
Length Human Tetraspanin Reveals a Cholesterol-Binding Pocket.
Cell 2016, 167, 1041−1051.
(820) Manat, G.; Roure, S.; Auger, R.; Bouhss, A.; Barreteau, H.;
Mengin-Lecreulx, D.; Touze, T. Deciphering the Metabolism of
Undecaprenyl-Phosphate: The Bacterial Cell-Wall Unit Carrier at the
Membrane Frontier. Microb. Drug Resist. 2014, 20, 199−214.
(821) Chang, H. Y.; Chou, C. C.; Hsu, M. F.; Wang, A. H. Proposed
Carrier Lipid-Binding Site of Undecaprenyl Pyrophosphate Phospha-
tase from Escherichia Coli. J. Biol. Chem. 2014, 289, 18719−18735.
(822) Van Eerden, F. J.; Melo, M. N.; Frederix, P.; Marrink, S. J.
Prediction of Thylakoid Lipid Binding Sites on Photosystem Ii.
Biophys. J. 2017, 113, 2669−2681.
(823) Van Eerden, F. J.; Melo, M. N.; Frederix, P. W. J. M.; Periole,
X.; Marrink, S. J. Exchange Pathways of Plastoquinone and
Plastoquinol in the Photosystem Ii Complex. Nat. Commun. 2017,
8, 15214.
(824) Rapoport, T. A.; Li, L.; Park, E. Structural and Mechanistic
Insights into Protein Translocation. Annu. Rev. Cell Dev. Biol. 2017,
33, 369−390.
(825) Knyazev, D. G.; Kuttner, R.; Zimmermann, M.; Sobakinskaya,
E.; Pohl, P. Driving Forces of Translocation through Bacterial
Translocon Secyeg. J. Membr. Biol. 2018, 251, 329−343.
(826) Corey, R. A.; Pyle, E.; Allen, W. J.; Watkins, D. W.; Casiraghi,
M.; Miroux, B.; Arechaga, I.; Politis, A.; Collinson, I. Specific
Cardiolipin-Secy Interactions Are Required for Proton-Motive Force
Stimulation of Protein Secretion. Proc. Natl. Acad. Sci. U. S. A. 2018,
115, 7967−7972.
(827) Dalbey, R. E.; Kuhn, A.; Zhu, L.; Kiefer, D. The Membrane
Insertase Yidc. Biochim. Biophys. Acta, Mol. Cell Res. 2014, 1843,
1489−1496.
(828) Chen, Y.; Capponi, S.; Zhu, L.; Gellenbeck, P.; Freites, J. A.;
White, S. H.; Dalbey, R. E. Yidc Insertase of Escherichia Coli: Water
Accessibility and Membrane Shaping. Structure 2017, 25, 1403−1414.
(829) Zhang, B.; Miller, T. F. Long-Timescale Dynamics and
Regulation of Sec-Facilitated Protein Translocation. Cell Rep. 2012, 2,
927−937.
(830) Marshall, S. S.; Niesen, M. J. M.; Muller, A.; Tiemann, K.;
Saladi, S. M.; Galimidi, R. P.; Zhang, B.; Clemons, W. M.; Miller, T. F.
A Link between Integral Membrane Protein Expression and Simulated
Integration Efficiency. Cell Rep. 2016, 16, 2169−2177.
(831) Van Lehn, R. C.; Zhang, B.; Miller, T. F., 3rd. Regulation of
Multispanning Membrane Protein Topology Via Post-Translational
Annealing. eLife 2015, 4, No. e08697.
(832) Niesen, M. J. M.; Wang, C. Y.; Van Lehn, R. C.; Miller TF, I.
I. I. Structurally Detailed Coarse-Grained Model for Sec-Facilitated
Co-Translational Protein Translocation and Membrane Integration.
PLoS Comput. Biol. 2017, 13, e1005427.
(833) Fathizadeh, A.; Elber, R. A Mixed Alchemical and Equilibrium
Dynamics to Simulate Heterogeneous Dense Fluids: Illustrations for
Lennard-Jones Mixtures and Phospholipid Membranes. J. Chem. Phys.
2018, 149, 072325.
(834) Wan, C. K.; Han, W.; Wu, Y. D. Parameterization of Pace
Force Field for Membrane Environment and Simulation of Helical
Peptides and Helix-Helix Association. J. Chem. Theory Comput. 2012,
8, 300−313.
(835) Wassenaar, T. A.; Ingolfsson, H. I.; Priess, M.; Marrink, S. J.;
Schafer, L. V. Mixing Martini: Electrostatic Coupling in Hybrid
Atomistic-Coarse-Grained Biomolecular Simulations. J. Phys. Chem. B
2013, 117, 3516−3530.
(836) Mardt, A.; Pasquali, L.; Wu, H.; Noe, F. Vampnets for Deep
Learning of Molecular Kinetics. Nat. Commun. 2018, 9, 5.
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00451
Chem. Rev. XXXX, XXX, XXX−XXX
BU
(837) Huang, J.; Rauscher, S.; Nawrocki, G.; Ran, T.; Feig, M.; de
Groot, B. L.; Grubmuller, H.; MacKerell, A. D. Charmm36m: An
Improved Force Field for Folded and Intrinsically Disordered
Proteins. Nat. Methods 2017, 14, 71−73.
(838) Hong, H.; Blois, T. M.; Cao, Z.; Bowie, J. U. Method to
Measure Strong Protein-Protein Interactions in Lipid Bilayers Using a
Steric Trap. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 19802−19807.
(839) Sandoval-Perez, A.; Pluhackova, K.; Bockmann, R. A. Critical
Comparison of Biomembrane Force Fields: Protein-Lipid Interactions
at the Membrane Interface. J. Chem. Theory Comput. 2017, 13, 2310−
2321.
(840) Petrov, D.; Zagrovic, B. Are Current Atomistic Force Fields
Accurate Enough to Study Proteins in Crowded Environments? PLoS
Comput. Biol. 2014, 10, e1003638.
(841) Javanainen, M.; Martinez-Seara, H.; Vattulainen, I. Excessive
Aggregation of Membrane Proteins in the Martini Model. PLoS One
2017, 12, e0187936.
(842) Fleming, K. G. Energetics of Membrane Protein Folding.
Annu. Rev. Biophys. 2014, 43, 233−255.
(843) Frisz, J. F.; Lou, K. Y.; Klitzing, H. A.; Hanafin, W. P.;
Lizunov, V.; Wilson, R. L.; Carpenter, K. J.; Kim, R.; Hutcheon, I. D.;
Zimmerberg, J.; et al. Direct Chemical Evidence for Sphingolipid
Domains in the Plasma Membranes of Fibroblasts. Proc. Natl. Acad.
Sci. U. S. A. 2013, 110, E613−E622.
(844) Lyman, E.; Hsieh, C. L.; Eggeling, C. From Dynamics to
Membrane Organization: Experimental Breakthroughs Occasion a
″Modeling Manifesto’’. Biophys. J. 2018, 115, 595−604.
(845) Dorr, J. M.; Scheidelaar, S.; Koorengevel, M. C.; Dominguez,
J. J.; Schafer, M.; van Walree, C. A.; Killian, J. A. The Styrene-Maleic
Acid Copolymer: A Versatile Tool in Membrane Research. Eur.
Biophys. J. 2016, 45, 3−21.
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00451
Chem. Rev. XXXX, XXX, XXX−XXX
BV
